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The hetrotetrameric microtubule motor protein, kinesin-1 plays a central role in 
the intracellular transport of protein, ribonuclear protein, vesicles and organelles 
on microtubules. Kinesin-1 is composed of two heavy (KHC) and two light 
chains (KLC). In the absence of cargo, kinesin-1 exists in an autoinhibited state 
where the C-terminal tail of a single heavy chain binds to the N-terminal motor 
domain. KLCs contribute to the maintenance of this regulated state although the 
mechanism is unknown.  Kinesin-1 is activated upon cargo binding. Cargo have 
been shown to bind to the tetratricopeptide repeat (TPR) domain of KLC and 
the C-terminal tail of KHC. KLCs recognise a short peptide sequence present in 
many cargo that is characterised by a tryptophan flanked by acidic residues (W-
acidic). The aim of this thesis was to further investigate these cargo recognition 
mechanisms with the goal of providing a framework for understanding the 
general principles of kinesin-1 cargo recognition and cargo dependent 
activation. This was pursued by attempting a detailed molecular dissection of 
the mechanism of recognition of lysosomal cargo adaptor SKIP which carries a 
pair of W-acidic motifs. In this thesis the crystal structure of the TPR domain of 
KLC2 in complex with a tryptophan-acidic motif derived from SKIP is presented 
and the key residues responsible for the interaction are identified. Further 
studies revealed a direct interaction between SKIP and a specific site on the C-
terminal tail of KHC. Mapping of the KHC binding site on SKIP revealed both 
shared and distinct determinants for the KHC and KLC interaction, and binding 
to either may be mutually exclusive. Mutational separation of the KHC and KLC 
binding enabled the investigation of this novel KHC-cargo interaction in SKIP 
mediated cargo transport. Based on these findings a model is proposed to 
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CHAPTER 1 . INTRODUCTION 
 
1.1 Cytoskeletal motors 
The cytoskeleton is composed of microtubules, actin filaments and intermediate 
filaments that interact to form a complex network which maintains cell shape, is 
involved in many cellular processes such as cell motility, endocytosis and 
cytokinesis and allows for the dynamic control over the spatial distribution of 
subcellular components. 
 There are three classes of cytoskeletal motors; myosin, dynein and 
kinesins. All cytoskeletal motors contain a motor domain (also called the head) 
that has one or more adenosine triphosphate (ATP) binding sites as well as a 
binding site for the actin filament or microtubule tract. Cytoskeletal motors utilise 
energy released from ATP hydrolysis to drive conformational changes which 
results in the production of force for movement. Myosin interacts with actin 
filaments, and dynein and kinesins interact with microtubules. Figure 1.1 shows 
a schematic of representative examples of these motor proteins.  
A subset of cytoskeletal motors actively transport intracellular cargo 
along cytoskeletal filaments to their appropriate destination. Unlike diffusion, 
this transport is independent of concentration and is also highly specific as it 
allows the transport of specific cargo to specific destinations. Transport by 
motors also allows for the directed movement and control of the positioning of 
larger subcellular components that would otherwise only travel very short 
distances by diffusion. How motor proteins are regulated and are able to 
transport cargo at the correct time to the correct location is an important 
biological question. Transported cargoes include proteins required for large 
macromolecular structures such as cilia and centrosomes, proteins involved in 
signaling, membrane bound organelles (e.g. nucleus, mitochondria), mRNAs, 
and cytoskeletal filaments (Vale, 2003). 
The cytoskeleton is a dynamic structure and remodeling of the 
cytoskeleton is required for cell migration as well as meiosis and mitosis. Motors 
are also involved in regulating cytoskeletal dynamics. For example kinesin-8, 
kinesin-13 and kinesin-14 family proteins function to destabilise microtubules 
(Gupta et al., 2006, Mayr et al., 2007, Varga et al., 2006, Endow et al., 1994, 












Figure 1.1.  Examples of motor proteins from three major superfamilies: 
kinesin-1, cytoplasmic dynein and myosin-V.  
Kinesin-1; dark purple: motor domains; purple: heavy chain cargo attachment 
site; green: kinesin light chains. Cytoplasmic dynein-1; blue: microtubule 
binding domains, dark purple and blue ring: six AAA+ domains, green: 
associated protein subunits (DLIC: Light intermediate chains, DIC: Intermediate 
chains, Tctex-1: Tctex-1/rp3 light chains, roadblock: roadblock light chains, LC8: 
LC8 light chains) Myosin V; dark purple: motor domain; blue an grey: extended 
α helical neck region  (ELC: essential light chain and calmodulin binding region) 
Purple: DIL (conserved ~100 residue C-terminal domain); green: LC8 light 




























The myosin superfamily consists of at least 35 classes (Odronitz and Kollmar, 
2007). With the exception of class VI myosins (Wells et al., 1999), all of the 
myosin classes studied thus far have been shown to move to the barbed end of 
actin filaments (Sweeney and Houdusse, 2010, Wells et al., 1999). Myosins 
move on actin filaments and are involved in a wide range of functions in cells 
such as cell adhesion, cell motility, movement of mRNA, movement of pigment 
granules, cytokinesis, endocytosis and exocytosis (Hammer and Sellers, 2012).  
The best characterised member of the myosin superfamily is muscle 
myosin II that forms part of the sarcomere with actin filaments and is required to 
generate force for muscle contraction. Most myosin heavy chains are 
composed of three domains; an N terminal motor domain that is responsible for 
ATP hydrolysis as well as actin binding, an extended α helical neck region 
containing one or more IQ motifs that bind light chains (calmodulin or other 
members of the E-F hand family of proteins) and a C-terminal tail which vary 
dependent on myosin class and is involved in cargo binding or dimerisation of 
heavy chains (Krendel and Mooseker, 2005). Movement is driven by ATPase 
activity of the motor domain, which hydrolyses ATP to ADP.Pi, which is 
subsequently released and exchanged for ATP (Rief et al., 2000). Upon ATP 
hydrolysis the myosin ‘lever arm’ undergoes a conformational change and 
bends the myosin head to a position further along the actin filament. Binding of 
the myosin head to the actin filament stimulates the release of Pi, which triggers 
a second conformational change and movement along the filament (power 
stroke). 
 Class V myosins are important in organelle transport (shown in Figure 
1.1). Myosin V carries intracellular cargo processively along actin tracks in a 
hand-over-hand manner alternating the positions of the leading and trailing 
heads, resembling the action of kinesin-1 along microtubules (Warshaw et al., 
2005). The step size was shown to be 36nm using optical trapping nanometry 
(Mehta et al., 1999). Electron microscopic images further showed myosin V 
molecules associated with actin with the two heads spaced 36 nm apart (Walker 
et al., 2000). The walking of myosin V along actin tracks were also visualised by 
high-speed atomic force microscopy (Kodera et al., 2010). Although the motor 
domains of myosin V and kinesin-1 share no sequence homology and have 
distinct motile (Svoboda et al., 1993, Walker et al., 2000) and enzymatic 
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properties (Bagshaw and Trentham, 1974, Hackney, 1988), structurally the 
catalytic domains are very similar (Kull et al., 1996). 
 
1.3 Dyneins 
The dynein family of motor proteins can be divided into two groups; axonemal 
and cytoplasmic. Cytoplasmic dyneins are important in cargo transport whereas 
axonemal dyneins function in driving the bending of cilia and flagella (Gibbons, 
1981, DiBella and King, 2001). Dynein 1B and dynein 2 are involved in 
intraflagellar transport, moving cargo along the axoneme to the cell body, 
whereas dynein-1 is the only dynein responsible for minus-end directed 
transport of diverse cargos on microtubules in the cytoplasm (Schroer et al., 
1989). Examples of cargo include organelles such as endosomes (Driskell et 
al., 2007), lysosomes (Jordens et al., 2001), and mitochondria (Pilling et al., 
2006), components of the centrosome (Young et al., 2000), transcription factors 
(Harrell et al., 2004), cytoskeletal filaments (Shah et al., 2000) and mRNA-
containing ribonucleoprotein complexes (Wilkie and Davis, 2001). 
Cytoplasmic dynein-1 is a homodimer consisting of two dynein heavy 
chains (DHC) each containing a C-terminal motor domain composed of six 
AAA+ (ATPases associated with diverse activities) modules (Neuwald et al., 
1999) referred to as AAA1-AAA6. AAA1 is the main site of ATP hydrolysis for 
force generation (Kon et al., 2004) and AAA2–AAA4 bind nucleotides and 
appear to be required for regulation (Cho et al., 2008). The C-terminal region of 
the heavy chain spans between AAA6 and the stalk base. The N-terminal, 
lever-like linker swings by approximately 17nm during the ATPase cycle 
between AAA2 and the stalk base allowing for the forward movement of the 
motor (Roberts et al., 2009). Dynein intermediate chains (DIC) dynein 
intermediate light chains (DLIC) and dimers of three light chains (LC); the 
Tctex1 light chains, the Roadblock light chains; and the LC8 light chains binds 
to DHC (Pfister et al., 2006). This is shown in Figure 1.1. 
Within cells cytoplasmic dynein interacts with several regulatory proteins 
that regulate its function and localisation.  Adaptors include dynactin, 
lissencephaly 1 (LIS1), nuclear distribution protein E (NudE) and NudE-like 
(NudEL), Bicaudal D, Rod–ZW10–Zwilch (RZZ) and Spindly (Kardon and Vale, 
2009). Dynactin is the best characterised of the adaptors and is a large multi-
subunit protein complex consisting of the following subunits: p150Glued, p62, 
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dynamintin (p50), Arp11, Arp1, β- actin, CapZ α/β, p24, p27 and p25 (Schroer, 
2004). Dynactin has a large range of functions including mitotic spindle 
assembly and organelle transport (Schroer, 2004). Dynactin was first identified 
as an activator of dynein mediated vesicle transport (Gill et al., 1991). More 
recently dynactin has been shown to enhance the initial recruitment of dynein 
onto microtubules and promotes processivity through functioning as a tether to 
microtubules and decreasing the detachment rate of dynein from microtubules 
(Ayloo et al., 2014, King and Schroer, 2000). 
Dynein mostly moves in 8nm steps although variable step sizes 8 - 32 nm 
have been observed (Mallik et al., 2004, Toba et al., 2006) as well as lateral 
and backward stepping (Reck-Peterson et al., 2006). 
 
1.4 Kinesin Superfamily 
The kinesin superfamily can be divided into 14 sub families (Lawrence et al., 
2004). Kinesins 1-3 generally function in cargo transport along microtubules 
and Kinesin 4-14 are thought to function predominantly in meiosis and mitosis 
(Verhey and Hammond, 2009). All kinesins contain a motor domain with an 
adenosine triphosphate (ATP) binding site that is coupled to a site that allows 
binding to microtubules. The location of the motor domain gives an indication of 
the direction of transport. In general kinesins with an amino-terminal motor 
domain undergo motility to the plus end of microtubules, which tend to be 
located in the cell periphery, whereas kinesins with a carboxy-terminal motor 
(Kinesin-14 family) undergo minus end-directed motility. When the motor 
domain is located in the center of the kinesin molecule (Kinesin-13 family), the 
kinesin functions to destabilize microtubules at their plus and minus ends 
(Hirokawa et al., 2009). There are however a few exceptions for example 
Kinesin-8 and Kinesin-14 families can both walk along and destabilize 
microtubules (Gupta et al., 2006, Mayr et al., 2007, Varga et al., 2006). Some 
kinesins for example kinesin-5 also undergo diffusion along the microtubule 
surface in an ATP-independent manner, which may allow the motor to stay 
microtubule associated for longer (Kwok et al., 2006). Kinesin-5 also functions 





Microtubules are polymers of alpha and beta tubulin heterodimers that 
assemble to form protofilaments. The hollow cylindrical microtubule usually 
consists of 13 protofiliments (Evans et al., 1985). Microtubules are intrinsically 
polar, with the end that exposes β-tubulin (plus end) growing more rapidly than 
the end that exposes α-tubulin (minus end). Typically, microtubule arrays are 
radial with the minus end anchored at the microtubule organising centre 
(MTOC) and the plus end pointing to the cell periphery. Mitotic cells however 
have two radial arrays giving rise to the bipolar mitotic spindle.  
The centrosome is the main MTOC in animal cells. The centrosome is 
made up of a central pair of centrioles surrounded by pericentriolar material 
(PCM). The main cellular nucleator of microtubules is the γ-tubulin ring complex 
(γ-TuRC) that localises to the MTOC and is composed of γ-tubulin and the γ-
tubulin complex components (GCPs) 2, 3, 4, 5 and 6. (Moritz et al., 1995, 
Teixido-Travesa et al., 2012, Zheng et al., 1995). The PCM contains proteins 
such as pericentrin and ninein that are involved in the nucleation as well as 
anchoring of microtubules (Azimzadeh and Bornens, 2007, Teixido-Travesa et 
al., 2012). Nucleation can also be associated with other sites such as the Golgi 
complex (Luders and Stearns, 2007, Miller et al., 2009, Rivero et al., 2009). 
Linear, non-centrosomal microtubule arrays are typical of polarized, non-
migratory cells such as epithelial cells, terminally differentiated neuronal cells 
and skeletal muscle fibres (myotubes) (Bartolini and Gundersen, 2006). 
GTP bound αβ-tubulin forms a stabilizing cap to the GDP lattice and 
allows for microtubule growth. As a new αβ-tubulin dimer is added to the 
protofilament the previous tubulin bound GTP is hydrolysed (David-Pfeuty et al., 
1977). Loss of the stabilizing cap through GTP hydrolysis leads to rapid 
depolymerisation, which is characterized by peeling of protofilaments (Carlier et 
al., 1984, Mitchison and Kirschner, 1984) (Figure 1.2). This is also called 
“catastrophe”. “Rescue” refers to the transition from shrinking to growing. 
Microtubules can rapidly switch between phases of growth and shrinkage. This 
switching of microtubules between cycles of growth and shrinkage is known as 
dynamic instability. Rapid turnover of microtubules is essential for the 
remodeling of the cytoskeleton that occurs during mitosis and cell migration. 
Although the amount of available tubulin is one of the key factors that determine 
the rate of microtubule growth and shrinkage, the dynamic properties of 
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microtubules are not solely explained through local tubulin concentration, many 
different regulatory proteins control the dynamics of microtubules. Microtubule-
associated proteins (MAPs) may function as stabilising proteins. For example 
end binding protein-1 (EB1) is a plus-end tracking protein (+TIPs) that stabilise 
the tubular conformation of microtubules through binding to the GTP cap 
(Maurer et al., 2012). Other proteins, such as kinesin-13 and kinesin-8, function 
to destabilise microtubules. Kinesin-13 promotes catastrophe through 
promoting the bending of protofilaments into an outward curved conformation 
(Moores et al., 2002, Newton et al., 2004). Kinesin-8 also promotes microtubule 
disassembly through depolymerisation at the plus end. Kinesin-8 also 
depolymerise longer microtubules faster than shorter ones (Varga et al., 2006).   
Microtubules undergo post translational modifications, which include 
tyrosination, acetylation, glutamylation glycalation, detyrosination, 
deacetylation, deglutamylation and deglycalation (Garnham and Roll-Mecak, 
2012). As well as regulating dynamics, post-translational modification can affect 
processivity, (Wang and Sheetz, 2000, Reed et al., 2006) recruitment 
(Hammond et al., 2010, Reed et al., 2006) and subcellular targeting (Ikegami et 





























Figure 1.2. Schematic of the cycle of microtubule polymerisation.  
The hollow cylindrical microtubule usually consists of 13 protofiliments. 
Microtubules are intrinsically polar, with the plus end growing more rapidly than 
the minus end. GTP bound αβ-tubulin forms a stabilizing cap to the GDP lattice 
and allows for microtubule growth. As a new αβ-tubulin dimer is added to the 
protofilament the previous tubulin bound GTP is hydrolysed. Loss of the 
stabilizing cap through GTP hydrolysis leads to rapid depolymerisation, which is 
characterized by peeling of protofilaments The switch from microtubule growth 
to shrinkage is referred to as “catastrophe” and the switch from shrinkage to 









Kinesin-1 (also known as conventional kinesin), was the first kinesin family 
motor to be discovered. It was first isolated from squid giant axons by virtue of 
its capacity to bind to microtubules in an ATP dependent manner (Vale et al., 
1985a) and was shown to exist predominantly as a heterotetramer of two heavy 
chains (KHC) and two light chains (KLC) (Hirokawa et al., 1989, Kuznetsov et 
al., 1988). Kinesin-1 plays a key role in the intracellular transport of proteins, 
nucleic acids and membrane bound organelles such as mitochondria and 
lysosomes along microtubules (Hirokawa et al., 2009). 
 
1.6.1 Kinesin heavy chains 
There are three mammalian genes that encode the kinesin-1 heavy chains; 
Kif5A, Kif5B and Kif5C. Kif5A and Kif5C are expressed in predominantly 
neuronal cells whereas Kif5B is ubiquitously expressed (Kanai et al., 2000, Xia 
et al., 1998). The kinesin heavy chains form a homodimer (DeBoer et al., 2008) 
consisting of two globular heads that are the sites of ATP hydrolysis and 
microtubule binding and functions as the motor domain, a region known as the 
neck links these to an extended alpha-helical coiled coil domain (stalk) and a C-
terminal tail region (Figure 1.3). The neck plays a crucial role in the mechanism 
of kinesin-1 movement on microtubules (discussed in 1.6.6). The C-terminal 
domain is important for cargo binding and interaction with the light chains. The 
KLC binding site has been mapped to residues 771-813 on Kif5B. Within this 
heavy chain region are four highly conserved heptad repeats that interact with 
the heptad repeat at the N-terminus of KLC (Diefenbach et al., 1998). The 
extreme C-terminus of KHC contains a highly conserved autoinhibitory region 
that contributes to regulation of the motor. 
 The C-terminal tail of KHC has been shown to also contain an ATP-
independent microtubule binding site (Hackney and Stock, 2000, Navone et al., 
1992, Yonekura et al., 2006). This binding site has been mapped to residues 
892-914 (Kif5B) with the interaction being mediated by largely complementary 
electrostatic interactions between the tail and microtubules (Seeger and Rice, 
2010). The function of this second microtubule binding site is not fully 
understood. There has been a variety of suggestions, for example Seeger and 
Rice suggests that if cargo binds to one tail peptide the free KHC tail could 
tether to or diffuse along microtubules and keep kinesin-1 in close contact, 
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enhancing the processivity of the motor. Dietrich et al., 2008 suggest that the 
function may be to pause the motor in an inactive autoinhibited state on 
microtubules and propose that the reason why inactive kinesin is not found to 
be microtubule bound may be due to regulatory proteins masking the tail-
microtubule interaction preventing kinesin-1 from binding to microtubules. The 
binding sites of several cargo also span this ATP-independent microtubule 
binding region. Thus, the C-terminal tail of KHC is likely crucial in coordinating 
cargo binding and kinesin-1 activity. 
The majority of KHC exists in complex with KLC, however a proportion of 
KHC in mammalian cells has been reported to exist without KLC (DeLuca et al., 
2001). Roughly 50% of KHC in CV-1 cells were shown to exist without KLC and 
approximately 14% of KHC in mouse brain extracts lacks KLC (Sun et al., 2011, 
Gyoeva et al., 2004). KLC could also not be detected within photoreceptors 
(Mavlyutov et al., 2002). This KLC free component may have specific cargo 
transport functions. KLC independent transport has been demonstrated in the 
transport of mitochondria where KLC antagonises the binding of the cargo 
adaptor Milton to the heavy chain. Binding of KLC and Milton appear to be 
mutually exclusive (Glater et al., 2006, Cai et al., 2005). Cytoplasmic streaming 
and mRNA localisation to the posterior pole of the Drosophila oocyte is also 
























Figure 1.3. Schematic of Kinesin-1. 
Top: The three kinesin heavy chains (KHC) are shown in purple Kif5A, Kif5B 
and Kif5C with the motor domain and coiled coil (CC) region highlighted as well 
as the autoinhibitory IAK sequence. The four kinesin light chains (KLC) are 
shown in orange with the coiled-coil heptad repeat region as well as the TPR 
domain highlighted. Bottom: Schematic of kinesin-1 showing the make-up of the 
kinesin-1 tetramer. Kinesin-1 consists of two heavy chains and two light chains. 
The heptad repeat region of KHC interacts with the heptad repeat at the N-
terminus of KLC. The motor domain, neck, hinge, coiled coil stalk regions (1 
and 2) as well as the C-terminal tail of KHC highlighted as well as the 
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Figure 1.4 Structural alignment of KLC1-TPR domain with TPR domains of 
HOP1 and p67phox showing multiple modes of cargo binding. 
(A) KLC1-TPR domain (PDB: 3CEQ) (orange) (B) KLC1-TPR domain (orange) 
is aligned with the p67phox TPR domain (blue) in complex with Rac1 (Yellow) 
(PDB:1E96) using PyMOL align function illustrating the similar interface on the 
outer surface of KLC1 to p67phox. (C) KLC1-TPR domain (orange) is aligned 
with the HOP1 TPR domain (blue) in complex with Hsc70 peptide (green) 
(PDB:1ELW) using PyMOL align function illustrating the similar interface of 







1.6.2 Kinesin Light Chains 
The kinesin-1 light chains are encoded by 4 genes in mammalian cells (KLC1, 
KLC2, KLC3 and KLC4) which, like the heavy chains have distinct tissue 
expression profiles. KLC1 is expressed mainly in neuronal cells, KLC2 is 
expressed ubiquitously and KLC3 is expressed within spermatids. (Rahman et 
al., 1998, Junco et al., 2001) KLC4 has not yet been characterized, although all 
four types are expressed in HeLa (Maliga et al., 2013). 
Initially, immunoprecipitation analysis suggested that KLC (KLC1 or 
KLC2) forms homodimers (Gyoeva et al., 2004) that associate with KHC (Kif5A, 
Kif5B or Kif5C) homodimers, but do not show a clear specificity for a particular 
heavy chain (DeBoer et al., 2008). Maliga et al., 2013 however demonstrated 
by combining BAC transgenomics with the sensitivity of affinity purification mass 
spectrometry (AP-MS) that KLCs can form asymmetric motor complexes in 
HeLa cells with mixed light chains, suggesting that there may be a large array 
of kinesin-1 forms possible in mammalian cells. The variability in the light chain 
may enhance functional diversity and allow multiple types of cargo to be 
transported. Within the KLC binding region of KHC are heptad repeats that 
interact with the heptad repeat containing N-terminus of KLC. Since all of the 
KLCs interact within this same region, if two of the same KLCs were to bind, 
other regulatory factors would be necessary to ensure specific recognition and 
binding of two of the same KLCs. One possibility of how this may occur is if 
kinesin-1 is assembled cotranslationally, homodimerising before binding to 
KHC.  
Kinesin light chains (KLC) can be divided into three domains; a well 
conserved N-terminal region that contains a coiled-coil (heptad repeat) and 
binds to KHC (Diefenbach et al., 1998), a conserved tetratricopeptide repeat 
(TPR) domain and a variable C-terminal domain that both play a role in cargo 
binding. Cargo can interact directly with the KLC TPR domain to mediate 
transport. Alternative splicing within the C-terminal domain of KLC1 results in 
the expression of various KLC isoforms (McCart et al., 2003). The KLC isoforms 
have been shown to have differential association with the Golgi apparatus, 
mitochondria and rough endoplasmic reticulum. The C-terminal region of KLC 
was therefore suggested to play a role in targeting kinesin-1 to different cellular 




1.6.3 TPR domains 
A TPR domain consists of a tandem array of TPR motifs  (two anti-parallel α-
helices composed of 34 amino acids residues) typically forming a structure with 
an amphipathic groove that can bind target peptides and proteins. TPR 
domains have been identified that consist of between 3–16 TPR motifs 
(D'Andrea and Regan, 2003). KLC is composed of 5 or 6 illustrated in Figure 
1.3. 
Proteins have been shown to bind to various regions of TPR domains. 
The C-terminal residues of the Hsp90 chaperone have been shown to bind in 
an extended conformation to the concave groove of the protein phosphatase 5 
(Ppp5) TPR domain (Cliff et al., 2006), as well as the TPR2A domain of HOP1 
(Scheufler et al., 2000). The C-terminal residues of the Hsp70 chaperone also 
binds in an extended conformation to the concave groove of the HOP1 TPR1 
domain. In all three cases a ‘‘carboxylate clamp’’ in the inner groove of the TPR 
domain is utilised to interact with the C-terminal residues of Hsp90 and Hsp70 
respectively. The peroxisomal targeting signal-1 was also shown to bind in an 
extended conformation to the TPR domains of human PEX5 (Gatto et al., 
2000). The loop regions that connect the helices in a TPR bundle have also 
been shown to mediate the association with cargo proteins. For example the 
structure of the TPR domain of p67phox in complex with Rac.GTP revealed that 
Rac.GTP is recognized through the loops connecting the TPR repeats 
(Lapouge et al., 2000). The structural alignment of KLC1 TPR domain with 
p67phox as well as HOP1 illustrates a similar interface on the outer surface to 
p67phox a well as a similar interface on the inner groove to HOP1, suggesting 
that recognition of cargo by the KLC TPR domain is therefore likely to be highly 
varied (Figure 1.4). 
 
1.6.4 Cargo binding by kinesin-1 
1.6.4.1 KHC: Cargo interaction 
Kinesin-1 transports a large array of proteins, membrane-bound organelles 
such as vesicles, mitochondria, lysosomes and the nucleus. Many proteins that 
interact with kinesin-1 function as adaptors to other proteins and organelles. 
The binding sites for several cargo have been mapped to the C-terminal tail of 
KHC. Ong et al. showed through yeast two-hybrid assays that the C-terminus of 
the endoplasmic reticulum membrane protein, Kinectin interacted directly with 
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the C-terminal tail of KHC (residues 836-890 of Kif5A and residues 833-900 of 
Kif5B). Kinectin is an anchor for kinesin-dependent organelle motility in vivo 
(Ong et al., 2000). Another KHC binding partner has been reported to be 
Myosin Va. In a yeast two-hybrid assay Kif5B residues 763-856 were shown to 
interact with Myosin Va (Huang et al., 1999).  
The tail domains of Kif5B and Kif5C, but not Kif5A, were shown to 
interact directly in vivo with Ran-binding protein 2 (RanBP2) (Cai et al., 2001). A 
connecting segment between the Ran GTPase binding domains, RBD2 and 
RBD3, termed JX2 in RanBP2 were shown to be responsible for the interaction 
with KHC.  The molecular determinants of this specific interaction were further 
assessed by Cho et al. They showed that RanBP2 specifically interacts with 
Kif5C (827-936) and equivalent Kif5B region but does not interact with Kif5A. 
Through making M912S mutation unique to Kif5C (and equivalent on Kif5B) 
binding was lost. M912 was therefore identified as the residue that determines 
which Kif5 RanBP2 is able to bind to (Cho et al., 2007).  
Through yeast two-hybrid assays, the N-terminus of the SNARE proteins 
synaptosome associated protein 23 and 25 (SNAP23 and SNAP25) were also 
shown to interact directly with the C-terminal tail of Kif5B (residues 814-907). 
The heptad repeat region of SNAP23 and SNAP25 (residues 45-84 SNAP 25 
numbering) is likely to be the minimal binding region (Diefenbach et al., 2002a).  
Diefenbach et al. also showed using the same method, the interaction of Kif5B 
(residues 867-894) with the C-terminal RNA binding domain of HSV-1 tegument 
protein US11. The KHC:US11 interaction is suggested to have a major role in 
the anterograde transport of unenvoloped HSV nucleocapsids (Diefenbach et 
al., 2002b).  
Through yeast two-hybrid as well as immunoprecipitation assays, γ-
aminobutyric acid, type A (GABAA) receptor interacting factor-1 (GRIF-1) 
(residues 124-283) were shown to interact with Kif5C (Brickley et al., 2005). 
Smith et al further showed through immunoprecipitation as well as yeast two-
hybrid studies that GRIF-1 interacts with the C-terminal region of Kif5C 
(residues 827-957).  Through confocal imaging strategies GRIF-1 was shown to 
bind to Kif5C as well as the tetrameric kinesin-1 (Smith et al., 2006). Both 
TRAK1 (also called OIP106/MILTON1) and TRAK2 (also called GRIF-1/OIP98 
or Milt2) were shown to co-immunoprecipitate with Kif5C. The interactions were 
also verified through Förster resonance energy transfer (FRET) studies 
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(Brickley et al., 2011). Randall et al. further refined the binding region and 
showed that TRAK2 binding to Kif5A is dependent on multiple binding regions. 
TRAK2 has been shown to bind to Kif5A residues (942-961), (877-885) and 
(861-877) (Randall et al., 2013). TRAK2 is also shown to bind to the Kif5A 
equivalent region on Kif5C. TRAK1 however retained the ability to co-
immunoprecipitate Kif5A in the absence of the cargo binding domains identified 
for TRAK2. The stalk and tail regions of Kif5A, Kif5B and Kif5C were also 
shown to interact directly with the alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionate (AMPA) receptor subunit-GluR2-interacting protein GRIP-1 
(Setou et al., 2002). Dystrobrevin is another example of a scaffold protein that 
was shown to bind to the C-terminal tail of Kif5A through pull-down and co-
immunoprecipitation experiments (Macioce et al., 2003, Ceccarini et al., 2005). 
Kv3.1 N-terminal T1 tetramers, but not monomers, directly bind to Kif5 tail 
residues (Kif5A 863-932, Kif5B 865-934 also termed the T70 region) (Xu et al., 
2010). The Kv3.1 T1 binding site was further mapped to residues 875-919 
(Kif5B) (Barry et al., 2013). Barry et al. also shows basic amino acid residues at 
positions 892-894 (RKR) to be essential for the interaction. No binding is 
however observed when the binding site is further truncated at either end to 
870–896, 875–896 or 892–912, or through truncation and removal of the RKR 
sequence (865–891, 865–886, 913–934, 897–934, and 902–934).  
The AnkG-binding site in the Kif5 motor is the T70 region, the exact same 
binding site for the Kv3.1 T1 domain. Mutation of residues 892-894; RKR to 
DDD did not pull down AnkG MB (the N-terminal membrane-binding domain of 
AnkG that contains 24 ankyrin repeats) domain. Smaller fragments of Kif5B also 
did not bind, suggesting a large region consisting of multiple binding sites is 
required for AnkG binding as for the Kv3.1 T1 domain (Barry et al., 2014). 
Through yeast two-hybrid analysis UNC-76 was shown to bind to 
residues 850–975 of Drosophila KHC tail domain (Gindhart et al., 2003). FEZ1, 
the mammalian homologue of UNC-76, was also shown to bind to the C-
terminal tail of KHC residues 750-955. Deletion of the inhibitory region and 
surrounding residues results in loss of binding to residues 750-910. Mutation of 
residues 908-917 or 947-955 to alanine abolished binding (Blasius et al., 2007). 
A direct interaction between the C-terminal tail of KHC and JIP3 was 
shown in vitro through a GST pulldown of GST tagged Kif5C residues 807–956 
and His tagged JIP3 (Sun et al., 2011). Thus, research over many years has 
29 
 
highlighted the importance of the C-terminal region of KHC in recruitment of 
many different cargoes. The molecular basis of this recognition appears to be 
highly complex. Despite much progress, notably very few common principles 
have emerged.  
 
1.6.4.2 KLC: Cargo interaction 
JIP proteins 
The first demonstration of a direct interaction between conventional kinesin-1 
light chain and a cargo was through yeast two-hybrid screening of a mouse 
brain cDNA library using the KLC1 TPR domain as bait. Three scaffolding 
proteins for the JNK signaling pathway were found to interact with the TPR 
domain of KLC1: the c-jun NH2-terminal kinase (JNK)–interacting proteins 
(JIPs) JIP-1, JIP-2, and JIP-3. Through immunoprecipitation assays the 
identical C-terminal sequences in JIP1 and JIP2 (PTEDIYLE) were shown to be 
essential for binding to KLC TPR domain. Co-immunoprecipitation experiments 
also showed the coprecipitation of JIP-1 with cytoplasmic as well as 
transmembrane signaling molecules; dual leucine zipper kinase (DLK) and the 
Reelin receptor, ApoER2 respectively. This suggested that through the binding 
of JIP-1 to kinesin-1, other cargo might also be transported as part of a 
multiprotein complex by kinesin-1 (Verhey et al., 2001). KLC TPR motifs bind to 
internal residues in JIP3 (Sunday Driver). Bowman et al. showed a direct 
interaction between the NH2-terminal half of JIP-3 and KLC1/2 TPR domain 
through yeast two-hybrid as well as GST pulldown assays (Bowman et al., 
2000). In agreement with this, yeast two-hybrid screening of a mouse brain 
cDNA library using the KLC TPR domain as bait also only contained the amino 
terminal portion of JIP3 (Verhey et al., 2001). Kelkar et al. showed that the 
interaction between KLC1 TPR domain and JIP3/JIP4 is mediated by the 
leucine zipper domains of JIP3/JIP4 (Kelkar et al., 2005). 
Like JIP1-4, the leucine zipper-containing scaffolding protein, JLP also 
associates with JNK as well as KLC. The second leucine zipper (LZII) of JLP 
was shown to be responsible for this interaction. This was shown through the 
use of LZII of JLP as bait in yeast two-hybrid screening of a mouse brain cDNA 
library. Nguyen et al. further identifies a “leucine zipper-like” domain in KLC and 
shows that mutation of KLC1 residues L280, L287, V294 and L301 to alanine 
results in loss of binding to JLP (Nguyen et al., 2005). However, this region is 
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unlikely to function as a leucine zipper as the residues mutated form part of the 
TPR domain of KLC as shown by the structure published by Zhu et al. (Zhu et 
al., 2012). All of the residues that were mutated are also not accessible to bind 
to JLP simultaneously. The structure would therefore not allow leucine zipper 
dimerization to occur between JLP LZII and KLC. It is more likely that one or 
more of the residues mutated are sequence specific elements required for 
binding via an alternative mechanism. 
 
Other light chain cargo 
Several other cargo that interact with the TPR domain of KLC were also 
identified. Saturable binding of β-amyloid precursor protein (APP) to KLC was 
shown with a stoichiometry of 2 APP per KLC. The apparent Kd was found to 
be approximately 18±4 nM for KLC1 and 16±3 nM for KLC2. The binding was 
also shown to be direct through GST-pulldown assays of KLC1 (GST-TPR) and 
purified APP-GFP (Kamal et al, 2000).  Using predicted C-terminal alpha-helical 
subdomain of human wild-type torsinA as bait in a yeast two-hybrid assay KLC 
TPR was identified as a binding partner. The interaction between TorsinA and 
KLC1 was confirmed by GST pulldown assays and co-immunoprecipitation 
(Kamm et al., 2004). The C-terminal region of collapsin response mediator 
protein-2 (CRMP-2) (residues 440-572) was also shown to directly bind to the 
TPR domain of KLC through use of recombinant protein (Kimura et al., 2005). 
CRMP-2 is important for axon differentiation and is enriched at the distal part of 
growing axons in primary hippocampal neurons. The highly conserved integral 
membrane protein, Kidins220/ARMS was also shown to be a binding partner of 
KLC through yeast two-hybrid screen and confirmed though GST pulldown and 
co-immunoprecipitation assays. A relatively short sequence 
(NSQDSSIEISKLTDKVQAEYRDAYREYIAQMSQLEGGTGS) was further 
shown to be sufficient for the interaction between Kidins220/ARMS and KLC1, 
termed KLC-interacting motif (KIM). This sequence does not bear any 
similarities with other proteins shown to interact with KLC (Bracale et al., 2007). 
The interaction with Kidins220/ARMS is mediated by KLC1 residues 83–296. 
This region includes part of the heptad repeat region as well as a section of the 
TPR domain including TPR motif 1 and 2. The neuronal protein, Huntingtin-
associated protein-1 (HAP-1) is another protein that has been shown to be 
involved in neuronal transport interacts directly with KLC2 via its C-terminus. 
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This was shown through yeast two-hybrid assay, GST pulldown, and co-
immunoprecipitation (McGuire et al., 2006).  
 Thus, in a manner comparable to KHC, KLC also appears to interact with 
a wide range of intracellular cargoes. Again, whether there are common 
underlying molecular mechanisms had not been determined. 
 
Recognition of tryptophan based motifs by KLC 
There are a number of examples in eukaryotic cells where transport and 
trafficking machinery recognise particular peptide motifs within cargo proteins. 
For example, the clathrin adaptors recognise YxxΦ and acidic-dileucine motifs 
typically found in the cytoplasmic domains of transmembrane proteins that allow 
for their recruitment into vesicles. Similarly, importins can recognise mono- or 
bi-partite basic motifs that target proteins for nuclear import. Given this, it is 
perhaps surprising that motif recognition and common molecular determinants 
have not yet emerged as a common principle in motor-cargo recognition.  
Over recent years studies have begun to suggest that a short peptide 
sequence characterized by a tryptophan flanked by acidic residues (tryptophan- 
acidic motif) is responsible for the binding of several cargo proteins to kinesin-1 
(Figure 1.5). The neuronal transmembrane protein, calsyntenin-1 (CSTN-1, also 
referred to as alcadein) was shown to interact with the TPR domain of KLC1. 
GST pulldown assays demonstrated that two highly conserved tryptophan-
aspartic acid containing segments (KENEMDWDDS and ATRQLEWDDS) in the 
cytoplasmic domain of calsyntenin-1 mediate binding to the KLC1 TPR domain. 
Point mutations of the tryptophan to alanine significantly reduced binding to 
KLC1 (Konecna et al., 2006, Araki et al., 2007). Yeast two-hybrid screen from a 
mouse adult brain cDNA library using caman ataxia protein, caytaxin as bait 
identified KLC1 to be a binding partner of caytaxin. Residues 115-120 of 
caytaxin (ELEWED) were shown through GST pulldown assays to be 
responsible for the binding to the TPR domain of KLC1 (Aoyama et al., 2009). 
The endosomal trafficking protein Gadkin was also shown to contain a similar 
motif (DLEWEDEE). Mutation of the highly conserved tryptophan results in loss 
of binding between KLC2 and Gadkin (Schmidt et al., 2009). More recently, 
similar motifs were identified in the lysosomal kinesin-1 adaptor SKIP 
(discussed in detail in 1.9). 
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Moreover, closely related motifs in Vaccinia virus transmembrane 
protein, A36 were found to mediate the interaction with KLC1 and KLC2 to 
promote the transport of poxvirus vaccinia virus from its golgi localised site of 
assembly to the cell periphery where it is released. In experiments where the 
cytoplasmic domain of A36 was removed and replaced with tryptophan acidic 
regions of SKIP and CSTN1, KLC was recruited and transport of vaccinia virus 
to the cell periphery was promoted in the absence of A36 suggesting that these 
motifs can function outside of the context of the host protein in a modular 
fashion.  Dodding et al. also suggest that the tryptophan motif is often bipartite 
and through bioinformatic analysis identified related bipartite tryptophan-based 
motifs in over 450 human proteins. Kinesin-1 recruitment may therefore occur 
through many cargo and adaptors (Dodding et al., 2011). Yeast two-hybrid 
analysis using the nuclear envelope protein Nesp4 (residues 129-339) as bait, 
identified KLC 1-4 as possible binding partners for Nesp4. Immunofluorescence 
assays revealed that co-expression of Nesp4 and KLC results in accumulation 
of KLC at the nuclear envelope. Nesp4 was also shown to co-
immunoprecipitate with KLC (Roux et al., 2009). Another Kinesin-1 binding 
protein, BNIP-2, functions as an adaptor involved in vesicular transportation in 
the cytoplasm. BNIP-2 also contains a tryptophan-acidic motif, EFEWED and 
was shown through immunoprecipitation to interact with KLC through the 
conserved WED motif (Akamatsu et al., 2015). 
Zhu et al. presented the first biochemical data showing that single motifs 
that are 10 residues in length are sufficient in binding kinesin-1. Isothermal 
titration calorimetry (ITC) experiments showed that a 10 residue peptide 
centering on the tryptophan-acidic motif of CSTN-1 interacted with KLC1 TPR 
domain with a Kd of 50µM. The C-terminal 10 residues of JIP-1 were also 
sufficient for the interaction with KLC1 TPR domain and interacted with KLC1 
TPR domain with a Kd of 9.4µM (Zhu et al., 2012). Through isothermal titration 
calorimetry the specific interaction between KLC1 and JIP1 were attributed to 
residue N343 in the fourth TPR repeat. KLC2 with the corresponding residue 
S328 did not interact with JIP1, however mutation of this residue within KLC2 to 
asparagine (N) allowed binding to JIP1. For the binding of the tryptophan-acidic 
motif containing protein called calsyntenin-1 a different site located within the 
groove not involving N343 was identified (Zhu et al., 2012). It was therefore 
hypothesised that whilst both bind to the concave groove, JIP1 binds to an 
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alternative site in the groove of the TPR domain. This work also suggested that 
KLC1/2 TPR domains could also confer specificity. 
The TPR domains from KLC1 and KLC2, share a sequence homology of 
87% identity between the two forms when residues 232 to 495 of KLC1 and 217 
to 480 of KLC2 are compared (Zhu et al., 2012). How the different KLC TPR 
domains recognise specific cargo is not fully understood. KLC1 and KLC2 share 
several cargo, although there are some that bind specifically to one or the other 
KLC TPR domain. For example HAP1(McGuire et al., 2006), CRMP-2(Kimura 
et al., 2005) and CSTN-1 (Araki et al., 2007) are able to bind to both KLC1 and 
KLC2 whereas TorsinA (Kamm et al., 2004) and JIP1 (Zhu et al., 2012) bind 





































Figure 1.5 Functional tryptophan-acidic KLC binding motifs are found in a 
wide range of proteins. 
Kinesin Heavy Chain (KHC) is shown in purple, Kinesin Light Chain (KLC) is in 
orange with the tetratricopeptide repeat  (TPR) domain boxed. The structure 
shown in the solid box is that of the KLC2 TPR domain PDB code 3CEQ (Zhu et 
al., 2012). The table shows the WD/E motifs in proteins previously shown to 
interact with KLC. W–W indicates the number of residues separating the two 




Protein  Motif 1 W–W  Motif 
A36R  SDWEDH    32  LIWDNE
CAYTAXIN      LEWEDD
BNIP-2 FEWEDD 
CSTN-1 MDWDDS    70  LEWDDS  





1.6.5 Regulation of cargo binding to kinesin-1 
1.6.5.1 Phosphorylation of kinesin-1 
How kinesin-1 distinguishes between different cargo and is able to specifically 
transport each cargo, as well as how loading and unloading of cargo in specific 
locations occurs is not fully understood. Phosphorylation of Kif5-KLC complexes 
by protein kinase A (PKA) has however been shown to inhibit association of the 
kinesin-1 motor with synaptic vesicles (Sato-Yoshitake et al., 1992). Glycogen 
synthase kinase 3 has also been shown to phosphorylate KLC and inhibit the 
association of kinesin-1 with membrane-bounded organelles as well as 
signaling protein, Smad2 (Morfini et al., 2002, Manser et al., 2012, Morfini et al., 
2006).  More recent work by Vagnoni et al. has shown that phosphorylation of 
ser460 in KLC1 reduces binding of calsyntenin, but does not affect the binding 
of HAP1A, CRMP2, JIP1 or Kidins220 and is therefore able to modulate cargo 
selectivity. Ser460 is a predicted mitogen-activated protein kinase (MAPK) 
target and an extracellular-signal regulated kinase (ERK) has been shown to 
phosphorylate this residue in vitro (Vagnoni et al., 2011).  As mentioned in 
section 1.6.4.2 JIP1 is suggested to bind to an alternate site within the TPR 
domain of KLC when compared to calsyntenin-1. The binding of CRMP-2 and 
Kidins220/ARMS to KLC TPR domain is also not achieved through a 
tryptophan-acidic motif. Phosphorylation may therefore only affect tryptophan 
acidic motif containing cargo that is likely to bind within the same region as 
calsyntenin-1, and in such a way the regulation by phosphorylation of Ser460 
may be less specific and affect other cargo that binds within the same region 
within the TPR groove.  
 
1.6.5.2 Phosphorylation of cargo 
Phosphorylation of cargo functioning as adaptors can also regulate association 
of other cargo with motors. For example UNC76 binds directly to Kif5, and 
functions as a Kif5 adaptor by associating with synaptotagmin-1.  
Phosphorylation of UNC76 by UNC51 (autophagy-related kinase) allows 
UNC76 to interact with synaptotagmin-1. Dephosphorylation results in the loss 
of this association (Toda et al., 2008). Phosphorylation of the tail (at ser 1029) 
by Ca2+/calmodulin dependent protein kinase (CaMKII) has been shown to 
disrupt the interaction of kinesin-2 family, Kif17 with LIN10 (also known as 
MINT1) which in turn results in loss of binding of N-methyl-D-aspartate receptor 
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subunit NR2B containing vesicles through disruption of the scaffold complex 
LIN10-LIN2-LIN7 (Guillaud et al., 2008). This raises the question whether 
phosphorylation of kinesin-1 heavy chain tail could also play a role in the 
regulation of cargo binding.  
 
1.6.5.3 GTPase-activating proteins and guanine nucleotide 
exchange factors. 
GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors 
(GEFs) may also regulate the association and dissociation of kinesins and their 
cargo. Guanosine triphosphate (GTP) bound Rab GTPases binds to Rab 
effector proteins. The Rab effector protein DENN/MADD binds preferentially to 
the GTP bound form of Rab3. DENN/MADD interacts with kinesin-3 family 
proteins, Kif1A and Kif1Bβ. Another example of a Rab effector is the kinesin-6 
family protein, Kif20B, that specifically interacts with the GTP bound form of 
Rab6 (Echard et al., 1998). The kinesin-1 cargo SKIP has also been shown to 
bind specifically to the GTP-bound form of Arl8. Arl8 was shown to be 
responsible for attaching SKIP to lysosomes (Rosa-Ferreira and Munro, 2011).  
 
1.6.5.4 Calcium levels 
Calcium levels may also regulate cargo transport by kinesin-1. Kinesin-1 heavy 
chain interacts with the transmembrane protein of the outer mitochondrial 
membrane, Miro via the adaptor protein, Milton (Glater et al., 2006, Stowers et 
al., 2002, Fransson et al., 2006). EF hand motifs of Miro mediate calcium-
dependent arrest of mitochondrial motility. Several models have been proposed 
describing how the arrest in motility occurs, but there is little consensus 
(Saotome et al., 2008, Wang and Schwarz, 2009, Macaskill et al., 2009).  
Regulation of cargo transport by kinesin-1 is not fully understood. The 
examples given here have suggested possible mechanisms of regulation 
through phosphorylation of cargo, GTPases and calcium levels.  
 
1.6.6 Motility of Kinesin-1 
The Kinesin-1 motor takes 8nm steps in a hand-over hand stepping mechanism 
(Asbury et al., 2003, Kaseda et al., 2003, Svoboda et al., 1993, Yildiz et al., 
2004). Each step involves the hydrolysis of a single ATP molecule (Schnitzer 
and Block, 1997).  Kinesin-1 is highly processive and maintains an interaction 
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with the microtubule for several steps before dissociating from the microtubule 
(Block et al., 1990, Hackney, 1995, Howard et al., 1989). Figure 0.4 shows a 
model of the kinesin-1 hand over hand stepping mechanism.  
When kinesin-1 is not bound to microtubules, ADP binds to both heads. Once 
one head attaches to the microtubule, it releases ADP. The head that remains 
detached retains the ADP molecule (Hackney, 1994). ATP then binds to the 
attached head, resulting in a conformational change in the neck linker (indicated 
by >>). Neck-linker docking is the binding of a 15 amino acid length peptide (the 
neck linker) to the catalytic core of the motor (Rice et al., 1999, Asenjo et al., 
2006, Clancy et al., 2011, Sindelar and Downing, 2010). 
The neck-linker induces internal strain between the two heads (Yildiz et 
al., 2008) to enable the movement of the detached head to the forward binding 
site. The head binds strongly to the microtubule releasing ADP. The internal 
strain created, prevents the binding of ATP to the forward head (red) (Hackney, 
2005, Uemura and Ishiwata, 2003). Only after hydrolysis of ATP and the 
release of phosphate by the rear head is the internal strain released and ATP 
able to bind to the forward head. At this point the heads have changed positions 
and kinesin-1 has moved 8nm along the microtubule (Kawaguchi, 2008). This 
mechanism requires coordinated movement of the front and rear motor 
domains and has been proposed to be facilitated by a gating mechanism. Two 
main models have been proposed; one involves gating of the front motor with 
inhibited nucleotide binding to the front head (Klumpp et al., 2004, Rosenfeld et 
al., 2001) while the other proposes gating of the rear motor involving an 
accelerated ATP hydrolysis of the rear motor and so an accelerated release of 
the rear head (Crevel et al., 2004, Schief et al., 2004). More recent evidence 
has been provided that the supports the front head gating mechanism 
suggesting that kinesin-1 is gated by the backward orientation of its neck linker 


















Figure 1.6. Model of the kinesin-1 stepping mechanism 
When kinesin-1 is not bound to microtubules, ADP binds to both heads. (A) 
Once one head attaches to the microtubule, it releases ADP. The head that 
remains detached retains the ADP molecule. (B) ATP then binds to the 
attached head resulting in neck-linker docking (indicated by >>) and induces 
internal strain between the two heads (Yildiz et al., 2008). This enables a 
biased diffusional search by the detached head for the next forward binding 
site. (C and D) The head binds strongly to the microtubule and ADP is released.  
The internal strain created, prevents the binding of ATP to the forward head 
(red). (E) Only after hydrolysis of ATP and the release of phosphate by the rear 
head is the internal strain released and ATP able to bind to the forward head. At 
this point the heads have changed positions and kinesin-1 has moved 8nm 





When not transporting cargo, kinesin-1 adopts a folded conformation, where the 
heavy chain C-terminal tail inhibits the motor domain (Figure 1.8). The folded 
conformation was first observed in bovine adrenal medulla kinesin, by electron 
microscopy using low-angle rotary shadowing technique (Hisanaga et al., 
1989). Subsequently sedimentation experiments illustrated that the 
sedimentation coefficient increased upon lowering the ionic strength and that 
the folding was an intrinsic property of kinesin heavy chains (Hackney et al., 
1992, Stock et al., 1999).  
The tail region of KHC that contains a highly conserved isoleucine-
alanine-lysine motif (IAK) and surrounding residues (893-937) were shown to 
interact in a salt dependent manner with the motor region (1-365) (Stock et al., 
1999). An increase in the salt concentration lowers the affinity of the interaction. 
Friedman and Vale showed that the full length motor moved 10 times less 
frequently and exhibits discontinuous movement compared to the truncated 
kinesin lacking the C-terminal tail (Friedman and Vale, 1999). The C-terminal 
tail domain of KHC also negatively regulates the ATPase activity of the motor.  
Low ATPase activity is observed for the native kinesin-1 tetramer compared to a 
truncated kinesin-1 where the tail domain is deleted. Deletion of the hinged 
region that is required for the folding of KHC into the autoinhibited conformation 
also results in increased ATPase activity (Coy et al., 1999). This regulation is 
abolished upon deletion of the IAK region (Hackney and Stock, 2000). Further 
work refined the region of the C-terminal tail required for autoinhibition and 
highlighted the importance of the conserved IAK motif and surrounding residues 
(Yonekura et al., 2006, Dietrich et al., 2008).   
A major step in understanding came with the discovery that only one of 
the two tail peptides is necessary for binding and inhibition of ADP release from 
both motor domains, leading to proposition of the ‘half-site’ inhibition 
mechanism (Hackney et al., 2009). This was verified when the X-ray crystal 
structure of this tail monomer-motor dimer was recently solved and offered 
important insights into the mechanism of autoinhibition (Kaan et al., 2011). The 
location and function of the second tail peptide in this autoinhibited state is not 
known. The motor tail complex further revealed that in the autoinhibited 
conformation, movement of the motor domains are restricted due to cross-
linking of the motor domains at the coiled-coil and also the tail interface (Figure 
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1.7). This prevents undocking of the neck linker and in turn prevents ADP 
release. The structure revealed that the binding site for the tail domain is on the 
opposite side of the motor domain to the nucleotide-binding site, ruling out 
previously suggested models involving the tail blocking the release of ADP and 
the tail peptide interacting with the Switch I region (Dietrich et al., 2008). The 
possibility that the tail could interact with the neck linker or coiled coiled region 
is also ruled out. The structure also shows the microtubule binding sites 
exposed, therefore ruling out steric interference with microtubule binding (Kaan 
et al., 2011).  
Although this folding can occur in the absence of kinesin light chains, the 
light chains appear to be able to affect autoinhibition. However, their role is 
controversial. Immunofluorescence microscopy and microtubule co-
sedimentation experiments demonstrated that the binding of KHC to 
microtubules is inhibited by co-expression of KLC, suggesting that they support 
the autoinhibited state (Verhey et al., 1998). ATPase activity is also further 
reduced in the presence of KLC (Coy et al., 1999). This enhanced inhibition has 
been suggested to occur by KLC pushing the KHC motor domains apart, 
however this explanation would appear to be incompatible with the double 
lockdown mechanism described above (Cai et al., 2007). Wong and Rice 
however suggest that KLC are activators of kinesin-1, and help to destabilise 
the autoinhibited state, through suppressing the tail-head and tail microtubule 
interactions (Wong and Rice, 2010). The Verhey group proposed a model 
where cargo binding to both KHC and KLC is required for the release of 
autoinhibition and activation of transport of Kinesin-1 (Blasius et al., 2007). 
 
1.6.8 Autoinhibition in other kinesins  
Kinesin-2, kinesin-3, kinesin-7 and kinesin-13 families have also been shown to 
be regulated by autoinhibition. The kinesin-2 family member, Kif17, as well as 
the Kinesin-7 family member, CEnPE, is found in an autoinhibited state within 
cells. The mechanism of autoinhibition appears to be similar to that of kinesin-1 
as it involves direct interactions of the C-terminal tail with their motor domains 
(Imanishi et al., 2006, Espeut et al., 2008).  
Autoinhibition of Cenp-E is relieved by phosphorylation of the Cenp-E tail 
by MPS1 and/or CDK1-cyclin B. Kif17 is activated by protein kinase C (PKC) 
allowing it to bind to microtubules. Kif17 has several predicted PKC 
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phosphorylation sites and could therefore be regulated by PKC directly. PKC 
could on the other hand also prevent cargo that may be required for the 
activation of the Kif17 motor from binding (Espenel et al., 2013). 
The C-terminus of the kinesin-13 motor, MCAK has also been shown to bind to 
the two motor domains and regulates its activity through this conformational 
switch. Tubulin is suggested to trigger the dissociation of the C-terminal tail from 
the motor. MCAK functions as a microtubule depolymerase that regulates 
microtubule dynamics (Talapatra et al., 2015). 
Kinesin-3 motor, Kif1A also exists endogenously as an autoinhibited 
dimer. The forkhead associated (FHA) and the coiled-coil 2 (CC2) domains 
have been shown to contribute to autoinhibition by blocking microtubule 
binding. Additional mechanisms, may involve the coiled coil 1 (CC1) domain. 
Similar to kinesin-1, activation occurs upon cargo binging (Hammond et al., 
2009). 
For all the kinesin motors mentioned, autoinhibition prevents 
unnecessary ATP hydrolysis and movement of kinesin motors on the 


































Figure 1.7. Model for double lockdown mechanism of autoinhibition 
The kinesin heavy chain motor domain is represented in purple. The double 
lockdown mechanism prevents the separation of the motor domains that is 
required for neck linker (red, sticks) undocking and ADP  (red, spheres) release. 
Ser181 residues (green spheres) are apart in the free dimer bit close together in 
the presence of tail (orange, sticks) binding and are on opposite sides of the tail 










Double lockdown prevents 
the separation of the heads  
required for neck linker 
undocking and ADP release
Single point attachment of 
heads does not prevent 
neck linker undocking and 
ADP release














                   
 
Figure 1.8. Schematic of Kinesin-1 in a folded inactive state and a cargo 
bound unfolded active state. 













1.7 Coordination and competition between motors in bi-
directional transport 
Live cell imaging as well as in vitro studies have shown that many cargo 
proteins are transported bi-directionally by kinesin-1 and dynein to the plus and 
minus ends of microtubules, respectively. Numerous cargos have been shown 
to bind to oppositely directed motors simultaneously (Soppina et al., 2009, 
Hendricks et al., 2010, Encalada et al., 2011). 1-2 Kinesins and 6-12 dyneins 
have been shown to act together to move a single organelle along the 
microtubule (Hendricks et al., 2012, Hendricks et al., 2010, Rai et al., 2013). Bi-
directional movement of cargo has been described by several models (Gross, 
2004, Muller et al., 2008, Fu and Holzbaur, 2014). Two models that describe 
the interactions of opposing kinesin and dynein motors to the same cargo are 
the tug of war model and the coordination model.  
In the tug of war model the team of motors that applies the greater force 
determines the direction of transport and the coordination model suggests that 
motors are regulated so that only a single type of motor is switched on at any 
one time. With regard to how motors are able to coordinate the direction of 
movement, motors with opposite-polarity have been shown to activate one 
another by physical or mechanical interactions (Ally et al., 2009, Encalada et 
al., 2011). The physical contact may occur through the direct interaction of KLC 
with dynein intermediate chain or through the interaction of KLC with other 
dynein accessory subunits (Ligon et al., 2004, Martin et al., 1999). The 
mechanical activation of opposite polarity motors has been suggested to occur 
through plus and minus end directed motors pulling against each other (Ally et 
al., 2009). Motors of opposite polarity are also able to bind to the same cargo or 
adaptor proteins. Cargo proteins or adaptors may therefore play a role in the 
coordination of the direction of transport. For example, huntingtin binds directly 
to the intermediate chain of dynein (Caviston et al., 2007) as well as to HAP1 
(huntingtin associated protein 1). HAP1 also interacts with the p150Glued 
subunit of dynactin (Engelender et al., 1997) as well as interacting with kinesin-
1 (McGuire et al., 2006).   
Phosphorylation of cargo can also alter the directionality of transport. 
JIP1 binds directly to KHC stalk and tail and the p150Glued subunit of dynactin. 
Phosphorylation of residue S421 of JIP1 by JNK is shown to enhance binding to 
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KHC C-terminal tail and promotes anterograde transport (Fu and Holzbaur, 
2013). 
Inhibition or knockout studies have however shown that inhibiting one 
motor results in reduced transport in both directions, which suggests co-
dependence between the motors. In order to resolve this, three models were 
proposed in conjunction with the tug of war model by Hancock involving 
microtubule tethering, mechanical activation and steric disinhibition. In the 
microtubule tethering mechanism motors are suggested to remain weakly 
bound to the microtubule when inactive and bind strongly when the motor is 
active. Inhibition of one motor results in loss of cargo transport of the opposing 
motor due to a reduction in tethering, which may also lead to dissociation of the 
cargo. In the mechanical activation mechanism motors are activated by the 
opposing motor pulling on the cargo. When the opposing motor is inhibited, 
cargo transport does not occur due to there not being opposing forces and the 
motor being inactive. In the steric disinhibition mechanism, cargo bound motors 
remain in an autoinhibited state. Inhibition is relieved and transport commences 
upon the direct interaction of the opposing motor or other regulatory proteins. 
Inhibition of a motor in one direction results in the reduced motility of the 
opposing motor due to the one motor no longer being activated (Hancock, 
2014). 
 
1.8 Role in disease 
Disruption of transport can occur due to mutations in the genes that encode 
motor proteins or cargo (that are associated either directly or indirectly with 
motor proteins). Defects in transport have been shown to be associated with 
several neurodegenerative and neurodevelopmental diseases such as 
Huntington’s disease, Alzheimer’s disease and multiple forms of Charcot–
Marie–Tooth disease (CMT) (Millecamps and Julien, 2013, Hirokawa et al., 
2010, De Vos et al., 2008). 
Huntington’s disease is caused by polyQ stretches within the huntingtin 
protein. The underlying mechanism that results in Huntington’s disease remains 
unclear. Huntingtin associated protein-1, HAP1, binds KLC1, highlighting the 
involvement of HAP-1 in anterograde transport in neuronal cells (McGuire et al., 
2006). HAP1-Kif5 complex mediates delivery of GABAA receptors to synapses 
and this transport is disrupted by mutant huntingtin (Twelvetrees et al., 2010). A 
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key role of huntingtin is to promote BDNF transport (involving HAP1 and 
dynactin) and over expression of mutant huntingtin disrupt the transport of 
BDNF (Gauthier et al., 2004). Phosphorylated huntingtin promotes kinesin-1 
dependent anterograde transport and dephosphorylated huntingtin results in 
detachment of kinesin-1 and an increase in retrograde transport of vesicles and 
proteins including BDNF (Colin et al., 2008). Huntingtin also binds to directly to 
dynein intermediate chain and acts in a complex with dynactin and huntingtin-
associated protein-1 (HAP-1) to facilitate vesicular transport in the retrograde 
direction (Caviston et al., 2007). Wong and Holzbaur showed that polyQ-
huntingtin disrupts predominantly retrograde transport of autophagosomes 
(Wong and Holzbaur, 2014). 
Alzheimer’s disease is characterised by neurofibrillary tangles containing 
paired helical filaments with hyperphosphorylated microtubule associated 
protein tau as well as amyloid plaques that are areas of degenerating neurites 
surrounding a core of amyloid-β peptide. The amyloid- β peptide is derived from 
serial proteolysis of APP by β and γ-secretases. Axonal transport defects have 
been described as an early pathological feature of Alzheimer’s disease 
(Hirokawa et al., 2010). It has been a controversial issue whether transport 
defects are caused by amyloid-β accumulation or arise due to it.  APP was 
initially shown to interact directly with kinesin light chain (Kamal et al., 2000). 
However, Lazarov et al. give evidence that the interaction is not direct and show 
that endogenous APP does not co-fractionate with kinesin-1 in membrane 
fractions or detergent homogenates prepared from mouse brain (Lazarov et al., 
2005). Satpute-Krishnan supports the first study that there is a direct interaction 
between APP and kinesin-1. They identify a C-terminal short peptide sequence 
from APP and show that it is sufficient to mediate anterograde transport of 
peptide-conjugated beads in the squid giant axon (Satpute-Krishnan et al., 
2006). Morihara et al. identify kinesin light chain-1 splice variant E (KLC1vE) as 
a modifier of amyloid-β accumulation (Morihara et al., 2014). Gan et al. propose 
that KLC1vE triggers amyloid-β accumulation through reducing APP transport. 
The transport of other KLC1 cargo that regulate amyloidogenesis is also 
impaired by KLC1vE (Gan et al., 2015). Anterograde APP transport has also 
been shown to be mediated by direct binding to kinesin-1 cargo JIP-1 
(Scheinfeld et al., 2002). Fu et al. also show that JIP1 interacts with p150Glued, 
a subunit of the retrograde dynein–dynactin complex and phosphorylation of 
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JIP-1 alters KHC activation and also the direction of APP transport (Fu and 
Holzbaur, 2013). siRNA knockdown of calsyntenin-1 has also been shown to 
disrupt axonal transport of APP, suggesting that APP is co-transported with 
calsyntenin-1 through axons (Vagnoni et al., 2012).  
A small heat shock protein, HSPB1, is a mutant in CMT disease and 
increases the stability of microtubules (Almeida-Souza et al., 2011). How 
exactly the increased stability can cause CMT is not known although it has 
been suggested that the stabilisation blocks remodeling of the cytoskeleton at 
synaptic sites (Conde and Caceres, 2009). Another possibility is that the mutant 
form of HSPB1 binds along the microtubule and sterically block transport (Dixit 
et al., 2008). Kif5A mutations have also been associated with Charcot-Marie-
Tooth Type 2 (CMT2) (as well as Hereditary Spastic Paraplegia (HSP)) 
(Crimella et al., 2012). The mechanism of mutant Kif5A involvement in the 
progressive axonal degeneration characteristic of these diseases is not well 
understood. Campbell et al. show that mutation of Kif5Aa diminishes axonal 
mitochondrial density in peripheral sensory neurons, which correlates with 
axonal degeneration and decreased sensory function (Campbell et al., 2014). 
Viruses as well as bacteria have been shown to hijack the cell’s internal 
transport system through binding to these motor proteins (Dodding and Way, 
2011, Boucrot et al., 2005). Dodding et al. showed that the vaccinia integral 
membrane protein, A36 interacts with KLC TPR domain through highly 
conserved tryptophan-acidic motifs and allows for the kinesin-1-dependent 
transport of the virus to the cell periphery (Dodding et al., 2011).  Adenovirus 
subunit hexon binds directly to dynein through its intermediate and light 
intermediate chains and recruits dynein for transport to the nucleus (Bremner et 
al., 2009). Both kinesin-1 as well as dynein bind to the herpes simplex virus 
(HSV1) tegumented capsid using different inner tegument structures (Radtke et 
al., 2010). HSV1 tegument protein, US11 interacts with the C-terminal tail of 
KHC (Diefenbach et al., 2002b). However, virions that lack US11 have also 
been shown to bind to kinesin-1. Radtke et al. suggest that HSV1 uses different 
structural features of the inner tegument, such as pUS3, pUL36, pUL37, ICP0, 
pUL14, pUL16, and pUL21 to recruit dynein or kinesin-1 (Radtke et al., 2010). 
In the case of HIV-1, inhibition of dynein disrupts viral transport towards the 




The PH domain of the kinesin-1 cargo SKIP binds the bacterial effector, SifA 
upon infection with salmonella (Boucrot et al., 2005). The SifA:SKIP interaction 
is required for the kinesin-1 dependent transport of vesicles that bud from the 
Salmonella-containing vacuole to the cell periphery (Dumont et al., 2010). 
Continued research into the molecular mechanisms involved in cargo 
recognition as well as activation should provide insights for future therapeutic 
approaches. 
 
1.9 SKIP  
SKIP (SifA and kinesin-interacting protein, also known as PLEKHM2) contains 
an N-terminal RPIP8, UNC-14, and NESCA (RUN) domain and a C-terminal 
pleckstrin homology (PH) domain (Boucrot et al., 2005)(Figure 1.9).  SKIP 
contains a pair of W-acidic motifs centered at amino acid positions 207 and 208 
(WD) and 236 and 237 (WE) that fall within the N-terminal kinesin-1 binding 
region (residues 1 to 310) that has been shown to interact with KLC (Rosa-
Ferreira and Munro, 2011, Dumont et al., 2010). 
The PH domain binds the bacterial effector, SifA upon infection with 
Salmonella (Boucrot et al., 2005).  Replication of Salmonella occurs within the 
membrane-bound compartment called the Salmonella-containing vacuole 
(SCV) within cells (Boucrot et al., 2003). In infected cells, SifA contributes to the 
fission of vesicles from the bacterial SCV. The SifA:SKIP interaction is required 
for the kinesin-1 dependent transport of vesicles that bud from the SCV to the 
cell periphery (Dumont et al., 2010).  
SKIP has been shown to be important in lysosomal trafficking to the cell 
periphery (Rosa-Ferreira and Munro, 2011). Recruitment of lysosomes to 
kinesin-1 occurs by the initial recruitment of the small GTPase Arl8 by the 
BORC complex, followed by the Arl8 dependent recruitment of SKIP via its RUN 
domain (Pu et al., 2015, Rosa-Ferreira and Munro, 2011). Arl8b associates with 
lysosomal membranes via its acetylated amino-terminal amphipathic helix 
(Hofmann and Munro, 2006). The acetylated N-terminal helix ensures tight 
membrane association of Arl8-GTP. GTP hydrolysis results in Arl8-GDP 
dissociating from the lysosomal membrane. (Bagshaw et al., 2006). SKIP 
interacts directly with kinesin-1 via KLC.  Rosa-Ferreira et al. showed that when 
SKIP is co-expressed with Arl8b, there is a peripheral scattering of lysosomes.  
When a mutant form of SKIP where both tryptophan acidic motifs are mutated is 
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co-expressed with Arl8b, peripheral scattering of lysosomes is not induced. 
Instead there is an accumulation in the perinuclear region (Rosa-Ferreira and 
Munro, 2011). This demonstrates that the movement of lysosomes to the 
periphery is dependent on the ability of SKIP to bind kinesin-1. Dodding et al., 
2011 showed that mutation of the separate tryptophan acidic motifs of SKIP 
resulted in a reduction in kinesin-1 dependent transport of vaccinia virus to the 
cell periphery with the first tryptophan acidic motif (WD) having a much greater 
effect than mutation of the second tryptophan acidic motif (WE) (Dodding et al., 
2011). 
This combination of clear interaction with kinesin-1 and convenient 
functional assays makes SKIP an ideal candidate to pursue further studies on 
the mechanisms underlying kinesin-1 cargo recognition. 
 
1.10 Project aims 
Despite the large diversity in kinesin-1 cargo, it is emerging that at least for 
KLC, there may be common underlying principles and molecular mechanisms 
that support cargo recognition.  This must be intimately related to the control of 
the activity of the motor. For KLC, it seems clear that a crucial element of this is 
achieved by interaction of the TPR domain with short linear peptide motifs.  The 
aim of this thesis is to further investigate these mechanisms with the goal of 
providing a framework for understanding the general principles of kinesin-1 
cargo recognition. I have pursued this by attempting a detailed molecular 
dissection of the mechanism of recognition of the lysosomal cargo adaptor 
SKIP which carries a pair of W-acidic motifs, seeking to apply the knowledge 

























Figure 1.9. Schematic of human SKIP 
The two Tryptophan-acidic motifs within the N-terminal kinesin-1 binding region 
(residues 1 to 310) are highlighted (SKIPWD, SKIPWE). The RUN domain and the 
C-terminal pleckstrin homology (PH) domain are also labeled. The region in 



























CHAPTER 2 . MATERIALS AND METHODS 
 
2.1 Recombinant DNA 
2.1.1 Polymerase chain reaction (PCR) 
Polymerase chain reactions were carried out to amplify sections of DNA from 
plasmids. Taq plus precision polymerase (Agilent) was used in all cases. 
Primers were purchased from Sigma-Aldrich. A typical reaction consisted of 
100ng template DNA, 0.5µl of each primer at 100µM, 1µl 10mM dNTP’s, 10µl 
Polymerase buffer, and 1µl polymerase made up to 100µl with H2O. Using a 
BioRad C1000 thermal cycler, reactions were subject to a 2 minute denaturing 
step at 95°C, followed by 25 cycles of 95°C for 30 seconds, 55°C for 1 minute 
and 72°C for 1 minute per kb of sequence to be amplified. Reactions were 
completed by a 7 minute incubation at 72°C.  
 
2.1.2 Site-directed mutagenesis 
Site directed mutagenesis was carried out according to the guidelines in the 
Quickchange mutagenesis kit (Stratagene). Complementary oligonucleotides 
were designed 20-40 nucleotides in length to target the region of interest whilst 
incorporating one or more nucleotide changes. A list of primers used is shown 
in Table 1. A typical reaction consisted of 100ng template plasmid DNA, 125ng 
of each primer, 1µl 10µM dNTP’s, 1µl (2.5U) Native Pfu Polymerase, and 10µl 
10x polymerase buffer made up to 100µl with H2O. After 3 minute 95°C 
denaturing step, reactions were subjected to thermal cycling of 12-18 cycles of 
1 minute at 95°C, 1 minute at 55°C and 1 minute per kilobase (kb) of template 
plasmid at 68°C. After thermal cycling, reactions were incubated for 20 minutes 
at 37°C in the presence of 1µl Dpn1 to digest methylated template DNA. 5µl of 
this reaction was used to transform Top 10 competent cells (Invitrogen). 
Colonies were picked after 24 hours and bacterial cultures prepared for small 
scale (mini prep) or large scale (midi prep). Plasmid integrity was verified by 







Table 1. Primers 













5' GAGCACTGGAGATCGAGGAGAAGGTCCTG 3'  
AS4 msKLC2 
R312E R 
5' CAGGACCTTCTCCTCGATCTCCAGTGCTC 3' 
AS5 msKLC2 
N287L F 
5' CTGCGACCCTCAACCTTCTGGCTGTTCTC 3' 
AS6 msKLC2 
N287 R 
5' GAGAACAGCCAGAAGGTTGAGGGTCGCAG 3' 
AS7 msKLC2 
L291D F 
5' CAACAATCTGGCTGTTGACTACGGCAAACGGGG 3' 
AS8 msKLC2 
L291D R 













5' CAACCTGGCCTTGAAGTGCCAGAACCAGG 3'  
AS12 msKLC2 
L333K R 
5' CCTGGTTCTGGCACTTCAAGGCCAGGTTG 3' 
AS13 msKLC2 
V290K F 
5' CCTCAACAATCTGGCTAAGCTCTACGGCAAACGGG 3'  
AS14 msKLC2 
V290K R 
5' CCCGTTTGCCGTAGAGCTTAGCCAGATTGTTGAGG 3' 
AS15 msKLC2 
V290Y F 
5' CCTCAACAATCTGGCTTATCTCTACGGCAAACGG 3'  
AS16 msKLC2 
V290Y R 













5' CCAGATGTGGCCGCGCAGCTCAGCAAC 3' 
AS20 msKLC2 
K325A R 
5' GTTGCTGAGCTGCGCGGCCACATCTGG 3' 
AS21 msKLC2 
N329L F 
5' CCAAGCAGCTCAGCTTACTGGCCTTGCTGTGC 3'  
AS22 msKLC2 
N329L R 
5' GCACAGCAAGGCCAGTAAGCTGAGCTGCTTGG 3' 
AS23 msKLC2 
C305S F 
5' GCTGAGCCACTGAGCAAGAGAGCAC 3'  






5' CAACAATCTGGCTGCTCTCTACGGCAAAC 3' 
AS26 msKLC2 
V290A R 
5' GTTTGCCGTAGAGAGCAGCCAGATTGTTG 3' 
AS27 msKLC2 
L291T F 
5' CAACAATCTGGCTGTTACCTACGGCAAACGGGG 3' 
AS28 msKLC2 
L291T R 
5' CCCCGTTTGCCGTAGGTAACAGCCAGATTGTTG 3' 
AS29 msKLC2 
L291A F 
5' CAATCTGGCTGTTGCCTACGGCAAACGGG 3' 
AS30 msKLC2 
L291A R 













5' GTGGCTGCGACCCTCCTAAATCTGGCTGTTCTC 3' 
AS34 msKLC2 
L286L R 
5' GAGAACAGCCAGATTTAGGAGGGTCGCAGCCAC 3' 
AS35 msKLC2 
R270D F 
5' GATGCCCTGGCTATCGACGAAAAGACACTGGGC 3' 
AS36 msKLC2 
L270D R 
5' GCCCAGTGTCTTTTCGTCGATAGCCAGGGCATC 3' 
AS37 msKLC2 
R251A F 
5' CCTGGCACTGGTTTATGCGGACCAGAATAAGTAC 3' 
AS38 msKLC2 
R251A R 


































5' TATAGCGGCCGCATGAAGGCCTTGGAGAGTGCGCTC 3' 
AS75 rKIF5C 
Not 1 M1 




































5' CATCAAGGAGGCTGTGTAGGCCAAGAACATGGC 3' 
AS84 KHC 
R908_ R 
5' GCCATGTTCTTGGCCTACACAGCCTCCTTGATG 3' 
AS85 KHC 
S918_ F 












































































5' CTTCAACGAGGAGCCGTAAGAGACTGTGTCCTC 3' 
AS113  SKIP 
A277_  R 
5' GAGGACACAGTCTCTTACGGCTCCTCGTTGAAG 3' 
AS114 SKIP 
A291_ F 
5' CCCCCGTGCACACCTAATCTCAGGAGAAGGAG 3' 
AS115  SKIP 
A291_ R 
5' CTCCTTCTCCTGAGATTAGGTGTGCACGGGGG 3' 
AS116 SKIP 
E217_ F 
5' CGATTGCCCCATCTAGTTAGGATTATGATTTTGG 3' 
AS117 SKIP 
E217_ R 
5' CCAAAATCATAATCCTAACTAGATGGGGCAATCG 3' 
AS118 SKIP 
F151_ F 
5' CTAGAGTTCATTCGTTAAGAGCTGGATCTGGATGC 3' 
AS119 SKIP 
F151_ R 
5' GCATCCAGATCCAGCTCTTAACGAATGAACTCTAG 3' 
AS120 SKIP 
K171_ F 
5' GCCCGACTACTACTAACCTCAGTACCTG 3' 
AS121 SKIP 
K171_ R 
5' CAGGTACTGAGGTTAGTAGTAGTCGGGC 3' 
AS122 SKIP 
T244_ F 
5' GAGACCTCACAGACTAGGTCAGTGGTCCC 3' 
AS123 SKIP 
T244_ R 
5' GGGACCACTGACCTAGTCTGTGAGGTCTC 3' 
AS124 SKIP 
T203_ F 
5' CAACTCCGTCACCTCCTAAAACCTGGAGTGGGATG 3' 
AS125 SKIP 
T203_ R 













2.1.3 Agarose gel electrophoresis 
DNA was added to 6x DNA loading buffer (Qiagen). Samples were loaded on a 
1% (W/V) agarose gel containing 10µl SafeView (NBS Biologicals Ltd) Nucleic 
Acid Stain (NBS Biologicals Ltd). Hyper ladder 1 (Bioline) was used as a DNA 
marker. 
 
2.1.4 Purification of DNA from agarose gels 
Bands were excised and the DNA extracted using the QIAquick Gel Extraction 
Kit (Qiagen) according to the manufacturers guidelines. The gel slice was 
dissolved in QG buffer (300µl of Buffer QG per 100mg of gel) and incubated at 
50°C for 10 minutes (or until the gel slice had completely dissolved). 1 gel 
volume of isopropanol was added to the sample and mixed.  The sample was 
applied to the QIAquick column, and centrifuged at 13,000 rpm for 1 minute.  
The flow-through was discarded and the QIAquick column placed back in the 
same collection tube. 0.75 ml of Buffer PE was added to the QIAquick column 
and centrifuged for 1 minute. The flow-through was discarded and the QIAquick 
column centifuged for an additional 1 minute at 13,000 rpm. To elute DNA,  50µl 
of buffer EB or water was added to the center of the QIAquick membrane and 
centrifuged for 1 minute at 13,000 rpm.  
 
2.1.5 Transformation of chemically competent bacteria 
Chemically competent E.coli BL21(DE3) cells (BioLabs)  or  chemically 
competent E.coli TOP10 cells (Invitrogen) and DNA (typically 50µl and 5µl) 
were incubated with on ice for 30 minutes. This was followed by heat-shock at 
42°C for 30 seconds and incubation on ice for 2 minutes. 250µl S.O.C medium 
was added to the transformation reaction. This was followed by incubation at 
37°C, 250RMP for 1 hour. 30µl and 60µl were then plated on LB-agar plates 
containing appropriate antibiotic (either ampicillin or kanamycin (Sigma) at 
50ug/ml) and incubated overnight at 37°C. 
 
2.1.6 Purification of plasmid DNA from bacteria 
Small scale purification by mini-prep: 
A single bacterial colony was picked and grown overnight in 5ml LB broth (10g 
bacto-tryptone, 5g bacto- yeast extract, 10g NaCl in 1 litre, pH7.5) 
supplemented with the appropriate antibiotic (either ampicillin or kanamycin at 
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50µg/ml). Using the Plasmid Mini kit (Qiagen) according to manufacturers 
protocol.  
 
Large scale purification by midi-prep: 
Plasmid DNA picked from a single colony was grown overnight in 100ml LB 
broth supplemented with the appropriate antibiotic (either ampicillin or 
kanamycin at 50µg/ml). The DNA was purified using the Plasmid Midi Kit 
(Qiagen) according to manufacturers protocol. 
 
2.1.7 Restriction enzyme digest of DNA 
For sub-cloning or to confirm the identity of plasmids according to restriction 
digest profile, plasmid DNA was digested with the relevant restriction enzyme. 
All enzymes were supplied by Roche and used in buffers recommended by the 
manufacturer. A typical reaction consisted of 1µg of plasmid DNA, 2.5µl 10x 
restriction buffer, 1µl restriction enzyme made up to 25µl with H2O, incubated at 
37°C for 2 hours. Reactions were subsequently analysed by agarose gel 
electrophoresis. 
 
2.1.8 Annealing oligonucleotides 
Oligonucleotides were obtained from Sigma 0.025µM Scale. Oligos were 
dissolved in 50µl H2O. 1µl from each oligo (forward & reverse) was added to 
48µl annealing buffer (100mM potassium acetate, 30mM HEPES-KOH pH7.4, 
2mM Mg-acetate) and incubated at 95°C for 4 minutes followed by a 10 minute 
incubation at 70°C. The annealed oligos were cooled slowly to 4°C. 
 
2.1.9 Phosphorylation of oligonucleotides 
2µl of the annealed oligos, 1 µl DNA ligase buffer, 5µl H2O and 1µl T4 
polynucleotide kinase (BioLabs) were incubated at 37°C for 30 minutes followed 
by a 10 minute incubation at 70°C. The phosphorylated oligonucleotides were 
ligated into a restriction digested and CIP treated plasmid (see 2.1.10). 
 
2.1.10  Dephosphorylation of plasmid 
1µg plasmid DNA was restriction digested by relevant restriction enzymes and 
purified by gel purification and eluted in 35µl H2O. 1µl Alkaline phosphatase, 
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Calf Intestinal (CIP) (BioLabs) and 3.5µl NEB (New England Biolabs) buffer 3 
was added and incubated at 37°C for 30 minutes. 
 
2.1.11 DNA ligation 
Ligation reactions were carried out at 16°C for 16 hours using T4 DNA ligase 
(New England Biolabs) in 1x DNA ligase buffer. A typical reaction consisted of a 
1:5 molar ratio of vector: insert and 1µl ligase made up to 20µl with H2O. 
 
2.1.12 DNA sequencing 
DNA samples were sent at a concentration of 100µg/µl to be sequenced by 
Source Bioscience. 
 
2.2 Protein expression an purification 
2.2.1 Protein expression 
Proteins were expressed in E.coli BL21(DE3) cells. Single bacterial colonies 
were picked and grown overnight in 5ml LB broth (10g bacto-tryptone, 5g bacto- 
yeast extract, 10g NaCl in 1 litre, pH7.5) supplemented with the appropriate 
antibiotic (either ampicillin or kanamycin at 50µg/ml). 2ml small-scale overnight 
bacterial cultures were used to inoculate 500ml LB broth supplemented with the 
appropriate antibiotic (either ampicillin or kanamycin at 50µg/ml). Cultures were 
incubated at 37°C until they reached an OD600 of 0.5. The temperature was 
then lowered to 16°C and protein synthesis was induced by the addition of 
300µM Isopropyl β-D-1-thiogalactopyranoside (IPTG) for 16 hours. Cells were 
harvested by centrifugation at 5000 x g for 15 minutes at 4°C and resuspended 
in 20mM HEPES pH 7.5, 500mM NaCl, 20mM imidazole, 5mM β- 
mercaptoethanol supplemented with protease inhibitor cocktail (Roche). 
 
2.2.2 Protein purification using Ni2+ column 
Cell lysis was accomplished by sonication. Insoluble material was sedimented 
by centrifugation at 13000 rpm for 30 minutes at 4°C and the supernatant 
filtered using 0.22µm prior to loading on a His-trap HP column (GE Healthcare) 
pre-equilibrated with lysis buffer (in 20mM HEPES pH 7.5, 500mM NaCl, 20mM 
imidazole, 5mM β- mercaptoethanol). The protein was eluted with an imidazole 
gradient (20mM to 300mM Imidazole) and fractions containing the target protein 
collected and dialysed overnight against imidazole-free lysis buffer.  
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2.2.3 Size-exclusion chromatography (SEC) 
The sample was applied to a HiLoad 16⁄600 Superdex 75 prep grade column 
(GE Healthcare) pre-equilibrated with sample buffer (20mM HEPES pH 7.5, 
500mM NaCl, 5mM β- mercaptoethanol) and 2ml fractions collected using an 
AKTA prime plus. Typically a 4L bacterial culture yielded 25mg of purified 
protein after Ni2+ column purification followed by SEC. 
 
2.2.4 Batch purification using GST beads 
Cell lysis was accomplished by sonication. Insoluble material was sedimented 
by centrifugation at 13,000rpm for 30 minutes at 4°C and the supernatant 
filtered using a 0.22µm filter. The glutathione Sepharose 4 Fast Flow beads 
were washed 5 times with buffer (20mM HEPES pH 7.5, 500mM NaCl, 5mM β-
mercaptoethanol) This was followed by incubation of the cell lysate with 0.5ml 
of glutathione Sepharose 4 Fast Flow beads (GEHealthcare life sciences) per 
1L bacterial culture for 2 hours at 4°C with end-over-end rotation. This was 
followed by a further 5 washes. The GST fusion protein was eluted by adding 
0.5 ml 50 mM Tris-HCl, 10mM reduced glutathione, pH 8.0 per 1 ml original 
slurry of glutathione Sepharose 4 Fast Flow. This was repeated for a total of 
three elutions. Typically a 2L bacterial culture yielded 10mg of purified protein 
after batch purification. 
 
2.2.5 Thrombin cleavage 
Thrombin cleavage was carried out using Novagen Thrombin cleavage capture 
kit according to the manufacturers guidelines. 1:25 dilution was made of 
thrombin in Thrombin Dilution/Storage Buffer. The dilution contained 
approximately 0.04 U enzyme per µl. Each reaction contained 1µl diluted 
thrombin/10ug target protein in 1X Thrombin Cleavage/Capture Buffer. The 
reactions were incubated at 4°C overnight.  
Biotinylated thrombin was removed with streptavidin agarose (using a 
ratio of 16μl settled resin (32μl  of the 50% slurry) per unit of enzyme.  The 
desired amount of streptavidin beads was transferred to the reaction and 
incubated at room temperature for 30 minutes with gentle shaking and this was 
followed by the reaction being transferred to the sample cup of a Spin Filter and 




2.2.6 C3 cleavage 
PreScission protease (GE Healthcare) was added to the target protein (in 
buffer: 20mM HEPES pH 7.5, 500mM NaCl, 5mM β-mercaptoethanol) at a 1 
unit  protease to 100µg target protein ratio. The reaction was incubated at 4℃ 
overnight.  The GST-HRV 3C protease, Cleaved GST as well as any uncleaved 
protein were removed by incubation with glutatione Sepharose 4 fast flow 
beads (GE healthcare) for 1 ½ hr. 
 
2.3 SDS polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western Blot 
2.3.1 SDS/PAGE 
Denaturing 10% or 12% polyacrylamide gels were cast using Novex cassettes 
(Novex Life Technologies). Running gels were made up to 10% or 12% 
acrylamide (30% stock Acrylamide/Bis-acrylamide (Sigma), 375mM Tris-HCL, 
pH 8.8, 0.1% SDS, 0.1% ammonium persulphate (APS), and 8ul TEMED. 2.5 
ml stacking gels consisted of 5% acrylamide, 124mM Tris-HCl pH6.8, 0.1% 
SDS, 0.1% APS and 10uL TEMED. Samples were resuspended in1x (or diluted 
5x) SDS loading buffer (1x (10% glycerol, 2% SDS(w/v) 60mM Tris pH 6.8, 
0.001% bromophenol blue, 100mM DTT and heated to 100°C for 5 minutes. 
Gels were run at 180V for 1 hour in 1x SDS Running Buffer (1% SDS, 27.6mM 
Tris, 0.2M glycine pH 8.8) A 17- prestained protein ladder (Precision Plus 
Protein™) was used as a standard. 
 
2.3.2 Transfer to PDVF membrane and western Blot 
Protein samples that had been separated on SDS-PAGE gel were transferred 
to a PVDF membrane (Immobilon-P, Millipore). Membranes were prepared by 
wetting for 1 minute in methanol followed by 5 minutes in transfer buffer (25mM 
Tris, 192mM glycine, 10% methanol).  Transfer was typically 1 hour at 100 
volts. 
 
2.3.3 Analysis of samples by western blot 
The membrane was blocked overnight at 4 °C in 5% milk (skim milk powder 
(MERCK) in TBST (20mM Tris, 0.25M NaCl, 0.1% Tween-20, pH 7.5 with HCl). 
Membranes were probed with the appropriate antibodies at the concentration 
61 
 
indicated in Table 2. Membranes were washes 3 x in TBS-T prior to incubation 
with a horseradish peroxidase conjugated secondary antibody if required. This 
was followed by another 3 washes in TBST. The Clarity Western ECL substrate 


































Table 2. Antibodies used 

































































































In order to obtain crystals that will diffract to a high resolution, the protein in 
solution must be pure and homogenous. During crystallisation a protein self 
assembles into a periodic lattice.  For crystallization, the protein must be 
concentrated to supersaturation to allow for nucleation to occur and crystal 
formation (McPherson, 1990). This is illustrated in the phase diagram in Figure 
2.1.  
It is not predictable which conditions will yield well diffracting crystals. 
Many crystallisation trials involve varying reagents (such as buffers, precipitants 
and additives), concentrations of reagents, pH or temperature. Vapour diffusion 
is the most common technique used to obtain crystals. Both the hanging drop 
and the sitting drop techniques use evaporation to achieve supersaturation. 
This is illustrated in the diagram shown below. In the vapour diffusion method 
the protein solution is mixed with reservoir (precipitant) solution and is placed 
on the glass slide covering and sealing the reservoir in the case of the hanging 
drop technique and in a sub-well in the sitting drop technique.  The protein-
precipitant concentration in the hanging or sitting drop is much lower than that 
in the reservoir. As water evaporates from the drop into the reservoir the 
concentration of the protein is increased steadily until the solution becomes 


























Figure 2.1. Phase diagram of crystal growth.  
Nucleation is thought to occur in the nucleation zone followed by further growth 
in the metastable zone. If the protein concentration or the precipitant 
concentration is too high, the protein will precipitate out of solution. Adapted 














Figure 2.2. Schematic of crystallisation techniques 
(A) Schematic of the hanging drop and sitting drop techniques. (B) Schematic of 
the optimisation grid set up for protein crystalisation. Components of the 
optimisation grid are shown separately. 1 and 2 represents components kept 
















2.5 Crystalisation Method 
2.5.1 Pre-Crystallisation Screen 
A pre-crystallisation screen was carried out according to the guidelines in the 
Hampton Research user guide. Sample concentrations were between 5 and 20 
mg/ml. 
 
2.5.2 Crystallisation screens 
96-well sitting drop vapour diffusion crystallisation screens were set up using a 
Mosquito (TTP Labtech) robotic crystallization device. Initial screens were set 
up using drops of 200nl of the protein sample (at the concentration determined 
by the pre-crystallisation screen ~ 5mg/ml) mixed in a 1:1 ratio with the 
reservoir in the top drop. In the lower drop, the drop was set up 133nl protein 
and 267nl reservoir. (1:2 ratio). The crystallisation screens used in trials were 
PGA, MIDAS, Proplex (Molecular Dimensions) and JCSG+ (Qiagen). Plates 
were sealed and stored at 18C.	   For optimisation of conditions that produced 
crystals, a grid screening around the condition was made in 96-well sitting drop 
plate. 
 
2.6 Protein interaction assays 
2.6.1 Fluorescence polarisation 
Light polarized by passing through a vertical polarizing filter is absorbed by and 
excites fluorescent molecules that are oriented in the vertical polarized plane in 
the sample tube. These fluorescent molecules subsequently emit light. The 
emitted light is measured perpendicular and parallel to the plane of the 
excitation beam. Polarization is a measure of the extent of molecular rotation 
during the period between excitation and emission and is dependent upon 
fluorescent lifetime of the fluorophore. The polarization value, P, is a ratio of 
light intensities expressed in millipolarization units (1 Polarization Unit = 1000 
mP Units). P = (F1 – F2)/ (F1 + F2) (F1= fluorescence intensity parallel to the 
excitation plane, F2= fluorescence intensity perpendicular to the excitation 
plane). Small molecules rotate quickly during the excited state and have low 
polarization values. Large molecules, caused by the binding of the fluorescent 
peptide to a second protein, rotate little during the excited state, and therefore 
have high polarization values. 
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N-terminal carboxytetramethylrhodamine (TAMRA) conjugated peptides used 
for fluorescence polarization measurements SKIPWD: TAMRA- STNLEWDDSAI,  
TAMRA-SKIPWE: TAMRA-VPSTDWEDGDL, TAMRA-SKIPWDWE: TAMRA-
STNLEWDDSAIAPSSEDYDFGDVFPAVPSVPSTDWEDGDL were supplied by 
BioSynthesis (Lewisville, TX, USA). Measurements were performed on a Horiba 
Fluoromax-4 spectrofluorometer at 20 °C by incubating 100nM TAMRA-labeled 
peptides with KLC2TPR (or KHC(866-917)) at increasing concentrations in 
25mM Hepes pH 7.5, 5 mM β-mercaptoethanol  and 150mM NaCl. Data 
analysis was performed using the Prism (GraphPad Software Inc., San Diego 
CA, USA) package. Data was fitted assuming first order kinetics, generating a 
binding curve from which a dissociation constant (Kd) and Bmax were 
calculated. Polarisation values for peptide with buffer alone was subtracted from 
polarization values and data was normalised to calculated Bmax. The data are 
presented are as normalised fluorescence polarisation. 
 
2.6.2 GST Pull-down of purified protein 
All samples were dialysed overnight into a buffer containing 20mM HEPES 
pH7.5, 150mM NaCl and 5mM β-mercaptoethanol (and 20mM imidazole if His-
tagged protein was involved in the pull-down). 0.5nmoles GST/ GST fusion 
construct (1.6 µM) was incubated with 1.2µM target protein in a volume of 300µl 
for 1 ½ hours followed by a 1 ½ hour incubation with 20µl prewashed GST 
beads. Beads were centrifuged at 2000g for 2 minutes. This was followed by 
three wash steps with 1ml buffer: 20mM HEPES pH7.5, 150mM NaCl and 5mM 
β-mercaptoethanol (and 20mM imidazole if His-tagged protein was involved in 
the pull-down). The beads were transferred to a new microcentrifuge tube 
during the second wash step. Binding was analysed by gel electrophoresis 
followed by western blot analysis and coomassie staining.  
 
2.6.3  GST Pull-down of protein expressed in 293T 
0.25nmoles (0.83µM) purified GST /GST fusion protein was incubated with 20µl 
prewashed GST beads in a volume of 300µl for 90 minutes. Beads were 
centrifuged at 2000g for 2 minutes. This was followed by the removal of the 
supernatant and three wash steps with 1ml wash buffer (20mM HEPES pH7.5, 




293T cells were plated at a density of 1.5 x 105 per 10cm dish 5 hours prior to 
transfection. Cells were transfected with 2µg DNA (CB6 expression vectors) 
using Effectene transfection reagent (Qiagen). 10µl DNA (200ng/µl stock), 16µl 
Enhancer and 273µl buffer EC (that provides optimal salt conditions for efficient 
DNA condensation) were combined. Samples were vortexed for 1 second and 
incubated for a further 2 minutes at room temperature. 20µl Effectene Reagent 
was then added to the samples and the samples were vortexed for 30 seconds 
and the mixture was incubated for 20 minutes to allow Effectene-DNA 
complexes to form and added directly to the cells. The cells were then 
incubated at 37°C. After 16 hours, transfected cells were lysed in 1ml of 25 mM 
HEPES pH 7.5, 150 mM NaCl, 0.1% NP-40, 0.1X Triton-X 100 containing a 
protease inhibitor cocktail (Roche) for 10 minutes prior to centrifugation at 13 
000g for 10 min at 4°C. The resulting supernatant was incubated with the 20µl 
GST beads described above for 90 minutes. 50µl of supernatant was retained 
for analysis of cell lysate. 10µl 6x loading buffer was added. Beads were 
washed four times and boiled in 60µl SDS-loading buffer. 20µl samples were 
subjected to SDS–PAGE and analysed by western blot. 
 
2.6.4 Immunoprecipitation 
293T cells were plated at a density of 1.5 x 105 per 10cm dish 5 hours prior to 
transfection. Cells were transfected with 2µg DNA (CB6 expression vectors) 
using Effectene transfection reagent (Qiagen). 10µl DNA (200ng/µl stock), 16µl 
Enhancer and 273µl buffer EC (that provides optimal salt conditions for efficient 
DNA condensation) were combined. Samples were vortexed for 1 second and 
incubated for a further 2 minutes at room temperature. 20µl Effectene Reagent 
was then added to the samples and the samples were vortexed for 30 seconds 
and the mixture was incubated for 20 minutes to allow Effectene-DNA 
complexes to form and added directly to the cells. The cells were then 
incubated at 37°C.  After 16 hours, transfected cells were lysed in 1ml of 25 mM 
HEPES pH 7.5, 150 mM NaCl, 0.1% NP-40, 0.1X Trition-X 100 containing a 
protease inhibitor cocktail (Roche) for 10 minutes prior to centrifugation at 13 
000g for 10 min at 4°C. The resulting supernatant was incubated with 15µl of 
prewashed GFPTrap beads (ChromoTek) for 90 minutes. 50µl of supernatant 
was retained for analysis of cell lysate. 10µl 6x loading buffer was added. 
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Beads were washed four times and boiled in 60µl SDS-loading buffer. 20µl 
samples were subjected to SDS–PAGE and analysed by western blot.  
 
2.7 Immunofluorescence 
Cells were plated at a density of 1.5 x 104 per well on fibronectin-coated glass 
cover slips in a 6 well plate 6 hours prior to transfection. Cells were transfected 
using Effectene transfection reagent (Qiagen). Cells were transfected with 
0.8µg DNA (CB6 expression vectors) using Effectene transfection reagent 
(Qiagen). 4µl DNA (200ng/µl stock), 3.2µl Enhancer and 92.8µl buffer EC (that 
provides optimal salt conditions for efficient DNA condensation) were combined. 
Samples were vortexed for 1 second and incubated for a further 2 minutes at 
room temperature. 5µl Effectene Reagent was then added to the samples and 
the samples were vortexed for 30 seconds and the mixture was incubated for 
20 minutes to allow Effectene-DNA complexes to form and added directly to the 
cells. The cells were then incubated at 37°C for 16 hours. 
Cells were fixed for 10 minutes at room temperature in 4% 
paraformaldehyde (PFA). To allow entry of antibodies, cells were permeabilised 
with 0.2% Triton X in PBS for 10 minutes at room temperature prior to blocking 
with 1% BSA in PBS for 20 minutes. Alternatively, cells were fixed at -20°C with 
100% methanol for 10 minutes. Cells were washed three times with PBS. Cells 
were then probed with the appropriate antibody diluted in blocking solution 1% 
BSA in PBS). After 2 hours at room temperature, cells were washed three times 
for 5 minutes each with PBS followed by incubation with a secondary 
fluorescent conjugated antibody (in blocking solution) for 30 minutes. Coverslips 
were washed 3 more times with PBS, placed cell side down in fluor save 
reagent (Calbiochem). Widefield fluorescence images were collected using a 
Zeiss Olympus IX-81 microscope with a 40x objective running Metamorph. 
Confocal images were collected using a Nikon A1 system with a 100x objective 
running NIS Elements. 
 
2.8 Quantification of lysosome distribution  
To quantify lysosome distribution, widefield images were acquired at a 40x 
magnification. The cell perimeter was defined by thresholding equivalent 
saturated images and the area was scaled at 10% decrements using ImageJ.  
70 
 
The image was binarised and the cumulative LAMP-1 distribution (relative to 
the whole cell) was then plotted for increasing incremental deciles. Data points 
are from a minimum of 15 cells in 3 replicates and are representative of at least 
3 independent experiments. For analysis of the resulting curves, the non-linear 
regression function in Graphpad Prism was used to fit a centered 6th order 
polynominal. R2 values were all above 0.8. To compare models and assess the 
statistical significance of differences in distribution profiles, the extra sum of F-
squares test was applied. P values for particular comparisons are indicated on 


























CHAPTER 3 . EXPRESSION, PURIFICATION AND 
CRYSTALLISATION OF KLC2TPR BOUND TO SKIP  
 
Despite many examples of robust biochemical experiments that clearly 
demonstrate interactions between microtubule motors and many cargo proteins, 
no structural information is available that describes these interfaces. This holds 
back our understanding of these crucial transport processes. Recent reports 
from several groups have uncovered that a significant component of the 
kinesin-1 cargo mechanism involves binding of short, charged, peptides by the 
KLC TPR domain with low micromolar affinity. There are numerous examples of 
TPR-domain peptide X-ray crystal structures with similar properties. Therefore, 
at least in the case of kinesin-1, it appeared that this problem may be tractable 
using structural approaches. This chapter describes experiments that aimed to 
solve an X-ray crystal structure of a tryptophan-acidic motif in complex with the 
KLC2 TPR domain, focusing on the pair of motifs found within the lysosomal 
cargo adaptor SKIP, which in several complementary reports have been found 
to play a role in kinesin-1 dependent microtubule transport (Dumont et al., 2010, 
Rosa-Ferreira and Munro, 2011). These reports have shown that the N-terminal 
domain of SKIP (amino acids 1-310, with W-acidic motifs located at 207-208 
and 236-237) is both necessary and sufficient for binding to kinesin-1.  
 
3.1 Determination of the relative importance of the two 
tryptophan acidic motifs of SKIP. 
To begin to determine the best approach for X-ray crystallography a GFP-TRAP 
immuno-precipitation strategy was used to determine the relative contribution of 
each motif to KLC2 binding, reasoning that the motif that made the biggest 
contribution to binding was most likely to be successful in downstream 
applications.  HeLa cells were co-transfected with plasmids designed to express 
N-terminally hemagglutinin (HA) tagged KLC2 (HA-KLC2) and N-terminally 
green fluorescent protein (GFP) tagged SKIP(1-310) (either wild-type, carrying 
alanine substitution at  residues 207-208 (WD), 236-237 (WE) or both WD and 
WE), or with amino acids 219 to 238 deleted (ΔExon7).  GFP-SKIP(1-310) was 
immunoprecipitated with GFP-TRAP beads and the amount of co-
immunoprecipitated  HA-KLC2 was assessed by western blot (Figure 3.1). 
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Disruption of the WD motif essentially eliminated the GFP-SKIP interaction with 
HA-KLC2, whereas equivalent mutations in the WE motif had relatively little 
effect. When both tryptophan-acidic motifs were mutated, the reduction in 
binding was similar to the WD mutation alone. Deletion of Exon7 (DelEx7), 
which encompasses the WE motif and surrounding residues, did considerably 
reduce binding, suggesting some contribution from these residues in binding to 
KLC2. It was notable that in experiments where an interaction did occur, there 
was an apparent increase in HA-KLC2 expression in the cell extract, compared 
to the GFP control, although the extent of this tended to vary between repeats 
of experiments. This may is due to some level of SKIP dependent stabilisation 
of KLC2 in this over expression system. Taken together, these data suggest 
that this first W-acidic acidic motif of SKIP is the primary determinant of 
interaction with KLC2 but that the second motif and intervening residues may 
also make a contribution to binding. 
 
3.2 Fluorescence polarization analysis of the SKIP-KLC2 
interaction. 
To validate these findings in vitro and further biophysically characterise the 
interactions between KLC2 TPR and SKIP W-acidic motifs, fluorescent 
polarisation assays were carried out in collaboration with Dr. Stefano Pernigo, 
Steiner group, KCL (see methods for details). These assays should ideally be 
performed with the most pure recombinant proteins possible. 
To allow comparison with data from Zhu et al., 2012 who performed 
isothermal titration calorimetry (ITC) based characterisation of similar W-acidic 
motifs binding to KLC2, the KLC2 TPR chosen for these experiments consisted 
of residues 219-480, and does not include the first helix of TPR1. The authors 
found that deletion of this helix stabilised the protein and improved crystal 
quality (PDB code 3CEQ).   KLC2 TPR was expressed in E.coli as an N-
terminally His6-tagged protein and was first purified by Ni2+-affinity 
chromatography followed by size exclusion chromatography (SEC). KLC2 TPR 
eluted as a single peak at 66.57 ml during SEC with very few low molecular 
weight impurities (Figure 3.2). 
N-terminal carboxytetramethylrhodamine (TAMRA) conjugated peptides 
that centered on the first W-acidic motif of SKIP  (SKIPWD: STNLEWDDSAI), or 
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the second motif (SKIPWE: VPSTDWEDGDL) (comparable to peptides used by 
Zhu et al.), as well as a long peptide encompassing the entire region were 
obtained from Biosynthesis Inc. at >95% purity.     
 Peptides were added at 100nM concentration to increasing 
concentrations of KLC2 TPR in saturation binding experiments (in triplicate) and 
analysed using a spectrophotometer. Binding of the protein to the peptide at 
equilibrium is associated with an increase in the polarisation of emitted light 
(see methods). Fitting the data assuming first order kinetics, enables a binding 
curve to be generated from which a dissociation constant (Kd) and Bmax can 
be calculated. Following subtraction of polarisation values for peptide with 
buffer alone and normalising to calculated Bmax, the data are presented as 
normalised fluorescence polarisation.  
Whilst it was not possible to achieve saturation in all three cases, these 
fluorescence polarisation measurements clearly show that the first SKIP 
tryptophan-acidic motif (SKIPWD) has a higher affinity for the TPR domain of 
KLC2 than the second motif (SKIPWE). (SKIPWD = 24 µM, SKIPWE above 110 
µM) (Figure 3.3). The longer peptide containing both tryptophan-acidic motifs as 
well as including Exon7 yielded a Kd of 4.9µM.  These low micromolar affinities 
(for SKIPWD and SKIPWDWE) are broadly comparable to similar measurements 
made by Zhu et al. using ITC. Importantly, they strongly reinforce the 
conclusions of the immunoprecipitation experiment above that suggests that the 
first W-acidic motif of SKIP makes the key contribution to binding and was 
therefore the best candidate for downstream crystallographic approaches. They 
do however also suggest that incorporation of both motifs (or further residues C-















Figure 3.1. Alanine substitution of the first W-acidic motif (SKIPWD) 
abrogates SKIP:KLC2 binding, whereas the same substitution in the 
second motif (SKIPWE) has a smaller effect. 
GFP-Trap of HA-KLC2 (70.0 kDa) with GFP-SKIP (62.1 kDa), mutants of SKIP 
(WD/AA (61.9 kDa), WE/AA (61.9 kDa), WEWD/AAAA (61.7 kDa)), SKIP 
containing a deletion of exon 7(DelEx7)(59.8 kDa) or GFP (26.9 kDa) control 
expressed in HeLa cells. Input lysates and co-immunoprecipitated HA-KLC2 
(bound) were blotted for KLC2 using an anti-HA mouse monoclonal antibody. 
GFP and GFP-SKIP were blotted for using an anti-GFP mouse monoclonal 
antibody. A goat polyclonal anti-mouse HRP antibody was used as a secondary 
antibody to allow for detection using the Clarity Western ECL substrate. The 
blot is representative of three experiments involving three independent repeat 
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Figure 3.2. Purification of KLC2TPR. 
(A) Coomassie stained SDS-PAGE gel showing collected fractions of Ni2+ 
column purification. The soluble cell lysate is labeled load. The flow through as 
well as the wash buffer were collected after passing through the column 
(flowthrough 1,2 and wash 1, 2, 3 respectively). KLC2TPR (32.1kDa) was 
eluted with an imidazole gradient and fractions containing the target protein 
collected. (B) Coomassie stained gel of fractions eluted during size exclusion 
chromatography using a HiLoad 16⁄600 Superdex 75pg column. (C) Size 
exclusion chromatogram showing absorbance measurements at 280nm of 






































































































Figure 3.3. SKIPWD has a higher binding affinity for KLC2 than SKIPWE.  
Fluorescence polarisation measurements of increasing concentrations of 
KLC2TPR with 100nM N-terminal carboxytetramethylrhodamine (TAMRA) 
conjugated peptides (SKIPWE (blue), SKIPWD(red),  and SKIPWDWE(black)) in 
25mM Hepes pH 7.5, 5 mM β-mercaptoethanol  and 150mM NaCl. Calculated 
values for dissociation constants are shown in the box. The graph shows 
average values from three independent experiments utilising the same 
KLC2TPR(218-480) preparation and TAMRA conjugated peptide stock 
solutions. Measurements were performed on a Horiba Fluoromax-4 
spectrofluorometer at 20 °C. A one site - specific binding curve was fitted to the 
data: Y = Bmax*X/(Kd + X). Experiment carried out in collaboration with Dr. 
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KLC2TPR (218-480) [μM]
SKIPWDWE:KLC2TPR, Kd = 4.9 μM, Kd Std. Error = 0.47
SKIPWD:KLC2TPR, Kd = 23.7 μM, Kd Std. Error = 2.05
SKIPWE:KLC2TPR, Kd ≈ 111 μM, Kd Std. Error =22.71
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3.3 Construct design 
Previous attempts in the group and by others at crystallising the KLC2 TPR 
domain and W-acidic peptides had proven unsuccessful. The data described in 
the previous section suggested that this may in part be due to the relatively low 
affinity of the KLC2 TPR – W-acidic interaction. Further fluorescence 
polarisation experiments by Dr. Pernigo had also suggested that this interaction 
may be highly sensitive to the salt concentration in the buffer.  In an attempt to 
overcome these potential obstacles, the approach of Pellegrini et al. was 
adopted where a peptide from Rad51 was fused to BRCA2 in a chimeric 
construct. This enabled crystallisation and structural determination for the 
complex construct (Pellegrini et al., 2002). Thus, the first W-acidic motif of SKIP 
(identified as binding with the highest affinity) was fused via a flexible TGS(4) 
linker to the TPR domain of KLC2 (lacking the first helix of TPR1). Fusing the 
peptide and the KLC2 TPR domain brings them in close proximity, and may 
make the interaction more likely to occur in the often high salt conditions of 
crystallisation experiments (Figure 3.4) The KLC2 TPR consisted of residues 
219-480 and did not include the first helix of the first TPR, as this is the section 
that has previously been crystallised (PDB code 3CEQ) and so was thought 
most likely to be successful (Zhu et al., 2012). The SKIPWD (10aa) and the 
TGS(4) linker sequence were introduced by annealing oligos and inserting at an 
NdeI site prior to the TPR region in the 219-480 construct described earlier. 
 
3.4 Cloning and expression of SKIPWD_KLC2TPR 
SKIPWD_KLC2TPR was expressed in E.coli as an N-terminally His6-tagged 
protein and was first purified by Ni2+-affinity chromatography followed by size 
exclusion chromatography (SEC). SKIPWD_KLC2TPR eluted as a single tailing 
peak at 55.01ml. The tailing could be caused by the presence of an impurity 
that is slightly smaller and therefore eluted slightly after SKIPWD_KLC2TPR 
(Figure 3.5). The most pure samples were pooled and concentrated to 5mg/ml 


















Figure 3.4. Schematic of SKIPWD_KLC2TPR construct design. 
The SKIPWD peptide (green) is fused N-Terminal to KLC2TPR residues 219-480 
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Figure 3.5. Purification of SKIPWD_KLC2TPR. 
(A) Coomassie stained gel of the collected fractions of Ni2+ column purification. 
The soluble cell lysate is labeled load. The flow through as well as the wash 
buffer were collected after passing through the column (flow through 1,2 and 
wash 1, 2 respectively). The SKIPWD_ KLC2TPR chimera (34.5kDa) was eluted 
with an imidazole gradient and fractions containing the target protein collected. 
(B) Coomassie stained gel of fractions eluted during size exclusion 
chromatography. A size exclusion chromatography column (HiLoad 16⁄600 
Superdex 75pg) was used. (C) Size exclusion chromatogram showing 































































































3.5 Crystallisation of SKIPWD_KLC2TPR 
Initial screening experiments were set up using the histidine tagged SKIPWD_ 
KLC2TPR. The crystallisation screens used in trials were PGA, MIDAS, and 
ProComplex and JCSG+ (Qiagen). Hits were obtained in the poly-γ- glutamic 
acid (PGA) screen and also in ammonium sulphate based conditions of the 
ProComplex screen (Figure 3.7). The most frequent crystallising agent for the 
un-cleaved construct was PGA. The nature of the precipitant clearly influenced 
the morphology of the resulting crystals. More needle shaped crystals grew in 
the presence of ammonium sulphate while more single separated crystals grew 
using PGA as a precipitant (Figure 3.6). The presence of potassium bromide 
also resulted in more needle like crystals. The optimal pH at which 
SKIPWD_KLC2TPR crystals grew was centered on 6.5. For all of the conditions 
in Figure 3.7 apart from number 4 the drops remained clear for 3 days, after 
which small singular crystals appeared. Nucleation took a relatively short period 
of time, but once the nucleation process was accomplished the crystals grew 
relatively slowly. Nucleation took a week longer in condition number 4.   
For a second set of screens, the N-terminal histidine affinity purification 
tag was removed by thrombin cleavage (Figure 3.8A). Western blot analysis 
using an anti-His antibody confirmed highly efficient proteolytic processing. 
However, following size exclusion chromatography, the resultant product eluted 
with two peaks. This could be due to the histidine cleaved SKIPWD_KLC2TPR 
existing in two different conformations in solution. The fraction containing the 
highest concentration of the protein that eluted at 55.89 ml was concentrated to 
5mg/ml for crystallisation screens. Whilst some crystals were obtained, these 
were judged to be smaller and less promising and so further work with the tag-
free protein was not pursued. 
 Optimisation screens were set up for the conditions that yielded crystals 
for the un-cleaved SKIPWD_KLC2TPR construct. Three screens were set up 
each with a pH vs PGA gradient (pH(5-9) vs PGA concentration (3-13%)) 
keeping the concentration of the respective additive (potassium bromide, 
magnesium chloride or L-proline) constant. Another screen was set up with a 
pH and ammonium sulphate gradient (pH(5-9) vs ammonium sulphate 
concentration (0.2-1)). Figure 3.7B shows the conditions from the optimisation 
screens from which SKIPWD_KLC2TPR crystals were chosen for data collection 
due to their larger dimensions and sharp edges. The crystal that produced the 
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best diffraction pattern for highest resolution was obtained using 0.10 M MES 
pH 6.5, 0.2 L-proline, 7% PGA. A complete data set was collected at 2.9 Å 
resolution at the I24 beamline of Diamond Light Source (Didcot, Oxford, UK) by 









































Figure 3.6. Examples of SKIPWD_KLC2TPR crystals. 
Images of singular as well as needle like SKIPWD_KLC2TPR crystals. Single 
separated crystals: (A) 0.1M MES pH6, 0.2M L-proline, 9% PGA,  (B) 0.1M 
MES pH6, 0.2M L-proline, 10% PGA. Needle like crystals: (C) 0.1M Sodium 
Cacodylate pH6.5, 0.45 ammonium sulphate, (D) 0.1M sodium cacodylate 






















Figure 3.7. Conditions that produced SKIPWD_ KLC2TPR crystals. 
(A) List of the conditions from the initial crystal screens that produced crystals 
(no.1-3: PGA, No.4,5: ProPlex). (B) List of the conditions from the optimisation 
screens that produced crystals. Optimization screens that produced crystals 
were pH(5-9) vs PGA concentration (3-13%) with 0.2M L-proline, pH(5-9) vs 
PGA concentration (3-13%) with 0.3M potassium bromide and pH pH(5-9) vs 
ammonium sulphate concentration (0.2-1 M). 
 
  
No  Buffer  pH   Precipitating Agent  Additive
                                                                      1  0.1M Sodium   6.5  8% w/v PGA   0.3M Potassium bromide 
  cacodylate
2  0.1M  Sodium   6.5  8% w/v PGA   0.2M Magnesium chloride
  cacodylate
3  0.1M Sodium   6.5  8% w/v PGA   0.2M L-Proline
  cacodylate
4  0.1M MES  6.5  0.5M (NH4)2 SO4 
5  0.1M MES  6  8% w/v PEG 6000  0.1M Magnesium chloride
A
B
1  0.1M MES  6  7% w/v PGA   0.2M L-Proline
2  0.1M MES  6  8% w/v PGA   0.2M L-Proline
3  0.1M MES  6  10% w/v PGA   0.2M L-Proline
4  0.1M MES  6.5  8% w/v PGA   0.2M L-Proline
5  0.1M MES  6.5  10% w/v PGA   0.2M L-Proline
6  0.1M MES  6  3% w/v PGA   0.3M Potassium bromide
7  0.1M MES  6  4% w/v PGA   0.3M Potassium bromide
8  0.1M MES  6  11% w/v PGA   0.3M Potassium bromide
9  0.1M MES  6.5  0.3 M Ammonium sulphate 
10  0.1M MES  6.5  0.6 M Ammonium sulphate 
11  0.1M HEPES  7  0.4 M Ammonium sulphate






Figure 3.8. Thrombin cleavage of Histidine tag. 
(A) Coomassie stained gel and western-blot (blotting with a monoclonal HRP 
conjugated anti His antibody) of the thrombin cleaved (32.6kDa) and un-cleaved 
SKIPWD_KLC2TPR (34.5kDa). (B) Coomassie stained gel of fractions eluted 
during size exclusion chromatography (C) Size exclusion chromatogram 




























































3.6 Structural determination  
Using molecular replacement for phase information, the structure of the 
tryptophan-acidic motif containing peptide from SKIP in complex with the KLC2 
TPR (SKIPWD_KLC2TPR) was solved by Dr. Stefano Pernigo and Dr. Roberto 
Steiner and the figures of the structure presented here were created by them 
and the structure is deposited in the PDB under code 3ZFW (Figure 3.9 and 
Figure 3.10). The Rfactor/Rfree gives an indication as to whether the structure that 
was solved agrees with the data collected. The R-value can range from zero 
(for perfect agreement between calculated and observed) to approximately 60% 
for a random model compared to an experimental data set. An Rfactor of 20% is 
desirable for a protein model refined with data to 2.5Å. 20.27% is therefore a 
good Rfactor value for a model refined to 2.9Å. The Rfree value enables the 
assessment of possible overmodelling of the data and validate the extent to 
which the model explains the diffraction data. The Rfree value was calculated 
against 5% of the total reflections that are set apart during scaling and is not 
used for refinement. This aids in reducing model bias and over fitting of data. 
Iterative model fitting and refinement cycles results in model improvement and 
both Rfactor and Rfree values dropping (Brunger, 1992). The molprobity score is a 
log-weighted combination of the clashscore, percentage Ramachandran not 
favored and percentage bad side-chain rotamers, giving one number that 
reflects the crystallographic resolution at which those values would be expected 
(Chen et al., 2010). Since the molprobity score is lower than its actual 
crystallographic resolution, the quality of the structure modelled is thought to be 
better than the average structure solved at that resolution (Figure 3.10). 
The SKIPWD_KLC2TPR structure shows the KLC2 TPR domain (orange) 
consisting of TPR motifs 2-6 as a concave alpha helical structure similar to that 
found by (Zhu et al., 2012). The construct includes the external helix of TPR1, 
however the residues could not be assigned, so the KLC2TPR starts from 
TPR2. Each TPR motif consists of two anti-parallel alpha helices, one that is 
internal to the TPR domain and one external. This is denoted by or I or E for the 
helix at the center of the TPR domain (internal) and the outer helix (external) 
respectively. The SKIP peptide (green) spans the length of the TPR domain and 
residues throughout the peptide interact via H-bonds and salt bridges with the 
TPR domain. When comparing the cargo free KLC2 TPR (3CEQ) (grey) domain 
and the cargo bound KLC2 TPR (orange), the N-terminal TPR2-3 appears to 
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fold around the SKIP peptide (Figure 3.9). The SKIP peptide is highly negatively 
charged and the electrostatic surface representation of the binding pocket 
shows the surface to be largely positive in charge (blue) suggesting that 
recognition of cargo is partly achieved by charge complementarity (Figure 3.11). 
The tryptophan sits within a relatively hydrophobic leucine-rich pocket in 
the centre of the structure, interacting with residues on TPR2 (L248, R251, 
L263) and TPR3 (N287, L290, L291). The aspartic acid (SKIP D208) and the 
glutamic acid (SKIP E206) point in the opposite direction and face the TPR3-4 
side of KLC2TPR groove. The carboxylate side chain of SKIP D208 form a 
network of salt bridges and H-bonds with the positively charged R312 and K325 
side-chains and SKIP E206 is stabilized by ionic interactions with K325 of KLC2 
TPR. The leucine at the -2 position is common for W-acidic motif containing 
proteins and the structure shows that SKIP L205 is buried in a pocket between 
TPR3 and TPR4, involving V290, C305 (from TPR3) and N329, L332, and L333 










Figure 3.9. Structure of the SKIPWD_KLC2TPR cargo complex. 
(A and B) Illustrated representations of the SKIPWD motif (displayed as 
stickmodel in green) bound to KLC2TPR domain (orange) in two orthogonal 
orientations. Simulated annealing (Fo-Fc) omit map for the W-acidic cargo motif 
is contoured at the 3s level. Individual TPR repeats composed by helix-turn-
helix elements (“I” and “E” for internal and external, respectively) are highlighted 
in (A). A non-TPR helix (αN) is between TPR5 and TPR6. (B) also shows the 
cargofree KLC2TPR structure (gray transparent), with an orange arrow 
indicating the movement of the TPR2-TPR3 region with respect to the common 
TPR4-TPR6 reference frame. (C) Electrostatic potential surface representation 
of KLC2TPR with its SKIPWD-bound cargo. Positive and negative potential is 
shown in blue and red, respectively. Cargo recognition is achieved by a 
combination of charge complementarity and sequence specificity. (Figure 










Figure 3.10. Data collection and refinement statistics. 






3.7 Verification of the binding pocket 
3.7.1 Co-immunoprecipitation 
To verify the structural model and to examine the importance of the main 
residues found within the binding pocket of the KLC2 TPR domain in cargo 
recognition, a series of key residues that appeared to interact with the SKIPWD 
peptide were mutated. Both charge reversal mutations as well as mutations not 
affecting charge were made; for example R to E and R to A. A GFP-TRAP 
immunoprecipitation assay was used to determine the effect of making 
mutations of key residues within the KLC2 binding pocket. HeLa cells were co-
transfected with plasmids designed to express N-terminally hemagglutinin (HA) 
tagged KLC2 and mutants of KLC2 (R251D, N287L, V290K, L291D, R312E, 
R312A, K325E, L333K) and N-terminally green fluorescent protein (GFP) 
tagged SKIP(1-310). GFP and GFP-SKIPWEWD (Both WE and WD mutated) 
were also included as negative controls. GFP/GFP-SKIP(1-310) was 
immunoprecipitated with GFP-TRAP beads and the amount of co-
immunoprecipated  HA-KLC2 was assessed by western blot.  Binding was 
significantly reduced or lost completely for all of the mutations made. The 
charge reversal mutations give an indication of the large part that electrostatic 
interactions play in cargo binding. Mutating R251, R312, K325 of KLC2 to acidic 
residues resulted in substantial loss of binding to SKIP (Figure 3.11B). The 
R312E mutation had the largest impact; supporting the fact that this residue is 
directly involved in forming salt bridges with the side chain of the aspartic acid 
(of the tryptophan-acidic motif) on the cargo.  The R312E mutation had a 
greater impact than R312A, illustrating that the interaction is not only due to 
sequence specificity but also due to charge complementarity (Figure 3.11B). 
 
3.7.2 Fluorescence polarisation analysis of key mutations 
To further validate the structure in a biophysical assay, the effect of making the 
KLC2 point mutations (N287L, R251D or R312E) on the affinity of the 
SKIP:KLC interaction, fluorescence polarisation assays were carried out in 
collaboration with Dr. Stefano Pernigo, Steiner group, KCL. N287L, R251D and 
R312E were chosen because N287 and R251 make direct interactions with the 
tryptophan and R312 interacts with the aspartic acid flanking the tryptophan (D-
208) in the tryptophan-acidic motif (WD). 
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As described earlier, N-terminal carboxytetramethylrhodamine (TAMRA) 
conjugated peptide (SKIPWD) was added at 100nM concentration to increasing 
concentrations of wildtype KLC2 TPR(219-480) and proteins  containing a point 
mutations (N287L, R251D or R312E). This enabled binding curves to be 
generated from which dissociation constants (Kd) could be calculated. These 
fluorescence polarization measurements confirm that upon making mutations of 
key residues within the KLC2 binding pocket, binding is significantly reduced.   
 
3.7.3 Immunofluorescence 
When full length SKIP and its small guanosine triphosphatase binding partner 
Arl8 are co-expressed in cells they associate strongly with lysosomes and 
promote their trafficking to the cell periphery (Rosa-Ferreira and Munro, 2011). 
When co-expressed, GFP-KLC2 associates with the same lysosomes (Figure 
3.11, top). Thus, this provides a convenient assay to determine whether the 
mutations defined by the structure impact upon cargo binding in vivo. This 
association does not occur upon making the KLC2 mutations (R251D, N287L, 
and R312E) (Figure 3.12), providing further validation of the model in a cellular 
context where full length SKIP is present. 
 
3.7.4 Disruption of the SKIP:KLC interface disrupts the association of 
SKIP with the kinesin-1 tetramer 
The experiments described above confirm that mutational disruption of the KLC 
TPR – W-acidic interface prevents SKIP interaction with the light chain in 
biochemical, biophysical and cell based assays. However, they do not 
demonstrate that this interface is crucial for binding the kinesin-1 tetramer. If 
this interface is crucial for kinesin-1 cargo recognition then it would be expected 
that the same mutations would also inhibit this interaction.  
To test this, GST-tagged SKIP (1-310) was purified from E.coli and 
bound to glutathione coated beads. GST-SKIP beads (or control GST beads) 
were incubated with 293T cell extracts expressing N-terminally citrulline (Cit) 
tagged KHC alone or Cit-KHC co-expressed with wildtype and mutant HA-KLC2 
constructs. As expected, both HA-KLC2 and Cit-KHC were pulled down robustly 
by GST-SKIP (but not GST) from extracts with wildtype KLC2. KHC expressed 
alone was not pulled down by GST-SKIP. It was also notable that co-expression 
of light chain appeared to enhance expression of KHC. More importantly 
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however, mutation of the W-acidic binding site using N287L or R251D 
dramatically reduced binding of both the heavy and light chains. Taken 
together, these data confirm the importance of the W-acidic interface defined in 



































Figure 3.11. Mutations in the SKIPWD:KLC2TPR interface disrupt binding. 
(A) Details of the SKIPWD:KLC2TPR interface. KLCTPR side chains stabilising 
the SKIPWD cargo peptide (green) are shown as gray sticks emanating from the 
orange model. Non-carbon elements are nitrogen, dark blue; oxygen, red; and 
sulfur, yellow. Hydrogen bonds are represented by dotted light blue lines. 
(Figure supplied by Steiner group) (B) Co-immunoprecipitation of HA-KLC2TPR 
(70.0 kDa) and KLC2TPR containing mutations at the SKIPWD:KLC2TPR 
interface with GFP-SKIP (62.1 kDa) or GFP (29.9 kDa) control. Input lysates 
and co-immunoprecipitated HA-KLC2 (bound) were blotted for KLC2 using an 
anti-HA mouse monoclonal antibody. GFP and GFP-SKIP were blotted for using 
an anti-GFP mouse monoclonal antibody. A goat polyclonal anti-mouse HRP 
antibody was used as a secondary antibody to allow for detection using Clarity 
Western ECL substrate. The blot is representative of three experiments 
involving three independent repeat transfections followed by co-
immunoprecipitation (C) Fluorescence polarization measurements showing that 
R251D, N287L, and R312E mutations in KLC2 dramatically reduce the affinity 
of the TPR domain for the SKIPWD peptide. The graph shows average values 
from three independent experiments utilising the same KLC2TPR/mutant 
preparation and TAMRA conjugated peptide stock solutions. Measurements 
were performed on a Horiba Fluoromax-4 spectrofluorometer at 20 °C. A one 
site - specific binding curve was fitted to the data: Y = Bmax*X/(Kd + X). Kd 
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Figure 3.12. Replacement of key KLC2TPR residues results in loss of GFP-
KLC2 association with Arl8/SKIP– positive lysosomal membranes. 
Representative confocal fluorescence images showing HeLa cells transfected 
with GFP-KLC2 or KLC2 mutant (N287L, R251D or R312E), Arl8-HA and myc-
SKIP. The primary antibodies used were a rabbit polyclonal anti-HA antibody 
and a mouse monoclonal anti-myc antibody. The secondary antibodies were 
Alexa 633 goat anti-rabbit antibody and Alexa 568 goat anti-mouse antibody 
probing for Arl8-HA and myc-SKIP respectively. In merge panels, GFP-KLC2, 



















Figure 3.13. KLC2 TPR domain mutations prevent binding to the kinesin-1 
tetramer.  
Pull-down of Cit-KHC(135.6 kDa) and HA-KLC2 (70.0 kDa)  (or HA-KLC2 
mutants N287L or R251D) from 293T cell lysate using GST-SKIP(1-310) (61.8 
kDa) or GST (25.5 kDa) as control.  Input lysates were blotted for HA-KLC2 (or 
HA-KLC2 mutants N287L or R251D) and Cit-KHC as control using a mouse 
monoclonal anti-HA antibody and a mouse monoclonal anti-GFP (detecting the 
citrulline tag). A goat polyclonal anti-mouse HRP antibody was used as a 
secondary antibody to allow for detection using Clarity Western ECL substrate. 
GST and GST-SKIP(1-310) were visualized by ponceau staining. The blot is 
representative of three experiments involving three independent repeat 
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The aim of the experiments in this chapter was to determine an X-ray crystal 
structure of a W-acidic motif in complex with the TPR domain of KLC2 in order 
to shed much needed light on the molecular mechanisms underlying the 
kinesin-1 cargo recognition. This was achieved through the careful 
characterisation of the determinants of the SKIP – KLC interaction and 
development of a suitable crystallisation strategy. Validation of the resulting 
structure was achieved with a series of biochemical, biophysical and cell based 
assays. Specific recognition is achieved though a combination of sequence 
specific and electrostatic interactions.  
Fluorescent polarisation assays show that the KLC2 TPR domain 
specifically recognises the tryptophan acidic motif(s) in SKIP and that they 
make different contributions to KLC2 binding (Figure 3.1 and Figure 3.3). 
Consistent with this, significantly more binding is lost when the first motif is 
replaced by alanine compared to the second motif (Figure 3.1). This appears to 
parallel the situation in vaccinia A36R protein where one motif makes a much 
more important contribution than the other (Dodding et al. 2011). In that same 
study, replacement of the cytoplasmic domain of A36 with the kinesin binding 
region of SKIP (aa157–264) was sufficient for kinesin-1 recruitment and 
transport. This was dependent upon both W-acidic motifs in SKIP. However, 
supporting the data shown here, the first motif of SKIP plays a bigger role 
(Dodding et al. 2011), but does perhaps suggest that the second motif is still 
important.  
Extension of the peptide in FP experiments to encompass both W-acidic 
motifs resulted in a substantial increase in binding affinity compared to either 
motif alone.  Two hypotheses have the potential to explain this effect. Firstly, it 
may be the case that co-operativity and/or avidity effects operating between the 
motifs contribute to an increase in apparent affinity. Alternatively, residues in 
the intervening sequence may directly contribute to binding. Some experimental 
evidence that the second mechanism may at least make a contribution is 
suggested by the larger effect of the exon 7 deletion on KLC binding than the 
WE mutation alone, however further (although likely very costly) studies using 
mutated peptides may provide a more definitive answer. The SKIP peptide: 
KLC TPR domain interaction is of a relatively low affinity. Whether this 
interaction alone is sufficient for transport through the cell remains to be 
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established. The TPR construct used in the fluorescence polarisation 
experiments did not include the first helix of the first TPR and as a result the 
binding affinity quantified may also not be representative for the full length TPR 
domain.  
Calsyntenin-1 contains two tryptophan-acidic motifs where both motifs 
contribute to similar degrees to binding to KLC1 (Konecna et al., 2006). In line 
with this, both motifs contribute to similar extents in a vaccinia virus transport 
assay (Dodding et al. 2011). Further work on this by Dr. Dodding and Dr. 
Perngio confirmed that both Calsyntenin-1 motif peptides bind KLC with 
comparable and high affinities (10µM) and that binding is inhibited by the 
mutations defined in this thesis (Pernigo et al. 2013), suggesting that the pocket 
defined here may be universal for these motifs.  However a single Calsyntenin-
1 motif is sufficient to mediate some degree of kinesin-1 activity and transport 
when fused to a TM domain (Kawano et al., 2012), suggesting that the 
relationship between cargo containing two tryptophan acidic-motifs and kinesin-
1 can vary depending on context and sequence. Indeed, since publication of 
this work, the Holzbaur group discovered a single W-acidic motif in Nesprin-2 
that contributes to nuclear positioning in myotubes (Wilson and Holzbaur, 
2015). Further validating the findings here, the mutations defined in this chapter 
also inhibit interaction with Nesprin-2. 
 Dodding et al. identify more than 1360 motifs as potential KLC binding 
partners based on bioinformatics analysis of a loose consensus W-acidic 
sequence. Given the difference in affinity between very similar motifs studied 
here, more effort will be needed to further understand the reasons for these 
differences to refine this consensus before more accurate predictions can be 
made. However, it seems likely that number is an overestimate. 
In this chapter, the binding pocket for tryptophan-acidic motifs is 
observed in the structure of the KLC2TPR domain in complex with the 
tryptophan-acidic motif containing peptide from SKIP (Figure 3.9). The 
KLC2TPR concave groove is highly positively charged and complements the 
highly negatively charged SKIP peptide. This suggests that recognition of cargo 
is partly achieved by charge complementarity (Figure 3.11). Upon SKIP binding 
to the KLC2 TPR domain the N-terminal TPR2-3 appears to fold around the 
SKIP peptide. This structural change is not typical for TPR domains and may be 
responsible for the transduction of a signal to activate kinesin-1. The key 
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residues identified from the crystal structure to be involved in interacting with 
SKIP, was verified through mutagenesis, co-immunoprecipitation, fluorescence 
polarisation as well as immunofluorescence. 
Amino acid substitution tested within the KLC2TPR groove significantly 
reduced binding to SKIP(1-310). The importance of electrostatic interactions in 
cargo recognition is highlighted by the charge-reversal mutations.  Replacement 
of R251, R312, K325 by acidic residues, results in substantial loss of binding. 
Less “extreme” mutations for example R312A also significantly impairs binding, 
but to a lesser extent than R312E. Fluorescence polarization also showed 
complete abrogation of binding upon making three key mutations within KLC2 
TPR domain (R251D, N287L, or R312E). This was verified in vivo, showing that 
KLC2 containing the mutations (R251D, N287L, or R312E) do not associate 
with lysosomes at the cell periphery. 
The structure suggests that the highly conserved leucine in the -2 
position from the tryptophan in the tryptophan-acidic motif plays an important 
part in cargo recognition as it occupies a relatively hydrophobic binding pocket 
on the TPR. This is supported by the fact that the SKIPWE peptide which does 
not have a leucine in the -2 position (but instead has a threonine residue) 
makes a lower affinity interaction with KLC2. The leucine in the -2 position of 
the second tryptophan-acidic motif of Calsyntenin-1 has also been shown to be 
essential for binding to KLC as mutation of the leucine to alanine abrogates 
binding to KLC1 (Kawano et al., 2012). The first tryptophan acidic motif from 
Calsyntenin-1 also contains a related methionine at the -2 position and binds to 
KLC1 with comparable affinity (Konecna et al., 2006, Pernigo et al., 2013). The 
constraints used by Dodding et al., 2011 to identify possible tryptophan-acidic 
motif containing binding partners did not include a leucine/methionine in the -2 
position. There are therefore likely to be far fewer higher affinity tryptophan-
acidic motifs than predicted. It is likely that this will have a significant impact on 
the real number of W-acidic cargoes in mammalian cells. 
 Despite this, there are examples of cargo that also bind to KLC TPR 
domain that do not have a tryptophan acidic motif.  Zhu et al. suggest that the 
acidic C-terminal peptide of JIP1 that also contains aromatic and hydrophobic 
residues (sequence EYTCPTEDIYLE) binds within the same positively charged 
groove (although perhaps making more important contacts with TPR3). It 
seems possible that the general principle of sequence specific and electrostatic 
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interactions established here may support the recognition of more diverse 
sequences, with peptides of different composition taking different paths through 
the charged groove.  Further attempts to address this question are described in 































CHAPTER 4 . SKIP BINDS DIRECTLY TO KINESIN 
HEAVY CHAIN. 
 
Chapter 3 has provided a greater understanding of how cargo recognition is 
achieved by KLC, through the crystallisation and solving of the structure of the 
first kinesin-cargo interface. Over expression experiments in cells suggest that 
SKIP has an intrinsic capacity to bind and activate kinesin-1 as transfection of 
full-length SKIP promotes kinesin-1 dependent lysosome dispersion. A number 
of reports suggested that full activation of kinesin-1 requires binding to the 
heavy chain in addition to contacts with the light chain (Blasius et al., 2007). 
Indeed, JIP-1 binds both the heavy and light chains (Fu and Holzbaur, 2013). 
Given this potent capacity of SKIP to drive lysosome dispersion, it seemed 
possible that SKIP may also possess a similar capacity to bind to both KHC and 
KLC. Experiments in this chapter test this hypothesis and show just a variety of 
biochemical and biophysical assays that SKIP does indeed have the capacity to 
interact directly with KHC. Further work fine maps the respective binding sites 
on both molecules.  
 
4.1 SKIP binds to KHC 
To determine whether SKIP binds directly to the cargo binding domain of KHC, 
a GST pulldown experiment was carried out using E.coli expressed GST tagged 
C-terminal tail region of KHC (Kif5C) (amino acid residues 815-955) and SKIP 
(amino acid residues 1-310). The C-terminal tail region of KHC was expressed 
as a GST fusion and eluted in a batch purification method with glutathione 
Sepharose 4 fast flow beads. GST-SKIP(1-310) was expressed and purified in 
the same way. The GST tag was then cleaved from SKIP(1-310) using the C3 
protease and the bulk of free GST or uncleaved GST-SKIP were removed by a 
second incubation with glutathione coated beads. This enabled the study of the 
KHC:SKIP interaction by GST pulldown (Figure 4.1A).  
Saturation binding experiments were carried out by incubating 1.6µM of 
GST-KHC(815-955) with increasing concentrations of SKIP(1-310), followed by 
pulldown with glutathione coated beads and analysis by SDS-PAGE (Figure 
4.1B). Binding was monitored by band densitometry that indicated that binding 
tends toward saturation. The binding curve appeared sigmoidal in character, 
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perhaps suggesting some degree of co-operativity.  Although such a non-
equilibrium experiment is not ideal for the determination of Kd, fitting binding 
data from three independent experiment suggested that the Kd is on the order 
of 1.5µM with a Hill coefficient of 2. This Hill coefficient is indicative of some co-
operativity. Due to the high concentration of GST-KHC(815-955) used, the 
calculated Kd should be treated with caution. At the lower concentrations of 
SKIP, SKIP is not in excess, which may cause the sigmoidal curve observed. 
This effect may be overcome by using a lower GST-KHC(815-955) 
concentration to pull down SKIP. However to enable binding to be seen by 
coomassie staining a high concentration of KHC was used. Within an 
equilibrium binding experiment, the concentration of the receptor is usually kept 
constant and below the Kd (R/Kd < 0.1 or lower). Higher receptor 
concentrations may lead to ligand depletion due to the binding of significant 
amounts of ligand. In Figure 4.6 a much lower concentration of receptor 
(TAMRA-SKIP (202-241)) is used than ligand KHC (866-917) which suggests 
that the shape of the curve is not due to ligand depletion, but may result from 
cooperative binding. 
 Confirming the statistical significance of the level of binding observed, 
comparison of SKIP bound at a concentration of 3.5µM bound significantly less 
to GST than GST-KHC (815-955) (p<0.001) (Figure 4.1C). The GST cleaved 
SKIP(1-310) used for the pulldown contains a series of breakdown products 
and some higher molecular weight impurities. It seems likely that that SKIP* and 
SKIP** highlighted in Figure 4.1B could be uncleaved SKIP and SKIP*** may be 
a breakdown product of an uncleaved SKIP as all of these contaminants bind 
GST-KHC in a concentration dependent manner but do not bind to GST alone. 
The KHC breakdown products (KHC* and KHC**), as expected, remain 
constant as a fixed concentration of KHC was used. Taken together, these data 










Figure 4.1. SKIP(1-310) tends toward saturable binding to GST-KHC (815-
955). 
(A) Coomassie stained gel of C3 cleavage of GST tag from GST-SKIP(1-310) 
(61.8 kDa). Lanes from left show uncleaved protein, protein sample after 
cleavage (35.3 kDa) and cleaved protein sample after removal of GST by GST 
Sepharose beads. (B) Coomassie stained gel of pull-down of SKIP(1-310) using 
GST-KHC(815-955) (42.6 kDa) or GST (25.5 kDa) as control.  The 
concentrations of SKIP(1-310) indicated were incubated with 0.5nmoles GST-
KHC(815-955) or GST in a volume of 300µl (1.6µM). (C) Graph of the band 
intensity of SKIP(1-310)  against concentration of SKIP(1-310) incubated with 
GST-KHC(815-955). Hill coefficient (h) = 2, h standard error=0.339. The graph 
is based on quantification from three experiments with the same protein 
preparations. A one site - specific binding curve with a hill slope was fitted to the 
data: Y=Bmax*X^h/(Kd^h + X^h). (D) Comparison of band intensity of SKIP(1-
310) incubated at 3.5µM with GST-KHC(815-955) and GST. ***P<0.001 (two-
tailed T-test). (E) Representative graph of one experiment showing the band 
intensities of SKIP(1-310) and the SKIP breakdown products (SKIP*, SKIP** 
and SKIP***). (F) Representative graph of one experiment showing the band 
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4.2 SKIP binding to the C-terminal tail of KHC requires amino 
acids 876-917 
To map where SKIP binds on the KHC tail a series of GST tagged C-terminal 
KHC fragments were expressed in E.coli  (Figure 4.2A and Figure 4.2B) and 
purified by batch purification with glutathione Sepharose 4 fast flow beads. 
GST-SKIP(1-310) was expressed and purified in the same way and the tag 
cleaved as described in the previous section.  SKIP(1-310) was incubated at 
the subsaturating concentration of 1.2µM with 1.6µM GST-KHC(815-955), GST 
alone or  GST-KHC fragments (815-907, 815-917, 815-931, and 907-955) in a 
volume of 300µl. A subsaturation concentration of SKIP was used to allow for 
subtle variation in binding to be observed.  Figure 4.2B shows the purified 
protein used in the GST-pulldown in Figure 4.2C.  Truncating the C-terminal tail 
from 815-955 to 815-917 has no effect on binding (compare lane 5 with lanes 3 
and 4). However, removing an additional 10 amino acids by truncating KHC 
815-917 to 815-907, binding to SKIP(1-310) is completely lost. This suggests 
that the region between 907 and 917 is essential for binding to KHC. The KHC 
fragment 907-955 however does not bind to SKIP(1-310) (Figure 4.2C lane 6 
and D). This suggests that although the 907-917 region of KHC is essential for 
binding to SKIP(1-310) it is not sufficient. These observations were supported 
by quantification of band densities from 3 independent experiments (Figure 
4.2C). These data suggested that further residues from the final coiled-coil of 
KHC are also required for the interaction.    
The 907-917 construct was extended at the amino terminal end further 
into the coiled-coil region of the KHC C-terminal tail to amino acids 903, 899 
and 891 (Figure 4.3A). However, no binding was seen extending the KHC 
construct as far as residue 891 into the coiled coil region (Figure 4.3B and C). A 
region prior to 891 is essential for binding to KHC. Expressing further GST-KHC 
fragments extending further into the coiled coil region showed that the region 
876-917 is sufficient for binding to SKIP(1-310) although some incremental 
binding is observed with further N-terminal extension to residue 815. Figure 
4.3C and E show a coomassie stained gel of the purified proteins used in 
Figure 4.3B and D. 
Given the apparent importance of residues in 907-917, a GST-pulldown 
was carried out mutating residues in triplicate between 907-917 to alanine in an 
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attempt to further map the SKIP(1-310) binding site on KHC. SKIP(1-310) was 
incubated at a concentration of 1.2μM with 0.5nmoles GST-KHC(815-955), 
GST-KHC(915-955) with mutations RAK, NMA or RRA to alanine and GST as 
control in a volume of 300µl (1.6µM) (Figure 4.4). However, these mutations did 
not have an appreciable affect binding. This may be caused by the other 
binding regions compensating for the disruption in binding of three amino acid 




































Figure 4.2. KHC residues 907-917 are essential for binding to (SKIP1-310) 
but not sufficient. 
(A) Schematic representation of rat KHC fragments used in this experiment.  
The predicted coiled-coil region as well as the IAK autoinhibitory sequence are 
highlighted. Molecular Weights are shown in brackets. (B) Coomassie stained 
gel of pulldown of SKIP(1-310) (35.3 kDa) at 1.2µM using GST-KHC fragments  
or GST as control at 0.5nmoles in a volume of 300µl (1.6µM). (C) Coomassie 
stained gel showing purity of samples used in B. (D) Comparison of bound band 
densities of SKIP (1-310) incubated at 1.2µM with GST-KHC fragments and 
GST. The graph shows data from three independent experiments with the same 


















































































































GST-KHC     
SKIP(1-310)


















Figure 4.3. The minimal SKIP(1-310) binding site on KHC is 876-917. 
(A) Schematic representation of additional rat KHC fragments expressed in this 
study.  The coiled coil region as well as the IAK autoinhibitory sequence are 
highlighted. Molecular Weights are shown in brackets. (C) and (E) Coomassie 
stained gel showing purity of samples used in B and D respectively. (B) and (D) 
Coomassie stained gel of pulldown of SKIP(1-310) (35.3 kDa)  at 1.2μM using 
GST-KHC fragments  or GST as control at 0.5nmoles in a volume of 300µl 
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Figure 4.4. Mutation of residues within the essential binding region 907-
917. 
(A) Sequence of KHC(815-955) with essential binding region highlighted in blue 
and autoinhibitory sequence (IAK) highlighted in bold. (B) Coomassie stained 
gel of pull-down of SKIP(1-310) at 1.2μM using GST-KHC(815-955) (42.2kDa) 
and GST(815-955) with amino acid residues in the 907-917 region mutated in 
triplicate (RAK, NMA, RRA) (42.5 kDa)  to alanine  or GST (25.5kDa) as control 
at 0.5nmoles in a volume of 300µl (1.6µM) (n=3) Pull-down was repeated using 
the same protein preparations. (C) Coomassie stained gel showing purity of 








































































4.3 KHC binds to an extended region of SKIP  
Having mapped the minimal SKIP binding site on KHC to amino acid residues 
876-917, the next task was to determine the KHC binding site on SKIP (1-310).  
SKIP 1-310 and a series of C-terminal truncations of SKIP (1-276,1-260, 1-
243,1-216 and 1-202) shown in Figure 4.5A were expressed in E.coli as N-
terminally His6-tagged proteins and were purified by Ni2+-affinity 
chromatography. The purity of the proteins expressed is shown in the 
Coomassie stained gel in Figure 4.5B. Due to the similar molecular weights of 
GST/GST-KHC and His-SKIP proteins, results were analysed by anti-His 
western blot rather than coomassie staining. GST-KHC is shown by ponceau 
staining of the same membrane. Consistent with the previous assays indicating 
a direct interaction between KHC and SKIP, His-SKIP (1-310) was pulled down 
by GST-KHC but not GST alone (Figure 4.5C). Interestingly, C-terminal 
truncation of SKIP to amino acid 276 appeared to enhance binding with a slight 
reduction in binding when that construct was truncated to amino acid 243. 
Strikingly however, binding was dramatically reduced when this construct was 
further truncated to residue 216 which removes both W-acidic motifs of SKIP 
and further diminished by truncation to residue 202.  These data suggest that 
an extended region of SKIP, encompassing the W-acidic motifs may be 
required for KHC binding. However, this interpretation may be complicated by 
the similar size of the His-SKIP (1-310) and GST-KHC proteins. In some cases, 
the relatively large amount of one protein can interfere with antibody binding to 
another protein that migrates at a similar position on the gel and so occupies 
the same area of membrane. To investigate this, the assay was adapted to pull 
down GFP-tagged SKIP proteins expressed in 293T cell extract which have 
higher molecular weights resulting from the inclusion of a 26kDa GFP tag. GST-
KHC did not pull down GFP alone but did efficiently pull down GFP-SKIP 
(Figure 4.5D). Broadly supportive of the conclusions from the direct binding 
experiments, C-terminal truncation of SKIP 1-310 did appear to enhance 
binding. Similarly, truncation from residue 243 to 216 essentially eliminated 




4.4 The SKIP binding region of KHC interacts with the SKIPWDWE 
peptide (202-241) in fluorescence polarisation assays 
The data described above suggested a crucial role for the region of SKIP that 
includes the two W-acidic motifs.  To verify these findings using another assay 
and to understand whether this region is sufficient to mediate an interaction,   
a fluorescence polarization assay was carried out using KHC amino acids 866-
917 and the TAMRA conjugated SKIPWDWE peptide (described in the previous 
chapter) adding a 100nM TAMRA conjugated SKIPWDWE peptide to increasing 
concentrations of KHC (866-917)(Figure 4.6). The concentration dependent 
increase in polarisation suggests that the protein and peptide interact.  Similar 
to that observed in pull down analyses, the binding curve is sigmoidal in 
character. Curve fitting indicated a Kd of 7.8 μM and a Hill co-efficient of 4. 
Whilst the Kd is slightly lower than that calculated in figure 4.1, these data do 
indicate that this region make a significant contribution to the SKIP KHC 
interaction. 
 
4.5 In vitro, KHC and KLC compete for overlapping binding 
sites on SKIP 
Since both tryptophan-acidic motifs (WD and WE) are present in the minimal 
SKIP binding region, the contribution of these residues to KHC binding was also 
investigated. Pull-down of GFP-SKIP and SKIP mutants (WD, WE, and both 
WD and WE) from 293T cell lysates using GST-KHC(815-955) or GST as 
control show that binding is dramatically reduced upon making alanine 
substitutions in either of the tryptophan acidic motifs. This suggests that both 
tryptophan-acidic motifs contribute to KHC binding (Figure 4.7A). It is possible, 
(although unlikely given the typically low expression of KLCs in non neuronal 
cells when compared to exogenous, over expressed protein) that this 
interpretation may be confounded by endogenous KLC in the cell lysates. To 
verify that this does indeed occur in direct binding experiments when both 
proteins are produced in E.coli, a GST-pulldown assay of His-SKIP and SKIP 
mutants (WD, WE, and both WD and WE) with GST-KHC(815-955) or GST  
was performed. This again showed that binding is significantly reduced upon 
making the alanine substitutions in the tryptophan-acidic motifs (Figure 4.7B).  
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Since both KHC and KLC appear to share the same binding region it was 
important to determine whether KLC binding could compete with KHC binding 
to SKIP(1-310) in a concentration dependent manner. GST pull-down of GFP-
SKIP from 293T cell lysates using GST-KHC(815-955) or GST as control in the 
presence of increasing concentrations of KLC2 TPR (produced in E.coli) show 
that upon increasing the concentration of KLC2 TPR, binding between KHC and 
SKIP is reduced (Figure 4.8A). KLC2 TPR binding to SKIP can compete off 
KHC binding. To verify that this is due to KLC2 TPR binding to SKIP, the N287L 
KLC2 mutant (shown to abrogate KLC:SKIP binding) was also added at 
increasing concentrations. Consistent with this interpretation, this did not have 





























Figure 4.5. Extended region of SKIP is required for KHC binding. 
(A) Schematic representation of the SKIP fragments expressed in this study.  
The RUN domain and the tryptophan-acidic residues (WD and WE) are 
highlighted (B) Coomassie stained gel showing purity of samples used in (C) 
(His-SKIP(1-310): 37.8 kDa, His-SKIP(1-276): 34.2k Da, His-SKIP(1-260): 32.4 
kDa, His-SKIP(1-243): 30.7 kDa, His-SKIP(1-216):  27.7kDa, His-SKIP(1-202): 
26.3 kDa, GST; 25.5 kDa, GST-KHC(815-955): 42.6 kDa). (C) Western blot of 
pull-down of His-SKIP(1-310) and truncations of SKIP at 1.2µM using GST-
KHC(815-955) or GST as control at 0.25nmoles in a volume of 300µl (0.83µM). 
His-SKIP was blotted for using a mouse monoclonal anti-His HRP conjugated 
antibody to allow for detection using Clarity Western ECL substrate. GST and 
GST-KHC(815-955) were visualized by ponceau staining. (n=3) Repeats 
involved three independent repeat transfections followed by pulldown using the 
same protein preparations. (D) Pull-down of GFP-SKIP(1-310) and SKIP 
truncations from 293T cell lysate using GST-KHC(815-955) or GST as control. 
Input lysates were blotted for GFP-SKIP and SKIP truncations as control using 
a mouse monoclonal anti-GFP antibody. A goat polyclonal anti-mouse HRP 
antibody was used as a secondary antibody to allow for detection using Clarity 
Western ECL substrate (GFP-SKIP(1-310): 62.1 kDa, GFP-SKIP(1-276): 58.5 k 
Da, GFP-SKIP(1-260): 56.6 kDa, GFP-SKIP(1-243): 55.0 kDa, GFP-SKIP(1-
216):  52.0 kDa, GFP -SKIP(1-202): 50.5 kDa, GFP; 26.9 kDa). GST and GST-
KHC(815-955) were visualized by ponceau staining. (n=3) Pull-downs were 








































































































































































Figure 4.6. The minimal SKIP binding region on KHC interacts with 
SKIP(202-241) peptide. 
Fluorescence polarisation measurements of increasing concentrations of 
KHC(866-917) with 100nM N-terminal carboxytetramethylrhodamine (TAMRA) 
conjugated peptide SKIP(202-241) in 25mM Hepes pH 7.5, 5 mM β-
mercaptoethanol  and 150mM NaCl. Measurements were performed on a 
Horiba Fluoromax-4 spectrofluorometer at 20 °C. A one site - specific binding 
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Figure 4.7. Light chain binding motifs are also required for heavy chain 
interaction.  
(A) Pull-down of GFP-SKIP(1-310) (62.1 kDa) and SKIP mutants (WD, WE, and 
both WD and WE) (61.9 kDa) from 293T cell lysate using GST-KHC(815-955) 
(42.6 kDa) or GST (25.5 kDa) as control. Input lysates were blotted for GFP-
SKIP(1-310) and SKIP mutants as control using a mouse monoclonal anti-GFP 
antibody. A goat polyclonal anti-mouse HRP antibody was used as a secondary 
antibody to allow for detection using Clarity Western ECL substrate. GST and 
GST-KHC(815-955) were visualized by ponceau staining. (n=3) Repeats 
involved three independent repeat transfections followed by pulldown using the 
same protein preparations. (B) Western-blot of pull-down of His-SKIP(1-310) 
and SKIP mutants (WD/AA, WE/AA, and WDWE/AAAA) (37.8 kDa) at 1.2µM 
using 0.25nmoles GST-KHC(815-955)  or GST as control in 300µl (0.83µM). 
His-SKIP was blotted for using a mouse monoclonal anti-His HRP conjugated 
antibody to allow for detection using Clarity Western ECL substrate (n=3). 
Repeats involved three independent repeat transfections followed by pulldown 
using the same protein preparations. (C) Coomassie stained gel showing purity 
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Figure 4.8. Increasing KLC2 concentration reduces KHC binding to SKIP. 
Pull-down of GFP-SKIP (1-310) (62.1 kDa) from 293T cell lysate using GST-
KHC (815-955) (42.6 kDa) or GST (25.5 kDa) as control in the presence of 
increasing concentrations of (A) KLC2 and (B) KLC2 N287L mutant. Input 
lysates were blotted for GFP-SKIP(1-310) and SKIP mutants as control using a 
mouse monoclonal anti-GFP antibody. A goat polyclonal anti-mouse HRP 
antibody was used as a secondary antibody to allow for detection using Clarity 
Western ECL substrate. GST and GST-KHC(815-955) were visualized by 
ponceau staining. (n=3). Repeats involved three independent repeat 
transfections followed by pulldown using the same protein preparations. Single 
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This chapter has described experiments aimed at determining whether 
SKIP interacts directly with KHC and demonstrate that SKIP(1-310) binds 
directly to the C-terminal tail of KHC. The region to which SKIP(1-310) binds on 
KHC has been mapped to amino acid residues 876-917. N and C terminal 
deletions from this construct show that the KHC regions 876-891 
(KALESALKEAKENAM) and 907-917 (VRAKNMARRAH) are essential for SKIP 
binding although neither is sufficient for binding on their own (Figure 4.2 and 
Figure 4.3).  The bulk of this minimal binding region is predicted to be 
composed of coiled-coil (although the final 10 amino acids may be less 
structured). It may be that the formation and stability of this coiled-coil dimer 
requires these extended N- and C- terminal regions. Since truncations were 
used to map the binding sites, there is the possibility that through truncation the 
tertiary and quaternary structure of the protein in question is affected. The KHC 
truncations used in mapping the SKIP binding site are expected to be dimeric in 
nature due to the length of the predicted coiled coil region. The shorter 
constructs with a shorter coiled coil region may however not be dimeric and 
extending the construct further into the coiled coil region may enable 
dimerization of the longer constructs. Extending the KHC construct from 891-
917 to 876-917, into the coiled coil region, may be required for dimerization and 
may not be an essential SKIP binding region itself, but through dimerization 
allow for SKIP to make a series of contacts along the length of KHC that is 
dependent upon dimerization. 
Mapping of the KHC binding site on SKIP reveals that whilst an extended 
region of SKIP appears to be important, the W-acidic containing region and the 
motifs themselves play a key role. Mutation of these motifs impairs binding to 
KHC and at high concentrations KLC is capable of competing for the same 
site(s).  Given the unstructured nature of the SKIP peptide, it is tempting to 
speculate that this peptide may make multiple specific contacts along the length 
of the coiled-coil. The 876-917 region of KHC is highly basic (pI 10.37) and the 
SKIP peptide is highly acidic (pI 2.74), so it is also likely that electrostatic 
interactions also make an important contribution.  Thus, the data here suggest 
that both KHC and KLC may recognise similar features within cargo proteins.  
When the binding sites of different cargo are compared, the region 
encompassing the sequence ALKEAKE (Kif5C(877-887)) of KHC appears not 
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only to be required for SKIP binding but also the binding of TRAK2 and the Kv3 
(Shaw) voltage-gated K+ channel T1 domain (Kv1.3 T1) (Figure 4.9)(Barry et 
al., 2013, Randall et al., 2013). This is not the sole binding region for any of the 
three, and each has other regions of KHC that are required for binding. 
However, the fact that the pI of the Kv1.3 T1 domain is relatively low at 4.39 
and the TRAK2 kinesin binding region (124-283)(Brickley et al., 2005), has a pI 
of 4.52) may suggest that charge-charge interactions may play a general role. 
Consistent with this, Barry et al. show the residues R892K893R894 to be essential 
for the binding of KHC to Kv3.1 T1 (Barry et al., 2013). Figure 4.3B shows that 
upon extending the KHC C-terminal tail from 899-917 to 891-917 (which 
contains the RKR sequence) binding is not achieved. Since it has been shown 
that multiple contacts are required for binding to be seen, this region may also 
be involved in binding to SKIP but not be sufficient for binding. Thus the precise 
mode of binding likely differs from cargo-to-cargo but similar underlying 
molecular principles may still apply. 
In the case of SKIP, whilst the W-acidic motifs appear to be central to the 
KHC interaction, a more extended region of SKIP appears to be able to 
modulate this interaction. Surprisingly, with both recombinant protein and pull 
down from cell extracts, shortening of the SKIP 1-310 construct appears to 
enhance binding to KHC. Whilst this may be an artifact of the truncations used, 
this could also point to an auto-inhibitory regulatory mechanism within SKIP 
itself that may control its propensity to associate with kinesin-1.  
 In this chapter, SKIP is shown to have overlapping binding sites for KLC 
and KHC. The KHC binding site has been mapped to SKIP(202-241) and 
mutation of both tryptophan acidic motifs to alanine within this region 
significantly reduces KHC binding (Figure 4.5 and Figure 4.7). In contrast to 
this, KLC binding is significantly reduced by mutation of the first tryptophan-
acidic motif, whereas mutation of the second tryptophan acidic motif has very 
little effect on KLC binding (Figure 3.1). This suggests that although the binding 
regions overlap, the relative importance of the residues within this region in 
binding to KLC and KHC varies. SKIP is also unlikely to be bound to both KHC 
and KLC simultaneously as residues involved in KLC binding are also required 
in KHC binding for example the first tryptophan acidic motif (WD). KLC2 is also 
shown to compete with KHC for the binding site on SKIP (Figure 4.8), which 
suggests that binding may be mutually exclusive.  
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 Thus, having established using a series of assays that KHC interacts 
with SKIP, the next task is to establish what if any is the functional role of this 









































Figure 4.9. C-terminal KHC cargo binding region. 
An alignment of the amino acid sequences of the rat Kif5A (Protein accession 
number: NP_997688), Kif5B (Protein accession number: NP_476550) and 
Kif5C (Protein accession number: NP_001101200) cargo binding domains. 
Binding regions of TRAK2 on Kif5C (black), TRAK2 on Kif5A(blue text and 
underlined), Kv3.1 (green) and SKIP (red) is shown on the respective Kif5 
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CHAPTER 5 . FUNCTIONAL ROLES OF THE KLC: 
CARGO AND THE KHC:CARGO  INTERACTIONS IN 
KINESIN-1 RECRUITMENT AND ACTIVATION. 
 
Data presented in the previous chapters have shown that SKIP, in addition to 
being able to interact with KLC, can also interact with the C-terminal tail of KHC. 
Whilst it is clear that cargo binding is important for activation of transport, the 
relative contributions of KLC and KHC binding in cargo recognition and 
activation of transport are not fully understood.  
Data presented in Chapter 3 showed that the SKIP:KLC interaction is 
required for recruitment. Specific disruption of the SKIP:KLC interface through 
making mutations (N287L, R251D) in the KLC cargo-binding pocket essentially 
eliminates the ability of SKIP to associate with the kinesin-1 tetramer. Moreover, 
full length KHC expressed alone in cells did not interact with SKIP(1-310). What 
the functional role is of the SKIP:KHC interaction remains to be established. 
Since the KHC and KLC binding sites on SKIP were shown to overlap 
answering this question requires the capacity to mutationally separate these 
two interactions and assess the functional consequences. The experiments 
described in this chapter aimed to firstly further dissect the determinants of the 
SKIP:KHC interaction, as well as examining its relationship to the SKIP:KLC 
interaction and thus also understand its function.  
 
5.1 SKIP only binds to KHC when autoinhibition is relieved  
The data in Chapter 4 described how the C-terminal tail of KHC (KHC-815-955) 
produced in E.coli is able to interact with either GFP-SKIP(1-310) expressed in 
cell extracts or recombinant protein. However, in the context of the kinesin-1 
tetramer, disruption of the KLC:SKIP interaction is sufficient to prevent 
association of SKIP and KHC (Figure 3.13). In addition, full length KHC 
expressed alone in cells did not interact with GST-SKIP(1-310) (Figure 3.12).  
Thus, despite the fact that KHC and SKIP interact directly, the binding site may 
not be accessible in the context of the full length protein. Moreover, this may 
imply a role for the light chain in making that site accessible. As the SKIP 
binding site is proximal to the residues involved in mediating autoinhibition, it 
may be that this discrepancy is caused by inaccessibility of this binding site in 
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the autoinhibited state. To test this hypothesis, 9 residues of the autoinhibitory 
‘IAK’ sequence (QIAKPIRPG/AAAAAAAA) were mutated to alanine to disrupt 
the binding of the C-terminal tail to the motor domain of KHC and prevent 
autoinhibition (Dietrich et al., 2008, Hackney and Stock, 2000). HA-KHC 
constructs were expressed in 293T cells and binding to SKIP(1-310) analysed 
by GST-pulldown. Consistent with the hypothesis proposed above, when the 
“IAK’ sequence is disrupted, GST-SKIP(1-310) is capable of interaction with full 
length KHC. The C-terminal tail of KHC is also pulled down to a similar extent in 

































Figure 5.1. SKIP only binds to full length KHC when autoinhibition is 
relieved.  
Western blot of pull-down of HA-KHC (109.2 kDa), HA-KHC with QIAKPIRPG 
mutated to alanine (110.5 kDa) and HA-KHC(815-955) (17.3 kDa) (bands 
highlighted with ***) from 293T cell lysate using 0.25nmoles GST-SKIP(1-310) 
(61.8 kDa) or GST(25.5 kDa) as control in a volume of 300µl (0.84µM). (Bands 
highlighted with * is GST-SKIP(1-310) and cross reactivity with the HA 
antibody.) Input lysates were blotted for HA-KHC, HA-KHC with QIAKPIRPG 
mutated to alanine and HA-KHC(815-955) as control using a mouse 
monoclonal anti-HA antibody. A goat polyclonal anti-mouse HRP antibody was 
used as a secondary antibody to allow for detection using Clarity Western ECL 
substrate. GST and GST-SKIP(1-310) were visualized by ponceau staining.  
(n=3). Repeats involved three independent repeat transfections followed by 




















































5.2 Mutation of key residues in SKIP disrupt KHC:SKIP binding 
without affecting KLC:SKIP interaction. 
Data presented in Chapter 3 and Chapter 4 have demonstrated that amino acid 
residues 202-241 of SKIP contain both KLC and KHC binding sites. KHC and 
KLC binding to SKIP were shown in Chapter 4 to share some determinants, 
because mutation of the first tryptophan acidic motif (WD) in SKIP not only 
disrupts KLC binding but also disrupts SKIP binding to KHC. However, some 
indication that these binding sites may also contain distinct determinants came 
from data showing that the WE residues of SKIP are largely dispensable for the 
KLC interaction, whereas it does make a significant contribution to KHC binding.  
A naturally occurring splice variant of SKIP, where exon 7 is deleted, results in 
the residues highlighted in green (amino acid residues 219 to 238) in Figure 
5.2A to not be expressed. This splice variant, that does not promote lysosome 
dispersion (Rosa-Ferreira and Munro, 2011) and also lacks the WE motif, was 
further impaired in its ability to interact with KHC suggesting that other KHC 
specific binding determinants may exist within this region. 
To determine whether this was the case, amino acid residues within exon 
7 were mutated in triplicate to alanine as indicated in Figure 5.2A.  293T cells 
were transfected with plasmids designed to express green fluorescent protein 
(GFP) tagged SKIP, SKIP mutants (WD, EDY, DFG, DVF, PAV, PSV, PSTD, 
WE, DGD, LTD) or splice variant with exon 7 deleted (DelEx7).  Pulldown of 
GFP-SKIP, SKIP mutants (WD, EDY, DFG, DVF, PAV, PSV, PSTD, WE, DGD, 
LTD) or splice variant DelEx7 from 293T cell lysate using GST-KHC(815-955) 
or GST as control is shown in Figure 5.2B. Expression levels between the 
different GFP-SKIP mutants tended to vary in these small scale screening pull 
down experiments and therefore, for quantitative purposes, binding was 
normalized to SKIP (1-310) input levels in this screen. Normalised binding from 
three independent experiments is shown in Figure 5.2C. This analysis 
suggested that as well as the WD and WE motifs of SKIP, the EDY, DFG, and 
DGD triplets located within exon 7 also contributed to SKIP binding (Figure 5.2C 
and Figure 5.2D). These results were confirmed in larger scale pulldowns 
(which tended to be affected less by variation in expression level) (Figure 5.2D). 
To determine whether the mutations that were identified to disrupt SKIP 
binding to KHC were also important in KLC binding, a GFP-TRAP 
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immunoprecipitation strategy was used. 293T cells were co-transfected with 
plasmids designed to express N-terminally hemagglutinin (HA) tagged KLC2 
and N-terminally green fluorescent protein (GFP) tagged SKIP(1-310) (either 
wild-type, carrying alanine substitution at  residues EDY, DFG, WE, DGD) or 
with amino acids 219 to 238 deleted (DelEx7).  GFP-SKIP(1-310) was 
immunoprecipitated with GFP-TRAP beads and the amount of co-
immunoprecipated  HA-KLC2 was assessed by western blot (Figure 5.3).  
Consistent with data presented in Chapter 3 (Figure 3.1) mutation of the WD 
motif to alanine essentially eliminated the GFP-SKIP interaction with HA-KLC2, 
whereas equivalent mutations in the WE motif had no effect. Deletion of exon 7, 
which encompasses the WE motif and surrounding residues did considerably 
reduce binding, suggesting some contribution from these residues in binding to 
KLC2. However, specific mutation of EDY, DFG, DGD had no effect on the 
interaction between SKIP and KLC, confirming that KLC and KHC binding 
capacity in SKIP is mutationally separable. 
 
5.3 Disruption of KHC:SKIP interaction reduces SKIP:kinesin-1 
tetramer interaction 
In order to examine the effect of independently disrupting SKIP:KHC binding on 
association of SKIP with the  kinesin-1 tetramer, 293T cells were co-transfected 
with plasmids designed to express N-terminally hemagglutinin (HA) tagged 
KLC2 and N-terminally HA tagged KHC. Pulldown of HA-KLC and HA-KHC 
from 293T cell lysates using GST-SKIP (1-310) or GST-SKIP containing alanine 
substitutions (EDY, DFG, WE, DGD) or GST as control is shown in Figure 5.4. 
Consistent with data presented in Figure 5.2D, these experiments revealed a 
key role for the EDY or DFG residues of SKIP in binding of the kinesin-1 
tetramer, although the effect of mutating the WE or DGD residues was less 
striking. Collectively, these experiments show that the capacity for SKIP to 
interact specifically with KHC is important for maintaining a stable interaction 







Figure 5.2. Mutation of amino acid residues within exon 7 disrupts KHC 
binding. 
(A) Amino acid sequence of SKIP(1-310). Run domain is highlighted in grey and 
the amino acids translated when exon 7 is not deleted is shown in green. The 
vertical lines indicate the triplets of alanine mutations. (B) Pull-down of GFP-
SKIP and SKIP mutants (WD, EDY, DFG, DVF, PAV, PSV, PSTD, WE, DGD, 
LTD) as well as splice variant where exon 7 is deleted (DelEx7) from 293T cell 
lysate using GST-KHC(815-955) (42.6 kDa) or GST (25.5 kDa) as control. Input 
lysates were blotted for GFP-SKIP(1-310) and SKIP mutants as control using a 
mouse monoclonal anti-GFP antibody. A goat polyclonal anti-mouse HRP 
antibody was used as a secondary antibody to allow for detection using Clarity 
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ponceau staining.  (n=3). Repeats involved three independent repeat 
transfections followed by pulldown using the same protein preparations. (C) 
Graph of fraction of GFP-SKIP(1-310) binding normalised to total GFP-SKIP(1-
310) binding. (D) Pull-down of GFP-SKIP and SKIP mutants (WD, EDY, DFG, 
WE, DGD) as well as splice variant DelEx7 from 293T cell lysates using GST-
KHC(815-955) or GST as control (n=3). Repeats involved three independent 










































Figure 5.3. Alanine replacement of key residues shown to be involved in 
KHC binding does not affect KLC binding. 
Co-immunoprecipitation of HA-KLC2 (70.0 kDa) with GFP-SKIP(1-310) (62.1 
kDa), mutants of SKIP (WD, EDY, WE, DGD), SKIP containing a deletion of 
exon 7 (59.8 kDa) or GFP (26.9 kDa) control. Input lysates and co-
immunoprecipitated HA-KLC2 (bound) were blotted for KLC2 using an anti-HA 
mouse monoclonal antibody. GFP and GFP-SKIP were blotted for using an 
anti-GFP mouse monoclonal antibody. A goat polyclonal anti- mouse HRP 
antibody was used as a secondary antibody to allow for detection using Clarity 
Western ECL substrate. The blot is representative of three experiments 
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Figure 5.4. Alanine replacement of key residues shown to be involved in 
KHC binding reduces binding to the kinesin-1 tetramer. 
Pull-down of HA-KLC2 (70.0 kDa) and HA-KHC (109.2 kDa) from 293T cell 
lysate using GST-SKIP(1-310) (61.8 kDa) and SKIP mutants (WD, EDY, DFG, 
WE, DGD) or GST(25.5 kDa)  as control. Input lysates were blotted for HA-
KLC2 and HA-KHC as control using a mouse monoclonal anti-HA antibody. A 
goat polyclonal anti-mouse HRP antibody was used as a secondary antibody to 
allow for detection using Clarity Western ECL substrate. GST and GST-SKIP(1-
310) were visualized by ponceau staining. The blot is representative of three 
experiments involving three independent repeat transfections followed by GST-
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5.4  Specific disruption of SKIP binding to KHC results in a 
reduced capacity to promote lysosomal transport to the 
cell periphery. 
 
Identification of the residues that independently disrupted SKIP binding to KHC 
offered an opportunity to determine their functional role.  Expression of full-
length SKIP in HeLa promotes kinesin-1 dependent lysosome transport to the 
cell periphery (Rosa-Ferreira and Munro, 2011).  This provides a useful assay 
to assess SKIP function. Consistent with Rosa-Ferreira and Munro, 2011, 
transfection of HeLa cells with full-length SKIP promoted dispersion of 
lysosomes and accumulation at the cell periphery (Figure 5.5A). To quantify this 
in an unbiased manner, the cell was segmented into scaled percentile regions 
and cumulative LAMP-1 distribution determined (Figure 5.5B, see methods). 
The graph in Figure 5.5C shows the effect of SKIP expression (compared to 
non transfected) on cumulative LAMP-1 distribution relative to the whole cell.  
SKIP promotes a relative shift in the curve to the right indicating dispersion. In 
contrast, expression of the dynein adaptor RILP (that promotes lysosome 
transport to the MTOC) accumulation promoted a left shift confirming the utility 
of this assay. The non-linear regression function in Graphpad Prism was used 
to fit a centered 6th order polynominal to the cumulative LAMP-1 distribution. To 
compare models to assess the statistical significance of differences in 
distribution profiles, the extra sum of F-squares test was applied. This analysis 
confirms a statistical significant difference between non-transfected and SKIP 
as well as non-transfected and RILP. Non-transfected and GFP is shown to not 
be statistically significantly different. P values are shown in Figure 5.5C. The 
cumulative distribution at the 60th centile is shown in Figure 5.5D. Whilst this 
data can be statistically analysed at any point on the curve, further analysis at 
the point of widest control/SKIP separation (60th centile) revealed that this 
change in distribution is statistically significant and was used as a benchmark 
for future analysis of mutants. In order to determine the effect of making SKIP 
mutations that were shown to disrupt KHC binding to SKIP (without affecting 
KLC binding) on the distribution of lysosomes, HeLa were transfected with myc-
SKIP or mutants of SKIP (EDY, DFG, WE, DGD) or splice variant DelEx7 as 
well as non transfected as control and stained for LAMP-1. Representative 
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confocal fluorescence images of the lysosomal distribution are presented in 
Figure 5.6A. This is quantified in Figure 5.6B-F. The non-linear regression 
function in Graphpad Prism was used to fit a centered 6th order polynominal to 
the cumulative LAMP-1 distribution. To compare models so assess the 
statistical significance of differences in distribution profiles, the extra sum of F-
squares test was applied. Transfection with the KHC specific EDY, DFG or 
DGD mutations significantly affected lysosomal distribution when compared to 
SKIP (P values are shown on the graphs in Figure 5.6B-F). Figure 5.6G also 
shows the reduced capacity of EDY, DFG and EDY mutations in promoting 
lysosome dispersion (as measured at the 60th centile) showing that capacity to 
































































































NT vs SKIP P < 0.0001
NT vs RILP  P < 0.0001




Figure 5.5. The assay used to study lysosomal distribution. 
(A) Representative confocal fluorescence images showing methanol fixed HeLa 
cells transfected with either myc-SKIP, GFP-RILP or GFP and stained for 
LAMP-1. Scale bar = 10µm The primary antibodies used were rabbit 
monoclonal anti-LAMP-1 and a mouse monoclonal anti-myc antibody. The 
secondary antibodies were Alexa 568 goat anti-rabbit antibody and Alexa 488 
goat anti-mouse antibody probing for LAMP-1 and myc-SKIP respectively. (B) 
The circumference of the non transfected cell in (A) was used to highlight the 
10% increments used to calculate the cumulative LAMP-1 intensity. The 60th 
centile is shown in red. (C) Graph showing the cumulative of LAMP-1 
distribution for myc-SKIP, GFP-RILP, GFP or non transfected (NT). A centered 
6th order polynominal was fitted to the cumulative LAMP-1 distribution: Y=B0 + 
B1*X + B2*X^2 + B3*X^3 + B4*X^4 + B5*X^5 + B6*X^6. To compare models to 
assess the statistical significance of differences in distribution profiles, the extra 
sum of F-squares test was applied (D) Graph showing the cumulative 
distribution of LAMP-1 intensity at the 60th centile. ***P<0.001 (Two-tailed T-
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EDY vs SKIP P < 0.0001
EDY vs NT  P < 0.0001
SKIP vs NT  P < 00001
DFG vs SKIP P < 0.0001
DFG vs NT  P < 0.0001
SKIP vs NT  P < 0.0001
DGD vs SKIP P < 0.0001
DGD vs NT  P < 0.0001
SKIP vs NT  P < 0.0001
WE vs SKIP P = 0.0122
WE vs NT  P < 0.0001
SKIP vs NT  P < 0.0001
DelEx7 vs SKIP P < 0.0001
DelEx7 vs NT  P < 0.0001
SKIP vs NT  P < 0.0001
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Figure 5.6. Disruption of KHC:SKIP interaction results in reduction in 
lysosomal transport to the cell periphery. 
(A) Representative confocal fluorescence images showing methanol fixed HeLa 
cells transfected with either myc-SKIP, or mutants of SKIP (EDY, DFG, WE, 
DGD) or SKIP with Exon 7 deleted  (DelEx7) or non transfected (NT) and 
stained for LAMP-1. Scale bar= 10µm The primary antibodies used were rabbit 
monoclonal anti-LAMP-1 and a mouse monoclonal anti-myc antibody. The 
secondary antibodies were Alexa 568 goat anti-rabbit antibody and Alexa 488 
goat anti-mouse antibody probing for LAMP-1 and myc-SKIP respectively. (B-F) 
Graphs showing the cumulative distribution of LAMP-1 for myc-SKIP, mutants 
of SKIP (EDY, DFG, WE, DGD) and SKIP with Exon 7 deleted  (DelEx7). A 
centered 6th order polynominal was fitted to the cumulative LAMP-1 
distribution: Y=B0 + B1*X + B2*X^2 + B3*X^3 + B4*X^4 + B5*X^5 + B6*X^6. To 
compare models to assess the statistical significance of differences in 
distribution profiles, the extra sum of F-squares test was applied. (C) Graph 
showing the cumulative distribution of LAMP-1 distribution at the 60th centile. 

























The experiments described in this chapter aimed to investigate further the 
determinants of the SKIP:KHC interaction, examine its relationship to the 
SKIP:KLC interaction and thus also separate the function of the KLC:SKIP and 
KHC :SKIP interaction in cargo recognition and transport. 
Figure 3.13 shows that KLC is important in recruitment of SKIP and that 
association with KHC can only occur once SKIP has bound to KLC TPR domain 
via its tryptophan acidic (WD) motif. SKIP is also only able to bind to KHC once 
autoinhibition has been relieved. This was shown through mutation of the 9 
residues of the autoinhibitory ‘IAK’ sequence (QIAKPIRPG/AAAAAAAA) 
allowing for KHC binding to SKIP (Figure 5.1).  
Since KHC and KLC binding sites appear to overlap, SKIP mutations 
were identified that separate KHC binding from KLC binding (Figure 5.2 and 
Figure 5.3) Disruption of the KHC:SKIP interaction (through mutation of EDY or 
DFG residues in SKIP) reduced binding of the kinesin-1 tetramer to SKIP 
suggesting that heavy chain binding is required for the stable interaction of 
SKIP to the kinesin-1 tetramer (Figure 5.4). Disruption of the KHC:SKIP 
interaction is shown to hinder transport of lysosomes to the cell periphery, 
suggesting the KHC:SKIP interaction is important in transport (Figure 5.6).  
Whether transport of cargo is triggered by KHC binding or whether the 
increased cargo transport observed results only from a more stable 
cargo:kinesin-1 tetramer interaction cannot be established from the data 
presented here. The presence of low level transport of lysosomes to the 
periphery seen when the SKIP:KHC interaction is disrupted may suggest that 
the latter is the case, however the transport of some lysosomes to the cell 
periphery may occur due to the presence of endogenous SKIP within HeLa. 
Taken together, these data suggest that KLC has some capacity to gate access 
to the heavy chain cargo binding site. 
Kawano et al. shows that a 10 residue peptide from Calsyntenin-1 
centering on the tryptophan acidic motif is sufficient for at least partial activation 
of Kinesin-1 and vesicle transport when fused to a transmembrane domain 
(Kawano et al., 2012). Pu et al. also gives further evidence that KLC binding is 
sufficient for transport. Expression of a Lamp-GFP construct containing three 
copies of the tryptophan- acidic motifs form SKIP (TNLEWDDSAI) links 
lysosomes to Kinesin-1 and results in the peripheral accumulation of lysosomes 
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(Pu et al., 2015). It is not clear whether three motifs were absolutely required or 
whether this simply made the process more efficient. It may be the case that 
three tryptophan acidic motifs from SKIP were perhaps used as more than one 
interaction with kinesin-1 is required for the stable association and transport of 
lysosomes. The fact that KLC binding alone can result in transport suggests 
that perhaps the latter model is the true model, where binding to KHC enables a 
more stable kinesin-1:cargo interaction resulting in more efficient transport. 
The cumulative distribution of LAMP-1 intensity at the 60th centile gives a 
clear indication of the proportion of lysosomes in the centre 60% of the cell 
compared to the periphery (40%). This method of quantification assumes that 
the mTOC is in the centre of the cell, and when there is perinuclear clustering of 
lysosomes that this clustering would occur in the centre of the cell. 
Accumulation of lysosomes do not always occur completely in the centre of the 
cell, which reduces the perinuclear clustering effect when quantified using this 
method compared to what is observed in cells. A clear difference could however 
still be seen between RILP and control, suggesting that although the method of 
quantification might reduce the effect seen, it is still possible to distinguish 
between transport to the periphery and perinuclear clustering. Another method 
could involve plating individual HeLa cells on a micropatterned array in order to 
quantify lysosomal distribution over a fixed cell shape as used by (Rosa-
Ferreira and Munro, 2011).  
The results presented in this chapter is summarised in Figure 5.7. Cargo 
first interacts with KLC, via its W-acidic motif, triggering a conformational 
change in kinesin-1, resulting in the autoinhibition to be at least partially 
relieved. Transport either commences when cargo interacts with the KHC 
binding site or more likely more efficient transport occurs due to a more stable 
kinesin-1 tetramer cargo interaction. Further experiments to investigate the 
effect of disruption of KHC binding on transport of cargo to the cell periphery will 






















Figure 5.7. Model of activation. 
Kinesin-1 is found in an autoinhibited state in the cell where the C-terminal tail 
of KHC binds to the motor domain. Cargo interaction with KLC via its W-acidic 
motif relieves autoinhibition as the interaction with KLC triggers a 
conformational change in kinesin-1. Transport either commences when cargo 
interacts with the KHC binding site or more efficient transport occurs due to a 










CHAPTER 6 . EXPRESSION, PURIFICATION AND 
CRYSTALLISATION OF KLC1TPR BOUND TO JIP1.  
 
Cargo binding to kinesin-1 is not restricted to those containing a tryptophan-
acidic motif. JNK-interacting protein-1 (JIP1) is an example of a kinesin-1 cargo 
protein that does not contain a tryptophan-acidic motif. The 11 amino acid at the 
C terminus of JIP1 (JIP1(C11) has been shown to bind preferentially to KLC1 
and does not bind to KLC2 (Zhu et al., 2012). 
Progress has been made in understanding the determinants of this 
apparent specificity. Data from isothermal titration experiments demonstrated 
that N343 of KLC1-TPR and the equivalent residue S328 in KLC2-TPR are 
crucial determinants of the different binding properties of the two TPR domains. 
This residue resides on the fourth TPR repeat and is distinct from the residues 
on TPR2/3 that primarily comprise the W-acidic motif binding site.   JIP1 was 
unable to bind the KLC1-N343S mutant, but was able to bind KLC2-S328N 
mutant. Mutation of these residues did not affect binding to the tryptophan 
acidic motif containing peptide from CSTN. This agrees with the structural data 
provided in Chapter 1, where this residue is outside the W-acidic binding site. 
Taken together, these data suggest that the groove of the TPR domain can bind 
other peptides of different sequence at at least one other distinct site.  
In order to have a greater understanding of the cargo recognition process 
of KLC and to determine the importance of the residues within the TPR domain 
in binding to a non-tryptophan acidic motif containing cargo, crystallisation was 
attempted of the TPR domain of KLC1 in complex with the 11 reside C-terminal 
region of JIP1 using similar approaches to those presented in Chapter 3. 
 
6.1 Construct design 
A chimeric construct was engineered in a similar way as for 
SKIPWD_KLC2TPR in which the C-terminal 11 residues of JIP1 were fused N-
terminal to KLC1TPR via a flexible (TGS)4 linker (JIP1(C11)_KLC1TPR) (Figure 
6.1). The KLC1TPR consisted of residues 229-491 and did not include the first 
helix of the first TPR, as this is the section that has previously been successfully 
crystallised (PDB code 3NF1). A histidine tag was fused N-Terminal to 
JIP1(C11)_KLC1TPR to aid in purification. Again, the advantage of this 
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approach is that the stoichiometry is defined and the interaction is more 
favorable than if the protein and peptide were not attached. Fusing the peptide 
and the KLC1TPR domain brings them in close proximity, making the 
interaction more likely.  
 
6.2 Expression and purification of JIP1(C11)_KLC1TPR 
JIP1(C11)_KLC1TPR was expressed in E.coli as an N-terminally His6-tagged 
protein and was first purified by Ni2+-affinity chromatography (Figure 6.2A) 
followed by size exclusion chromatography (SEC). JIP1(C11)_KLC1TPR eluted 
as a single symmetric peak at 61.64ml (Figure 6.2B and Figure 6.2C). The most 
pure samples were pooled and concentrated to 5mg/ml for crystallisation 
screens. 
 
6.3 Crystallisation of JIP1(C11)_KLC1TPR 
Initial screening experiments were set up using the histidine tagged 
JIP1(C11)_KLC1TPR. The crystallisation screens used in trials were PGA, 
MIDAS, and ProComplex and JCSG+ (Qiagen). No crystals formed under the 
conditions within these screens. To determine whether the N-terminal histidine 
tag had a detrimental effect on crystallisation, the tag was removed by thrombin 
cleavage.  
 
6.4 Thrombin cleavage of JIP1(C11)_KLC1TPR 
To increase the efficiency of the thrombin cleavage of the His-tag, the cleavage 
condition was optimised. An overnight incubation at 4°C with a 1:25 dilution of 
the biotinylated thrombin stock (at a concentration of approx 1 U/µl, Novagen) 
showed the best cleavage efficiency (Figure 6.3A). Figure 6.3B shows that the 
thrombin cleavage of JIP1(C11)_KLC1TPR was efficient with no uncleaved 
histidine tagged JIP1(C11)_KLC1TPR detectable by western blot (Figure 6.3B). 
The elution profile from SEC show that JIP1(C11)_KLC1TPR eluted in a single 
symmetric peak at 70.98ml (Figure 0.3D). The sample contains a very small 
fraction of lower and higher molecular weight impurities (Figure 6.3C). The 
crystallisation screens set up were JCSG+, MIDAS, PGA, PaCT Premier and 
Structure screen 1&2 (molecular dimensions) and ProComplex Suite (Qiagen). 

















Figure 6.1. Schematic of JIP1(C11)_KLC1TPR construct design. 
The JIP1(C11) peptide (green) is fused N-Terminal to KLC1TPR residues 229-




























Figure 6.2. Purification of His-JIP1(C11)_KLC1TPR. 
(A) Coomassie stained gel of the collected fractions of Ni2+ column purification. 
The soluble cell lysate is labeled load. The flow through as well as the wash 
buffer were collected after passing through the column (flow through 1,2 and 
wash 1, 2, 3 respectively). The JIP1(C11)_KLC1TPR (34.6 kDa) chimera was 
eluted with an imidazole gradient and fractions containing the target protein 
collected. (B) Coomassie stained gel of fractions eluted during size exclusion 
chromatography. A size exclusion chromatography column (HiLoad 16⁄600 
Superdex 75pg) was used. (C) Size exclusion chromatogram showing 























































































































Figure 6.3. Thrombin cleavage and purification of un-tagged 
JIP1(C11)_KLC1TPR. 
(A) Histidine tagged JIP1(C11)_KLC1TPR was incubated with a serial dilution of 
the Thrombin stock (1:25, 1:50,1:100,1:200),  for 1hr at room temperature, 
1hour at 4°C and overnight at 4°C. The amount of histidine tagged protein is 
shown by western blot and the protein load by coomassie stain (B) Western-blot 
of histidine tagged JIP1(C11)_KLC1TPR (34.6 kDa) and un-tagged 
JIP1(C11)_KLC1TPR (32.8 kDa) (C) Coomassie stained gel of fractions eluted 
during size exclusion chromatography. A size exclusion chromatography 
column (HiLoad 16⁄600 Superdex 75pg) was used. (D) Size exclusion 
chromatogram showing absorbance measurements at 280nm of eluted 
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6.5 Cloning C terminal fusion constructs 
The work carried out by Zhu et al. suggest that a polar patch (TPR4-5) in the 
KLC1TPR domain is involved in JIP1 binding, whereas another polar patch 
(TPR3-4) is involved in the tryptophan acidic motif containing protein, CSTN 
binding (Zhu et al., 2012). The JIP1 binding site is therefore suggested to be 
closer to the C-terminal end of the TPR domain than CSTN. As an alternative 
strategy, a similar construct was designed where the JIP1(C11) peptide is fused 
at the C-terminus of the KLC1TPR domain (KLC1TPR_JIP(C11) (Figure 6.4A) . 
An additional construct was designed that also incorporated the first helix of the 
first TPR motif as this may play a role in stabilising the complex and so its 
presence may aid in crystal formation. Another C-terminal fusion was therefore 
designed where the JIP(C11) peptide was fused to the C-terminus of the full 
length KLC1TPR domain (KLC1TPR(FL)_JIP(C11) (Figure 6.4B).  The 
KLC1TPR(FL)_JIP(C11) containing the full length KLC1TPR domain, with 
JIP1(C11) fused at the C terminus of the protein was ordered from Genscript. 
The KLC1TPR_JIP(C11) construct was cloned from the Genscript construct 
shortening the first TPR motif (including KLC1 residues 229-491) so that the 
TPR domain is the same length as in the JIP1(C11)_KLC1TPR construct 
(Figure 6.4B).  
 
6.6 Expression and Purification of KLC1TPR_JIP(C11)    
KLC1TPR_JIP(C11)  was expressed in E.coli as an N-terminally His6-tagged 
protein and was first purified by Ni2+-affinity chromatography followed by size 
exclusion chromatography (SEC). KLC1TPR_JIP(C11) eluted 59.64ml. The 
elution volume suggests that KLC1TPR_JIP1(C11) is slightly more extended 
than JIP1(C11)_KLC1TPR. The protein eluted with an impurity very close in 
succession making it difficult to separate the impurity form 
JIP1(C11)_KLC1TPR. Using the coomassie stained gel the purest fraction was 
selected and used for crystallisation. 
 
6.7 Crystallisation screens of KLC1TPR_JIP(C11)    
Initial screening experiments were set up using the histidine tagged 
KLC1TPR_JIP(C11). The crystallisation screens used in trials were JCSG+, 
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MIDAS, PGA, PaCT Premier and Structure screen 1&2 (molecular dimensions) 
















































Figure 6.4. Schematic of KLC1TPR_JIP(C11)  and KLC1TPR(FL)_JIP(C11) 
construct design. 
(A) KLC1TPR_JIP(C11): The JIP1(C11) peptide (green) is fused C-terminal to 
KLC1TPR residues 229-491 (orange) via a flexible (TGS)4 linker. (B) 
KLC1TPR(FL)_JIP(C11): The JIP1(C11) peptide (green) is fused C-terminal to 
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Figure 6.5. Purification of KLC1TPR_JIP1(C11). 
(A) Coomassie stained gel of the collected fractions of Ni2+ column purification. 
KLC1TPR_JIP(C11) (34.7 kDa) chimera was eluted with an imidazole gradient 
and fractions containing the target protein collected. (B) Coomassie stained gel 
of fractions eluted during size exclusion chromatography. A size exclusion 
chromatography column (HiLoad 16⁄600 Superdex 75pg) was used. (C) Size 
exclusion chromatogram showing absorbance measurements at 280nm of 








































































6.8 Expression and Purification of KLC1TPR(FL)_JIP(C11)    
KLC1TPR(FL)_JIP(C11) was expressed in E.coli as an N-terminally His6-
tagged protein and was first purified by Ni2+-affinity chromatography followed by 
size exclusion chromatography (SEC) (Figure 6.6A and Figure 6.6B/C) 
KLC1TPR(FL)_JIP(C11) eluted as a single peak at 65.07ml with a slight tail 
(Figure 6.6C). The most pure samples were pooled and concentrated to 5mg/ml 
for crystallisation trials. 
 
6.9 Crystallisation screens of KLC1TPR(FL)_JIP(C11)    
Initial screening experiments were set up using the histidine tagged 
KLC1TPR(FL)_JIP(C11). The crystallisation screens used in trials were JCSG+, 
MIDAS, PGA, PaCT Premier and Structure screen 1&2 (molecular dimensions) 
and ProComplex Suite (Qiagen). Figure 6.7A shows the conditions where initial 
crystals formed. Optimisation screens were set up for condition 1 and 5 shown 
in Figure 6.7A due to the larger dimensions of the crystals. A screen was set up 
based on condition 1 centering on 5% PEG8000 and 3%PGA with a PEG8000 
(0-10%) vs PGA gradient (0-6%) keeping the concentration of the additive 
(potassium bromide and potassium thiocyanate) constant. This screen did not 
yield any crystals, with the drops remaining clear. Three screens were set up 
based on condition 5 shown in Figure 6.7A one at pH4.5, pH5 and pH5.5, each 
with a PEG8000 (0-10%) vs PGA gradient (0-6%) keeping the concentration of 
the additive (0.1M ammonium sulphate and 0.3M sodium formate) constant.  
The pH5.5 screen did not produce any crystals. The crystals that formed in the 
pH5 grid centered on 9% PEG and 1% PGA. Another screen was therefore set 
up with a narrower PGA range (0-4%) and the PEG8000 concentration shifted 
to a higher percentage (5-15%) centering the new optimisation grid on 9% 
PEG8000 and 1% PGA. The conditions that yielded crystals in the pH4.5 and 
pH5 conditions are illustrated in Figure 6.7B, with examples of crystals shown in 
Figure 6.9. The crystals formed were all pentagonal in shape. The crystals 
yielded a diffraction pattern that showed it was protein, but was not sufficient for 
structure determination (acquisition of data was carried out by Dr. Stefano 
Pernigo, Steiner group KCL).  In an attempt to enable the crystals to form in a 
different crystal shape, the screens were attempted at PEGMME 2K, PEG3350, 
as well as PEG6K. The three screens involved using a 0-4% PGA gradient vs a 
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5-15% gradient of the respective PEG (PEGMME 2000, PEG3350, or 
PEG6000) keeping the concentration of the additive (0.1M ammonium sulphate 
and 0.3M sodium formate) constant. PEG3350 and PEG6000 yielded crystals 
of a similar shape to PEG8000. An additive screen was also used based on 
condition 5 in Figure 6.7 to aid in slowing down crystal formation. This also did 
not yield crystals that were sufficient for data collection. Examples of crystals 
are shown in Figure 6.10. 
This was followed by the removal of the histidine tag. To increase the 
efficiency of the thrombin cleavage of the histidine tag, the cleavage condition 
was optimised. An overnight incubation at 4°C with a 1:25 dilution of the 
biotinylated thrombin stock (at a concentration of approx. 1 U/µl, Novagen) 
showed the best cleavage efficiency (Figure 6.8A). Figure 6.8B shows that the 
thrombin cleavage of KLC1TPR(FL)_JIP(C11) was efficient with no uncleaved 
histidine tagged KLC1TPR(FL)_JIP(C11) detectable by western blot. The 
elution profile from SEC shows that JIP1(C11)_KLC1TPR eluted in a single 
symmetric peak at 68.38ml . The sample contains a very small fraction of lower 
and higher molecular weight impurities. The crystallisation screens set up were 
JCSG+, MIDAS, PGA, PaCT Premier and Structure screen 1&2 (molecular 
dimensions) and ProComplex Suite (Qiagen). The un-tagged 
























Figure 6.6. Purification of KLC1TPR(FL)_JIP(C11). 
(A) Coomassie stained gel of the collected fractions of Ni2+ column purification. 
The soluble cell lysate is labeled load. The flow through as well as the wash 
buffer were collected after passing through the column (flow through 1,2 and 
wash 1, 2, 3 respectively).  KLC1TPR(FL)_JIP(C11) (37.9 kDa) chimera was 
eluted with an imidazole gradient and fractions containing the target protein 
collected. (B) Coomassie stained gel of fractions eluted during size exclusion 
chromatography. A size exclusion chromatography column (HiLoad 16⁄600 
Superdex 75pg) was used. (C) Size exclusion chromatogram showing 

































































































Figure 6.7. Conditions that produced KLC1TPR(FL)_JIP1(C11) crystals. 
(A) List of the conditions from the initial crystal screens that produced crystals. 
(All the crystals were from the PGA screen (Molecular Dimensions). B) List of 
the conditions from the optimisation screens that produced crystals. 
 
No  Buffer   pH  Precipitating Agent  Additive
                                                                      1  0.1M Sodium    5  3% w/v PGA   0.2M Potassium bromide
  acetate    5% w/v PEG8000  0.2M Potassium thiocyanate 
  
2  0.1M Sodium   5  3% w/v PGA   0.1M Ammonium sulphate
  acetate    20% v/v PEG500MME  0.3 M Sodium formate
3  0.1M Sodium   5  3% w/v PGA   0.1M Ammonium sulphate
  acetate    10% PEG2000MME  0.3 M Sodium formate
4  0.1M Sodium   5  3% w/v PGA   0.1M Ammonium sulphate
  acetate    5% w/v PEG3350  0.3 M Sodium formate
5  0.1M Sodium  5  3% w/v PGA   0.1M Ammonium sulphate
  acetate    5% w/v PEG8000  0.3 MSodium formate
A
B
1  0.1M Sodium   4.5  2-4% w/v PGA   0.1M Ammonium sulphate
  acetate    5% w/v PEG8000  0.3 M Sodium formate
2  0.1M Sodium   5  0.5-2% w/v PGA  0.1M Ammonium sulphate
  acetate    5-10% w/v PEG8000  0.3 M Sodium formate
3  0.1M Sodium  5  1% w/v PGA   0.1M Ammonium sulphate   
  acetate    10% w/v PEG8000  0.3 M Sodium formate
           0.01 M Strontium chloride 
           hexahydrate
4  0.1M Sodium  5  1% w/v PGA   0.1M Ammonium sulphate   
  acetate    10% w/v PEG8000  0.3 M Sodium formate
           4% v/v 1-Propanol
5  0.1M Sodium  5  1-1.5% w/v PGA  0.1M Ammonium sulphate   
  acetate    10% w/v PEG3350  0.3 M Sodium formate
6  0.1M Sodium  5  1.5-3% w/v PGA  0.1M Ammonium sulphate   
  acetate    7% w/v PEG3350  0.3 M Sodium formate
7  0.1M Sodium  5  2-4% w/v PGA   0.1M Ammonium sulphate   
  acetate    8-9% w/v PEG3350  0.3 M Sodium formate
8  0.1M Sodium  5  3% w/v PGA   0.1M Ammonium sulphate   
  acetate    6% w/v PEG3350  0.3 M Sodium formate
9  0.1M Sodium  5  3% w/v PGA   0.1M Ammonium sulphate   
  acetate    6% w/v PEG3350  0.3 M Sodium formate
10  0.1M Sodium  5  5-9% w/v PGA   0.1M Ammonium sulphate   
  acetate    1-2% w/v PEG6000  0.3 M Sodium formate
11  0.1M Sodium  5  10-14% w/v PGA  0.1M Ammonium sulphate   
  acetate    1% w/v PEG6000  0.3 M Sodium formate
12  0.1M Sodium  5  13-15% w/v PGA  0.1M Ammonium sulphate   
  acetate    0.5% w/v PEG6000  0.3 M Sodium formate
13  0.1M Sodium  5  5-7% w/v PGA   0.1M Ammonium sulphate   
  acetate    3% w/v PEG6000  0.3 M Sodium formate







Figure 6.8. Thrombin cleavage and purification of KLC1TPR(FL)_ 
JIP1(C11). 
(A) Histidine tagged KLC1TPR(FL)_JIP1(C11) (37.9kDa) was incubated with a 
serial dilution of the Thrombin stock ( 1:25, 1:50,1:100,1:200), overnight at 4°C. 
The amount of histidine tagged protein is shown by western blot and the protein 
load by coomassie stained gel (B) 1:25 dilution of thrombin stock was used to 
cleave the histidine tag, thrombin was removed by incubation with streptavidin 
beads followed by removal of the histidine tag and any uncleaved protein by 
NiNTA beads. (C) Coomassie stained gel of fractions eluted during size 
exclusion chromatography (un-tagged KLC1TPR(FL)_JIP1(C11): 36.0 kDa).  A 
size exclusion chromatography column (HiLoad 16/600 superdex 75pg) was 
used. (D) Size exclusion chromatogram showing absorbance measurements at 
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Figure 6.9. Examples of KLC1TPR(FL)_JIP1(C11) crystals. 
The crystals shown above formed under the following conditions: (A) 0.1M 
ammonium sulphate, 0.3M sodium formate, 1M sodium acetate pH5 1%PGA, 
5%w/v PEG8000, (1:3 protein: well ratio) (B) 0.1M ammonium sulphate, 0.3M 
sodium formate, 1M sodium acetate pH5 1%PGA, 6%w/v PEG8000, (1:2 
protein: well ratio)  (C) 0.1M ammonium sulphate, 0.3M sodium formate, 1M 
sodium acetate pH5 1.5%PGA, 5%w/v PEG8000, (D) 0.1M ammonium 
sulphate, 0.3M sodium formate, 1M sodium acetate pH5 1%PGA, 5%w/v 




















Figure 6.10. Examples of optimised KLC1TPR(FL)_JIP1(C11) crystals. 
(A and B) Crystals yielded from the additive screen. Crystals were formed under 
the following conditions 0.1M ammonium sulphate, 0.3M sodium formate, 1M 
sodium acetate pH5, 1%PGA, 10%w/v PEG8000, with 0.01M strontium chloride 
hexahydrate in A or 4% v/v 1-Propanol in B, (C) 0.1M ammonium sulphate, 
0.3M sodium formate, 1M sodium acetate pH5, 2%PGA, 7%w/v PEG6000, (D) 
0.1M ammonium sulphate, 0.3M sodium formate, 1M sodium acetate pH5, 











In this chapter the aim was to crystallise KLC1 TPR domain in complex with the 
C-terminal 11 residues of JIP (JIP(C11). Crystals that were obtained however 
did not yield a diffraction pattern that was sufficient for data collection. 
Initial crystal hits for KLC1(FL)_JIP1 were obtained in a pH5 buffer. A lower or 
higher pH resulted in precipitation. The first optimisation screen was therefore 
not pH v precipitant, but varying the relative concentrations of the two 
precipitants (PGA vs PEG8000). This screen was set up at pH4.5 and pH5.5 in 
order to allow for slight changes in pH to affect crystal formation. The pH5 
screen yielded larger crystals and so this was further optimised centering on the 
conditions that yielded crystals and reducing the range of PGA and PEG. The 
largest crystals in the optimisation screen were in the following condition:0.1M 
sodium acetate pH5, 0.1M ammonium sulphate, 0.3M sodium formate, 10% 
PEG8K, 1% PGA.  The KLC1(FL)_JIP1 crystal morphology was poor, therefore 
an additive screen was used to aid in the packing of the crystals. The addition 
of additives may enable different crystal forms to appear (Larson et al., 2007). 
Additives may enable crosslinking within the crystal (McPherson and Cudney, 
2006). 
Since the initial crystal hits involved different types of PEG, varying the 
PEG may allow for the crystal to stack better and also form different shaped 
crystals. PEG2000MME, PEG3350 as well as PEG6000 were used in PGA vs 
PEG screens at pH5.  
Due to the time requirement for further optimisation, crystallisation of 
JIP1(C11) in complex with KLC1 TPR domain was further pursued by the 
Steiner group. Optimisation at PEG3350 yielded crystals that appeared as 
though it may have a different morphology as well as having larger dimensions. 
Further KLC1TPR(FL)_JIP1 optimisation by the Steiner group involved crystal 
seeding. Seeding techniques were applied in order to aid in creasing the size 
and quality of crystals (Bergfors, 2003). Crystal seeding involves using a seed 
stock produced using a ‘seed-bead’ method (Luft and DeTitta, 1999). Crystals 
from G4 from initial screens were placed in 50µl of the reservoir condition and 
homogenised by vortexing. These seeds were stored at 20°C and used for 
seeding experiments. 
Seeding experiments included varying seed stock dilution vs PEG3350 
concentration, pH vs precipitant concentration as well as PGA concentration vs 
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PEG3350 concentration. None of these screens yielded crystals that were 
appropriate for data collection. A microseed matrix-screen approach was also 
taken to aid in improving the packing of crystals (D'Arcy et al., 2007, Ireton and 
Stoddard, 2004). This method could allow for crystallisation where little or no 
nucleation is normally observed. 
Other approaches used to aid in improving the packing of the crystals 
involved the addition of a lysozyme tag as well as the addition of maltose 
binding protein (MBP), both of which have been used to aid crystallisation of 
other proteins (Moon et al., 2010, Zhao et al., 2011, Cherezov et al., 2007). The 
lysozyme tagged KLC1TPR(FL)_JIP1 was insoluble and the tagging of maltose 
binding protein yielded no crystals in the initial commercial screens. 
Currently camelid heavy chain antibodies (VHHs, also called 
‘nanobodies’) are being used in crystallisation attempts in collaboration with the 
Steiner group. Nanobodies are one of many protein chaperones used to aid in 
the formation of well diffracting crystals. Chaperones minimise the 
heterogeneity in the target protein conformation as it binds to a specific 
conformation. It also facilitates contacts between molecules in the crystal lattice, 
reducing the contacts that the protein of interest is required to make in order for 
crystallisation (Bukowska and Grutter, 2013, Koide, 2009).  
Other approaches to crystallisation could include changing the construct. 
This may involve the cloning of a construct that has a longer linker, since 
KLC2TPR_SKIPWD crystallised as a dimer with the SKIPWD peptide binding 
across to another KLC2TPR_SKIPWD. This construct may have crystallised in 
this way if the linker was too short to allow the SKIPWD to fold back round and 
crystallise as a monomer. Extending the linker length may allow the JIP1C11 to 
reach the groove more easily and perhaps crystallise as a monomer. A too long 
linker will on the other hand negatively affect crystallisation due to the flexibility 
of the linker. Crystallisation could also be attempted using KLC1 TPR with 
purified JIPC11 peptides. 
Once the structure is determined, the binding site could be verified by 







CHAPTER 7 DISCUSSION 
 
In this thesis, the molecular basis of the KLC:cargo interaction as well as the 
KHC:cargo interaction were investigated using SKIP as a model cargo. The 
independent functional roles of the KLC:cargo and KHC:cargo interactions in 
cargo recognition and activation of transport were also investigated. 
 
7.1 Kinesin-1 cargo recognition 
7.1.1 KLC : Cargo interaction 
7.1.1.1 KLC TPR domain tryptophan acidic binding pocket 
Data presented in this thesis has shown that the tryptophan-acidic SKIP peptide 
binds within a distinct highly positively charged groove of the KLC TPR domain. 
Early experiments showing that kinesin-1 is able to transport negatively charged 
beads (Vale et al., 1985b, Terasaki et al., 1995) gave an indication that kinesin-
1; cargo recognition is partly achieved through electrostatic interactions and 
charge complementarity and so these new data are consistent with this. The 
highly positively charged inner concave surface of the TPR domain 
complements the highly negatively charged tryptophan-acidic motif containing 
SKIP peptide (TNLEWDDSAIT). The SKIP peptide binds in an extended 
conformation making a series of contacts along the length of the TPR groove. 
The TPR domain appears to fold around the cargo upon binding. Whilst the 
importance of this conformational change is not yet determined, it seems 
possible that this structural change may transduce the signal that cargo has 
bound contributing in the relief of autoinhibition. This binding pocket is likely to 
be a universal binding pocket as another tryptophan-acidic motif containing 
protein, CSTN was shown to interact via its tryptophan acidic motifs with the 
same pocket of the TPR domain (Pernigo et al., 2013).  The structure presented 
in this thesis also establishes key residues within the binding pocket of KLC 
(KLC2 N287, R251, R312) to be responsible for interacting with tryptophan-
acidic motif containing proteins. These have since been used by the Holzbaur 
group, confirming that mutation of these residues disrupt the interaction with a 
similar W-acidic motif in Nesprin-2 (Wilson and Holzbaur, 2015). 
Not all kinesin-1 cargos contain tryptophan-acidic motifs. JIP1 is an 
example of a cargo that also interacts with the TPR domain of KLC, but has a 
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unique sequence. JIP1 is also highly negatively charged which complements 
the positively charged KLC TPR domain. Work by Zhu et al. suggests that JIP1 
binds within a different groove of the TPR domain, contributed to by residues 
from TPR 4-5 (Zhu et al., 2012). Structural determination would aid in further 
characterisation of the KLC TPR domain interactions with cargo.  
 
7.1.1.2 Tryptophan acidic motif recognition by KLC TPR domain 
Tryptophan-acidic motifs were identified within cargo as being responsible for 
binding specifically to the TPR domain of KLC (Konecna et al., 2006, Araki et 
al., 2007, Aoyama et al., 2009, Schmidt et al., 2009). Dodding et al. identified 
that hydrophilic residues (D, E, N or Q) preceded the tryptophan residue at the 
–1 position and was also found at the +2 position residue in known KLC binding 
proteins. Using this information the RefSeq database was searched for 
expressed human proteins for the presence of four combinations of bipartite 
motifs: W(DENQ)—W(DENQ)(DENQ); W(DENQ)—(DENQ) W(DENQ); 
W(DENQ) (DENQ)—W(DENQ) and (DENQ) W(DENQ)—W(DENQ) to identify 
potential kinesin-1 interacting proteins (Dodding et al., 2011). 
The SKIP(WD)_KLC2TPR structure presented in this thesis reveals a 
key role for a leucine residue at the W-2 position within the cargo binding motif. 
Further work in collaboration with the Steiner group also established that a 
methionine at the -2 position in tryptophan acidic motif containing cargo also 
binds to the same groove within the KLC TPR domain (Pernigo et al., 2013).  
Although bipartite motifs where both motifs are involved in KLC binding have 
been identified (in for example CSTN), for many cargo only one motif has been 
shown experimentally to be important in binding. In Chapter 3 mutation of the 
second tryptophan acidic motif of SKIP is also shown to have very little effect on 
KLC binding. The search for other possible cargo (that can interact with KLC) 
that contain tryptophan-acidic motifs can therefore likely be further constrained 
to those that have a methionine or leucine at the -2 position as well as acidic 
residues (an aspartic acid or a glutamic acid residue) at the -1 and +1 positions 
(M/L, E/D, W, E/D). 
 
7.1.2 KHC: Cargo interaction 
In Chapter 4, SKIP (1-310) is shown to bind to an extended region of the C-
terminal tail of KHC (867-917) making multiple contacts along the length of 
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KHC. Two main regions were identified as essential for binding: 876-891 
(KALESALKEAKENAM) and 907-917 (VRAKNMARRAH) although neither is 
sufficient for binding on their own (Figure 4.2 and Figure 4.3). Other kinesin-1 
cargos exhibit similar binding properties and bind to an extended region of the 
C-terminal tail region of KHC (Barry et al., 2013, Randall et al., 2013). The 
cargo binding sites of other kinesins have also been shown to be located at the 
C-terminal tail. Seeger and Rice show that the C-terminal tail within the majority 
of kinesin motors is highly intrinsically disordered and is responsible for binding 
to multiple cargos (Seeger and Rice, 2013). 
Kinesin-1 is found in an autoinhibited state within the cell and the SKIP 
binding site appears to flank the auto inhibitory sequence (IAK).  As shown in 
Chapter 4, SKIP is able to bind to the truncated C-terminal tail of KHC directly, 
but is unable to bind to the full length KHC in the absence of KLC (Figure 3.13 
and Figure 5.1). This may be because the SKIP binding site is inaccessible if 
autoinhibition is not relieved. Unlike SKIP, other cargos are able to bind to the 
full-length motor in the absence of KLC. This may be due to the recognition of 
additional regions of KHC that are accessible in the autoinhibited state. JIP-1 
for example binds to both the tail and the stalk region of KHC (Fu and Holzbaur, 
2013).  
 
7.1.3 Overlapping KHC and KLC binding sites on SKIP 
In this thesis, the binding determinant for KLC and KHC in SKIP were shown to 
overlap. The KHC binding site has been mapped to SKIP(202-241) and 
mutation of both tryptophan acidic motifs to alanine within this region 
significantly reduces KHC binding (Figure 4.5 and Figure 4.7). In contrast to 
this, KLC binding is significantly reduced by mutation of the first tryptophan-
acidic motif, whereas mutation of the second tryptophan acidic motif has very 
little effect on KLC binding (Chapter 3). This suggests that although the binding 
regions overlap the relative importance of the residues within this region in 
binding to KLC and KHC varies.  
Mutational analysis of the KHC binding region on SKIP illustrates that a 
relatively extended region of SKIP is also required for KHC binding (Figure 5.2). 
Further characterisation of the interaction through perhaps crystallisation of 
KHC (866-917) bound to the SKIP(202-241) should further define the 
underlying mechanisms of KHC-cargo recognition. 
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7.2 Proposed mechanism for cargo binding 
Since the KHC and KLC binding regions appear to overlap, KHC and KLC 
binding to SKIP are unlikely to occur simultaneously. Either SKIP binds to KLC, 
which opens the motor allowing for two more SKIP molecules to bind, or SKIP is 
transferred from KLC to KHC. Recent work in the Dodding group indicates that 
KLC is itself found in an autoinhibited state, where a highly conserved (leucine-
phenylalanine-proline (LFP)) motif and flanking acidic residues in the disordered 
region that links the heptad repeat to the TPR domain, itself binds to the 
concave groove of the TPR. A manuscript describing this work to which I made 
an early stage contribution is appended to this thesis. This interaction occludes 
the W-acidic binding site. Upon W-acidic cargo binding, this intramolecular 
interaction is displaced. Incorporating this data into my analysis, it seems 
possible that under this circumstance, KLC may rebind the highly conserved 
LFP motif upon transfer of cargo to KHC. This is likely to reduce the possible 
obstruction caused by KLC upon cargo transport if the cargo is transferred to 
KHC. This is illustrated in Figure 7.1. The exact mechanism of cargo binding 
needs to be established further. 
 
7.3 Independent functional roles of the KLC:cargo and KHC: 
cargo interactions in cargo recognition and activation of 
transport. 
In Chapter 3 it is reported that KLC is important in recruitment of SKIP and that 
association with KHC can only occur once SKIP has bound to KLC TPR domain 
via its tryptophan acidic (TNLEWDDSAIT) motif (Figure 3.13). SKIP is also only 
able to bind to KHC once autoinhibition has been relieved. This was shown 
through mutation of the 9 residues of the autoinhibitory ‘IAK’ sequence 
(QIAKPIRPG/AAAAAAAA) allowing for KHC binding to SKIP (Figure 5.1).  
Disruption of the KHC:SKIP interaction (through mutation of EDY or DFG 
residues on SKIP) reduced binding of the kinesin-1 tetramer to SKIP suggesting 
that heavy chain binding is required for the stable interaction of SKIP to kinesin-
1. Disruption of the KHC: SKIP interaction is also shown to hinder transport of 
lysosomes to the cell periphery, suggesting the KHC: SKIP interaction is 
important in transport.  
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The increased cargo transport observed is likely to occur due to a more 
stable cargo:kinesin-1 tetramer interaction as discussed in Chapter 5. Blasius et 
al. proposed another model where the autoinhibitory effects of both KHC as well 
as KLC must be relieved for activation to occur and transport to commence. 
JIP1 was shown to bind to KLC1, but requires the binding of a cofactor (FEZ1) 
to KHC to activate Kinesin-1 (Blasius et al., 2007). Both models may be true as 
JIP1 interacts with a different region of KLC and may therefore not transduce 
the signal to allow for autoinhibition to be relieved in the absence of KHC 
binding. 
In this thesis it is shown that KLC as well as KHC binding are required for 
efficient transport. The requirement of cargo to bind to KHC as well as KLC for 
full activation would allow for additional regulation of the cargo that is 
transported. This would also aid in explaining how such a large variety of cargo 
is able to bind to kinesin-1. 
 
7.4 Brief comparison of principles of kinesin-1: cargo 
recognition with cytoplasmic dynein-1 and myosin- V 
Kinesin-1 cargo recognition is partly achieved through electrostatic interactions 
and charge complementarity as well as involving sequence specific 
determinants. Although cytoplasmic dynein and myosin V also transport several 
cargo, consensus sequences for recognition have not been identified. However 
several dynein adaptor proteins (BICD2, Hook3 and Spindly FIP3, HAP1, RILP, 
Snapin, and TRAK1) have been shown to contain long coiled coil regions 
(>20nm) and are thought that they may interact with dynein and dynactin via 
these coiled coil regions as is seen for BicD2 (Cianfrocco et al., 2015, 
Urnavicius et al., 2015). The globular cargo binding tail of myosin-V has been 
shown to contain several non-overlapping recognition sites for binding to its 
cargoes (for example melanophillin, RILPL2 and and vesicle-bound GTPase 
Rab11) (Lu et al., 2014, Pylypenko et al., 2013). Whether there are consensus 














Figure 7.1. Proposed model of activation for Kinesin-1. 
Kinesin-1 is found in an autoinhibited state in the cell. Upon Tryptophan- acidic 
motif containing cargo interacting with KLC TPR domain, autoinhibition is 
relieved. KHC:cargo binding results in more efficient cargo transport. Either 
SKIP binds to KLC, which opens the motor allowing for two more SKIP 
molecules to bind, or SKIP is transferred from KLC to KHC. Boxed regions 
show a universally conserved LFP motif and flanking acidic residues (red), 
located within the otherwise divergent linker region of KLC interacting with the 
positive groove of the TPR domain. When this intramolecular interaction is 


























KHC: cargo interaction 
enables a more stable 
interaction with the 
Kinesin-1 tetramer 
resulting in more 
efficient transport of 
cargo.
Active motor is able
 to transport cargo
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7.5 Further work 
 
7.5.1 Mechanism of cargo binding 
The model described in Figure 7.1 attempting to describe the mechanism of 
cargo binding is not complete. To establish whether cargo is transferred from 
KLC to KHC or whether KLC binding allows for more SKIP binding could be 
further investigated through GST-pulldown or immunoprecipitation assays. 
 
7.5.2 Functional role of KHC: cargo interaction 
The KHC: cargo interaction is shown to be important in a more stable Kinesin-1: 
cargo interaction. The effect that this might have on amount of transport, rate of 
transport or the distance of transport need to be further investigated. In order to 
investigate the effect of disruption of KHC binding on transport of cargo to the 
cell periphery further, TIRF microscopy could be used to visualise KHC 
dependent transport of SKIP along microtubules in vitro in the presence of KLC. 
The number of motile events, velocity and run length could be established using 
this method. The ATPase rate of kinesin-1 (KHC and KLC) in the presence of 
increasing concentrations of SKIP (wild type or mutant disrupting KHC binding) 
could also be investigated to more fully grasp the effect of the KHC cargo 
interaction on transport. 
 
7.5.3 Targeting the motor:cargo interface with small molecules 
The data presented in Chapter 3 gave the first structural and biophysical 
characterisation of a microtubule motor/cargo interface. This opened up the 
opportunity to answer a key question that has so far not been addressed for any 
motor. Can we modulate the motor-cargo interaction using small molecules? 
As a result a time-resolved fluorescent resonance energy transfer (TRFRET) 
assay that will allow high-throughout screening of small molecules for their 
capacity to modulate the motor-cargo interaction interface, has been 
established and optimised within the Dodding group. This assay format is 
routinely used in drug discovery. The long fluorescence lifetime of terbium 
chelates allows signals to be read in a time-resolved manner reducing assay 
interference and a ratiometric approach decreases well-to-well variability. This 
assay involves using Lanthascreen reagents (Life Technologies), a highly 
stable, highly pure KLC2TPR domain construct (amino acids 161-480) purified 
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on Ni-NTA resin and by size-exclusion chromatography labeled with a terbium 
chelate compound on surface amine residues at a low molar ratio (one label per 
ten TPR molecules). This serves as a FRET donor. An N-terminally Cy5 labeled 
WD motif peptide from SKIP (5% labeled) is used as an acceptor. TRFRET is 
measured as a ratio of donor emission at 620 nm and acceptor emission at 665 
nm. The specificity of this interaction has been shown by competitive inhibition 
using unlabeled KLC2TPR. This assay could allow for the identification of 
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7.6 Appendix 1: Structural Basis for kinesin-1:cargo recognition 
PERNIGO, S., LAMPRECHT, A., STEINER, R. A. & DODDING, M. P. 2013. 
Structural basis for kinesin-1:cargo recognition. Science, 340, 356-9. 
 
This paper derived predominantly from data described Chapter 3 provides the 
first structural description of a kinesin-cargo interface. 
 
 
7.7 Appendix 2: The light chains of kinesin-1 are autoinhibited 
YIP, Y. Y., PERNIGO, S., SANGER, A., XU, M., PARSONS, M., STEINER, R. 
A. & DODDING, M. P. 2016. The light chains of kinesin-1 are autoinhibited. 
Proc Natl Acad Sci U S A, 113, 2418-23. 
 
This paper describes a novel intramolecular interaction within KLC2. I made the 









functional parallels to mismatch repair: After mis-
match targeting through helix-correlated sliding
and 3D steps, the ABC transporter family MutS
enzymes use a two-step conformational change
to adopt a sliding clamp configuration that dis-
plays accelerated, helix-uncorrelated 1D diffusion
(23–25). This transition requires a sole ADP-to-
ATP exchange, contrasting with EcoP15I that hy-
drolyzes many ATPs upon initiation (fig. S1).
Together this shows that ATP-triggered sliding
is a general function that has evolved in different
ATPase kingdoms.
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Stefano Pernigo,* Anneri Lamprecht,* Roberto A. Steiner,† Mark P. Dodding†
Kinesin-mediated cargo transport is required for many cellular functions and plays a key role
in pathological processes. Structural information on how kinesins recognize their cargoes is
required for a molecular understanding of this fundamental and ubiquitous process. Here, we
present the crystal structure of the tetratricopeptide repeat domain of kinesin light chain 2
in complex with a cargo peptide harboring a “tryptophan-acidic” motif derived from SKIP
(SifA-kinesin interacting protein), a critical host determinant in Salmonella pathogenesis and a
regulator of lysosomal positioning. Structural data together with biophysical, biochemical,
and cellular assays allow us to propose a framework for intracellular transport based on the binding
by kinesin-1 of W-acidic cargo motifs through a combination of electrostatic interactions and
sequence-specific elements, providing direct molecular evidence of the mechanisms for
kinesin-1:cargo recognition.
Theplus-end–directedmotor kinesin-1 playsa critical role in the intracellular transportof diverse protein, ribonuclear protein com-
plexes, and membrane compartments on micro-
tubules (1). Its functions are also usurped by
bacteria and viruses to aid in their replication
(2, 3). Kinesin-1 can perform this diverse range
of functions by virtue of its ability to interact with
many different cargo proteins (4). Diversity of
cargo recognition is accomplished largely through
the kinesin light chains (KLCs), which harbour
a tetratricopeptide repeat (TPR) domain, a versatile
protein interaction platform (5, 6). The KLCTPR
domain can recognize short peptide stretches with-
in relatively disordered regions of its targets. These
peptides are characterized by a tryptophan resi-
due flanked by acidic residues (such as EWD)
and are found in a growing list of KLC-binding
proteins (7–16). [Single-letter abbreviations for the
amino acid residues are as follows: A, Ala; C,
Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile;
K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln;
R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
In the mutants, other amino acids were substi-
tuted at certain locations; for example, R251D
indicates that arginine at position 251 was re-
placed by aspartic acid.] Although W-acidic mo-
tifs often occur in pairs, single motifs are also
functional and can support microtubule-based
transport even when explanted from their host
protein (7, 12, 17).
We set out to solve the structure of a KLCTPR
domain bound to a cargo W-acidic motif. We fo-
cused our attention on the SifA-kinesin interact-
ing protein (SKIP) cargo for its importance in
Salmonella pathogenesis. SKIP contains a pair
of W-acidic motifs centered at amino acid po-
sitions 207 and 208 (WD) and 236 and 237 (WE)
that fall within the N-terminal kinesin-1 binding
region (residues 1 to 310) (Fig. 1A) (3, 7, 13).
To assess the relative importance of the SKIP
W-acidic motifs for KLC binding, we cotrans-
fected HeLa cells with wild-type and WD/WEmu-
tant constructs expressing green fluorescent
protein (GFP)–SKIP(1-310) and hemagglutinin
(HA)–KLC2 (Fig. 1B).
Disruption of the WD motif reduced GFP-
SKIP interaction with HA-KLC2, whereas abroga-
tion of the WE motif had no obvious effects. A
double mutant with both motifs disrupted
displayedHA-KLC2 binding similar to the single
WD mutant. Thus, the WE motif has a very low
affinity for KLC2. Indeed, a 10-amino-acid-long
peptide centered on theWDmotif (SKIPWD) (Fig.
1A) bound to KLC2TPR with a dissociation con-
stant (Kd) of 24 mM, whereas the affinity of the
equivalent SKIPWE peptide was above 110 mM
(Fig. 1C). The presence of both motifs improves
the affinity for KLC2TPR because a 40-amino-acid-
long peptide SKIPWDWE that encompasses the
W-acid pair sequence bound with an apparent af-
finity higher than that of the single SKIPWD motif
(Kd = 4.9 mM). Binding affinity measurements at
varying NaCl concentrations showed that elec-
trostatic interactions play an important role in the
recognition process (fig. S1).
For structural studies, we focused on the
SKIPWD motif, and to facilitate the crystallization
process, we engineered a chimeric construct in
which the SKIPWD peptide was fused N-terminal
to KLC2TPR via a flexible (TGS)4 linker (18). Crys-
tals of SKIPWD-KLC2TPR were grown by using
vapor diffusion techniques and diffracted at 2.9 Å
by using synchrotron radiation. The final model of
the cargo complex is characterized by R and Rfree
values of 20.3 and 24.5%, respectively (table S1).
KLC2TPR consists of six TPR repeats (TPR1 to
TPR6), each contributed by a classical helix-turn-
helix structural motif arranged in a right-handed
super-helical conformation, with a non-TPR helix
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positioned between TPR5 and TPR6 (14). The
structure of SKIPWD-KLC2TPR revealed the cargo
peptide bound in an extended conformation at the
N-terminal portion of the KLC2TPR concave sur-
face, with a direction parallel to the external helix
of the repeat (Fig. 2, A and B, and fig. S2). Al-
though our construct includes the external helix
of TPR1, this region, as well as other flexible
stretches, could not be unambiguously interpreted
in the electron density. Thus, KLC2TPR starts from
TPR2 in our model.
A comparison between cargo-free KLC2TPR
(3CEQ) and cargo-bound KLC2TPR revealed
structural differences considered to arise from a
rigid jaw movement of the N-terminal TPR2-3
region, which closes upon cargo recognition en-
gendering the binding surface and pockets for
the SKIPWD peptide. (Fig. 2B and fig. S3). An
analysis performed by using the Protein Inter-
faces, Surfaces and Assemblies (PISA) algorithm
(19) indicates that all residues of the SKIPWD
peptide are involved in formation of the complex,
which is stabilized by residues from TPR2-TPR3
and the internal helix of TPR4 (Fig. 2C). This con-
cave groove surface displays a positive electro-
static charge ideally poised to complement the
negatively charged W-acidic cargo motifs (Fig. 2C
and fig. S4). Overall, the interface area of the
SKIPWD-KLC2TPR complex is ~770 Å2, stabilized
by a mixture of H-bonds, salt bridges, and hydro-
phobic interactions (Fig. 3A).
The W residue central to the motif is gener-
ally flanked by amino acids bearing a carboxylate
side chain. SKIPW207 (position 0, p0) is buried
within a leucine-rich pocket positioned roughly
in the middle along the TPR length and contrib-
uted by side chains from TPR2 (L248, R251,
and L263) and TPR3 (N287, L290, and L291).
In particular, the side-chain of N287 is in a con-
formation so that it serves the dual purpose of
stabilizing SKIPW207 indole group by lining one
side of the pocket while engaging at the same
time in hydrogen bonds with the main chain
amide and carbonyl oxygen of the residue at p+1.
The latter position is almost invariably occupied
by a glutamic or aspartic acid residue (7). The
carboxylate side-chain of SKIPD208 points in the
opposite direction to that of SKIPW207, engaging
in a network of salt bridges and H-bonds with
the positively charged R312 and K325 side chains
of a3E and a4I, respectively. An acidic side chain
at position p-1 (SKIPE206) of the motif is also
very conserved in other W-acidic motifs. Like
SKIPD208, the carboxylate side-chain of SKIPE206
faces the TPR3-TPR4 side of the KLC2TPR rec-
ognition groove, where it is stabilized by an ionic
interaction with K325. Position p-2 of SKIPWD
features a leucine residue (SKIPL205). The hydro-
phobic side chain of SKIPL205 is deeply buried
in a hydrophobic pocket formed by residues from
TPR3 and TPR4. The side chain of N329 plays a
similar dual role as that of N287. Although lining
the SKIPL205 pocket, it alsoH-bondswith themain
chain at position p-1. Together, N287 and N329
act like a clamp on opposite sides of SKIPWD,
providing 4 of the 10 hydrogen bonds that sta-
bilize the complex. Residues at positions p-(3,4)
are less important for complex stability consistent
with their general lack of sequence conservation
amongstW-acidic motif cargo (7). The C-terminal
stretch of SKIPWD encompassing p+(2,3,4,5)
Fig. 1. Binding of SKIP to KLC2. (A) Scheme of SKIP and KLC2. The two W-acidic motifs and KLC2 TPR
repeats are highlighted. (B) Coimmunoprecipitation shows that alanine replacement in the first W-acidic motif
(WD) abrogates SKIP:KLC2 binding, whereas the same substitution in the second motif (WE) has virtually no
effect. (C) Fluorescence polarization measurements confirm that the first SKIP W-acidic motif (SKIPWD) has a
higher affinity for the TPR domain of KLC2 than that of the second one (SKIPWE). A peptide encompassing both
motifs (SKIPWDWE) binds with higher affinity than the best single motif. Kd values reported here were calculated
at 150 mM NaCl. Binding affinity values at varying ionic strength values are given in fig. S1.
Fig. 2. Structureof theSKIPWD-KLC2TPR
cargo complex. (A andB) Illustrated rep-
resentations of the SKIPWD motif (dis-
played as stickmodel in green) bound to
KLC2TPR domain (orange) in two orthog-
onal orientations. Simulated annealing
(Fo-Fc) omit map for the W-acidic cargo
motif is contoured at the 3s level. Indi-
vidual TPR repeats composed by helix-
turn-helix elements (“I” and “E” for internal
and external, respectively) are highlighted
in (A). A non-TPR helix (aN) is between
TPR5 and TPR6. (B) also shows the cargo-
free KLC2TPR structure (gray transparent),
with an orange arrow indicating the
movement of the TPR2-TPR3 region with
respect to the common TPR4-TPR6 ref-
erence frame. (C) Electrostatic poten-
tial surface representation of KLC2TPR
with its SKIPWD-bound cargo. Positive and negative potential is shown in blue and red, respectively. Cargo
recognition is achieved by a combination of charge complementarity and sequence specificity.































is observed in a more compact, turn-like confor-
mation, with SKIPD209,S210 at p+(2,3) making
very minor contacts with the groove. As for the
N-terminal peripheral region of SKIPWD, the exact
nature of the amino acids at p+(4,5) does not
seem critical for complex stability. Alternative side
chains can be positioned at this topological po-
sition, possibly involving a rearrangement of the
main chain.
To investigate the effect of amino acid re-
placements within the KLC2TPR region on the in-
teractionwith SKIP, we used immunoprecipitation
as described above. All amino acid substitutions
tested resulted in abrogation or near-abrogation
of complex formation between KLC2 and SKIP
(Fig. 3, B and C). The importance of electrostatic
interactions in cargo recognition is underscored by
charge-reversal mutations (Fig. 3, B andC).When
coexpressed in cells, SKIP and its small guano-
sine triphosphatase–binding partner Arl8 asso-
ciate strongly with lysosomes and promote their
trafficking to the cell periphery. GFP-KLC2 asso-
ciates with the same lysosomes (Fig. 3D and fig.
S5) (13). This is essentially abolished by KLC2
mutations (R251D, N287L, and R312E) (Fig. 3D
and fig. S5). The samemutations strongly inhibited
the binding of KLC2TPR to theWDmotif peptide
(Fig. 3C). We conclude that optimal SKIP:KLC2
stability critically depends on a very conserved
cargo recognition-interaction groove. We ex-
tended our analysis to the well-characterized
Calsyntenin-1 (CSTN-1) cargo, which also ex-
hibits twoW-acidic motifs (9, 11, 12). Differently
fromSKIP, bothCSTN-1motifs bound toKLC2TPR
with similar affinity (fig. S6). However, the mu-
tations in the KLC2-binding groove that disrupted
SKIPWD binding also abrogated recognition of
CSTN-1 (fig. S6). A sequence alignment shows
total conservation of the KLCTPR residues in-
teracting with the cargo across the kinesin light
chain family (fig. S7). Thus, the concave groove
within the TPR domain where the SKIPWD pep-
tide binds is likely to be the primary site of in-
teraction for W-acidic cargo motifs in general.
However, we cannot exclude that secondary sites
also exist.
In the context of intracellular transport in which
kinesin-1 functions as a tetramer containing two
KLCs held together by a coiled-coil region and
both SKIP motifs contribute to transport (7, 13), it
is tempting to speculate that both chains can
contribute to the binding of the W-acidic cargo
pair. For SKIP, the higher-affinity WD motif
would direct the first binding event to one of the
KLCTPR, with avidity effect promoting the as-
sociation of the WE motif to the other KLC
(20, 21). It will be important to determine this
Fig. 3. TheSKIPWD-KLC2TPR interface and theeffect
of KLC2TPRmutations in cargo binding and cellu-
lar recruitment. (A) Details of the SKIPWD:KLC2TPR
interface. KLCTPR side chains stabilizing the SKIPWD
cargo peptide (green) are shown as gray sticks ema-
nating from the orangemodel. Noncarbon elements
are nitrogen, dark blue; oxygen, red; and sulfur, yellow.
Hydrogen bonds are represented by dotted light blue
lines. (B) Coimmunoprecipitation assay showing the
effect of KLC2TPR mutations at the SKIPWD:KLC2TPR
interface on the interaction. (C) Fluorescence polar-
ization measurements showing that R251D, N287L,
and R312E mutations in KLC2 dramatically reduce
the affinity of the TPR domain for the SKIPWD peptide.
Kd values reported here were calculated at 150 mM
NaCl. (D) Replacement of key KLC2TPR residues re-
sults in loss of GFP-KLC2 association with Arl8/SKIP–
positive lysosomal membranes. Scale bar, 10 mm. In
merge panels, GFP-KLC2, Arl8, and SKIP are shown
in green, red, and blue, respectively.































relationship to the kinesin-1 tetramer and examine
the importance of cargo-induced TPR conforma-
tional change in motor activation.
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Actin-Propelled Invasive Membrane
Protrusions Promote Fusogenic Protein
Engagement During Cell-Cell Fusion
Khurts Shilagardi, Shuo Li, Fengbao Luo, Faiz Marikar, Rui Duan, Peng Jin, Ji Hoon Kim,
Katherine Murnen, Elizabeth H. Chen*
Cell-cell fusion is critical for the conception, development, and physiology of multicellular
organisms. Although cellular fusogenic proteins and the actin cytoskeleton are implicated in
cell-cell fusion, it remains unclear whether and how they coordinate to promote plasma membrane
fusion. We reconstituted a high-efficiency, inducible cell fusion culture system in the normally
nonfusing Drosophila S2R+ cells. Both fusogenic proteins and actin cytoskeletal rearrangements
were necessary for cell fusion, and in combination they were sufficient to impart fusion
competence. Localized actin polymerization triggered by specific cell-cell or cell-matrix adhesion
molecules propelled invasive cell membrane protrusions, which in turn promoted fusogenic protein
engagement and plasma membrane fusion. This de novo cell fusion culture system reveals a
general role for actin-propelled invasive membrane protrusions in driving fusogenic protein
engagement during cell-cell fusion.
Cell-cell fusion occurs in many biologicalprocesses such as fertilization, myogene-sis, placenta formation, bone remodel-
ing, and immune response (1–3). Transmembrane
fusogenic proteins are implicated in the fusion of
multiple cell types inCaenorhabditis elegans (4),
whereas actin polymerization is implicated in the
fusion of muscle cells in Drosophila, zebrafish,
and mice (5–7). It remains unknown whether
fusogenic proteins and the actin cytoskeleton co-
ordinate during cell-cell fusion, and if so, how
this is accomplished. We addressed these ques-
tions by reconstituting cell fusion de novo in the
otherwise nonfusing S2R+ cells, a hemocyte-like
cell line derived from Drosophila embryos (8).
Transfection of known components of Dro-
sophila myoblast fusion, including cell adhesion
molecules (9, 10) and actin cytoskeletal regu-
lators (11–14), failed to induce S2R+ cell fusion,
despite causing extensive cell adhesion and F-actin
enrichment at cell-cell contact sites (fig. S1, A to
C). Expression of the C. elegans fusogenic pro-
tein Eff-1 (15, 16) induced low-level S2R+ cell
fusion (Fig. 1, A and F). Multinucleate syncytia
were observed 24 hours after Eff-1 transfection,
and by 72 hours after transfection, ~12% (12.1 T
1.1%) of Eff-1–positive cells were in multinucleate
syncytia, with each syncytium containing amedian
number of eight nuclei (Fig. 1, F and G). These
Eff-1–induced multinucleate syncytia resulted
from cell fusion (fig. S2, A to B´´´), and Eff-1 was
required in both fusion partners (fig. S2C), sim-
ilar to findings reported for moth Sf9 cells (16).
Because close membrane apposition is a pre-
requisite for membrane fusion, we asked whether
Eff-1–induced fusion could be enhanced by co-
expressing cell adhesionmolecules. Dumbfounded
(Duf) and Sticks and stones (Sns) are immuno-
globulin (Ig) domain–containing transmembrane
proteins that are required forDrosophilamyoblast
fusion (9, 10) but are not normally expressed in
S2R+ cells (fig. S1D). Exogenous Duf, but not
Sns, promotes homophilic cell adhesion in cul-
turedDrosophila cells (17–19), as does Echinoid
(Ed), an Ig domain–containing transmembrane
protein not implicated in myoblast fusion (20, 21).
Among the three proteins, only Sns enhanced
Eff-1–mediated fusion (Fig. 1, B, C, D, and F),
which suggests that membrane apposition me-
diated by cell adhesion per se is not sufficient
to promote Eff-1–mediated fusion. Nearly 90%
(86.3 T 2.9%) of the Sns-Eff-1–coexpressing cells
were in multinucleate syncytia (Fig. 1C), repre-
senting a factor of 7 increase over Eff-1–induced
fusion (Fig. 1F). These large syncytia contained
up to 220 nuclei, with a median number of 44
nuclei per cell (Fig. 1G). Live imaging confirmed
that Sns-Eff-1–induced syncytial formation resulted
from cell fusion (fig. S3, A and B, and movies S1
and S2). Besides Sns, overexpression of an a sub-
unit (aPS2) of the cell-matrix adhesion molecule
integrin (22), which has been implicated in mul-
tiple types of cell fusion events (23–26), enhanced
Eff-1–mediated fusion by a factor of 5 (63.9 T
4.3%) with a median number of 20 nuclei per
cell (Fig. 1, E to G). The marked enhancement of
Eff-1–mediated cell fusion by Sns and integrin,
neither of which facilitated homophilic cell ad-
hesion nor interacted with Eff-1 more strongly
than did Duf (fig. S4), prompted us to examine
the cellular mechanisms underlying their fusion-
enhancing activity.
In Drosophila, Sns and Duf trigger distinct
actin cytoskeletal changes during myoblast fu-
sion. Sns organizes an F-actin–enriched invasive
podosome-like structure (PLS) in the fusion com-
petent myoblast (27, 28), whereas Duf promotes
the formation of a thin sheath of actin underlying
the apposing founder cell membrane (27). Their
differential activity in remodeling the actin cyto-
skeletonwas recapitulated in S2R+ cells, as F-actin–
enriched foci were observed at cell-cell contact
sitesmarked by the accumulation of Eff-1 and the
cell adhesion molecule in Sns-Eff-1–expressing
cells (Fig. 1H and fig. S5A) but not in Duf-Eff-1–
expressing cells (Fig. 1I and fig. S5B). Live im-
aging of Sns-Eff-1–expressing cells using green
fluorescent protein (GFP) fused to the F-actin–
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The light chains of kinesin-1 are autoinhibited
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The light chains (KLCs) of the microtubule motor kinesin-1 bind
cargoes and regulate its activity. Through their tetratricopeptide
repeat domain (KLCTPR), they can recognize short linear peptide mo-
tifs found in many cargo proteins characterized by a central trypto-
phan flanked by aspartic/glutamic acid residues (W-acidic). Using a
fluorescence resonance energy transfer biosensor in combination
with X-ray crystallographic, biochemical, and biophysical ap-
proaches, we describe how an intramolecular interaction between
the KLC2TPR domain and a conserved peptide motif within an un-
structured region of the molecule, partly occludes the W-acidic
binding site on the TPR domain. Cargo binding displaces this in-
teraction, effecting a global conformational change in KLCs result-
ing in a more extended conformation. Thus, like the motor-bearing
kinesin heavy chains, KLCs exist in a dynamic conformational state
that is regulated by self-interaction and cargo binding. We pro-
pose a model by which, via this molecular switch, W-acidic cargo
binding regulates the activity of the holoenzyme.
kinesin | KLC | TPR domain | microtubule motor | cytoskeleton
The heterotetrameric microtubule (MT) motor kinesin-1 (alsoknown as conventional kinesin) has diverse roles in protein,
ribonuclear protein, vesicular, and organelle transport by virtue of
its ability to interact with many different cargoes (1, 2). It is also
hijacked by pathogens during infection (3). Accumulating evidence
suggests a key role for kinesin-1–dependent MT transport in several
neurological disorders including Alzheimer’s disease (4). Thus, de-
termining the molecular basis for cargo recognition and regulation
of kinesin-1 is important for understanding its role in normal cell
function and disease states.
Kinesin-1 is composed of two heavy (KHCs) and two light chains
(KLCs) that, in mammalian cells, are encoded by several closely
related genes with distinct cell and tissue expression profiles (Kif5A-C
and KLC1-4, respectively). The heavy chains have a MT-binding
ATPase motor domain at their amino terminus followed by a neck
coil and an extended series of coiled coils, separated by a hinge
region(s), that results in heavy-chain dimerization (5). The carboxyl-
terminal domain of the heavy chains is largely unstructured. The
light chains associate with the heavy-chain coiled coils at the car-
boxyl-terminal portion of the molecule through a series of heptad
repeats (6). A highly charged unstructured linker region connects
this heavy-chain binding region to a tetratricopeptide repeat do-
main (KLCTPR) formed of six helix-turn-helix TPR repeats (TPR1-
6), followed by a C-terminal region that varies considerably between
the different KLCs and splice variants.
In the absence of cargo binding, kinesin-1 exists in a folded,
compact state that prevents unnecessary cycles of ATP hydrolysis.
This is achieved via an intramolecular interaction in which the
C-terminal isoleucine–alanine–lysine (IAK) motif (and flanking
amino acids) of a single KHC tail binds at the N-terminal motor
dimer interface and participates in a “double-lockdown” mecha-
nism whereby it cross-links the motor domains preventing move-
ment of the neck linker region that is required for ADP release
(7–12). In the cargo-bound active state, tail-mediated inhibition is
relieved resulting in a more elongated structure that is able to hy-
drolyze ATP and translocate along MTs (12–16). As well as binding
to cargoes, the KLCs are thought to regulate KHC autoinhibition,
although the molecular mechanism(s) that couple these two
functions are unclear (17). Several studies suggest that KLCs reduce
interaction with MTs and help to maintain the autoinhibited state in
the absence of cargo (12, 13, 18), whereas in vitro biophysical
studies have suggested that the presence of light chains reduces the
affinity of the motor domains for the C-terminal autoinhibitory
heavy-chain tail through both steric and electrostatic factors (19).
Vesicular cargoes interact via adaptor proteins that can bind to
several sites on both KHCs and KLCs, and it is generally thought
that these multiple contacts help to stabilize the active state and/or
destabilize the inactive state and thus promote cargo-dependent
transport (15, 17, 20, 21). It has emerged that diversity of light-
chain cargo recognition is accomplished, in part, through TPR
domain interaction with short linear peptide motifs (22–25). We
have recently described how the TPR domain of KLC2 (KLC2TPR)
recognizes one class of these peptides that are characterized by
a central tryptophan typically flanked by aspartic or glutamic
acid residues (W-acidic). The X-ray structure of KLC2TPR in
complex with a W-acidic peptide of the lysosome adaptor SKIP
(SKIPWD) shows that these motifs interact with a concave posi-
tively charged groove at the KLCTPR N terminus. Both sequence-
specific and electrostatic elements contribute to peptide recogni-
tion, which is stabilized by residues from TPR2–TPR3 and the
internal helix of TPR4 (23). Functional W-acidic motifs have been
identified in a growing number of cargo adaptors, including the
neuronal protein calsyntenin-1 (CSTN1) that plays a role in the
axonal transport of amyloid precursor protein, as well as nesprin-2,
gadkin, vaccinia virus A36R, and cayman ataxia protein (BNIP-H),
where, in each case, they provide a crucial link between motor and
cargo with diverse functions (16, 23, 24, 26–31). It is interesting to
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note that W-acidic motifs share sequence similarity with the A
(acidic) motif of several actin nucleation-promoting factors (NPFs)
including WASP, N-WASP, and WAVE1 (32), and the mechanism
of binding to KLCTPR is somewhat similar to the interaction of the
fission yeast WASP A motif on the Arp2/3 complex (33). Indeed, in
the case of gadkin, there also appears to be functional overlap (32).
Here, we describe an intramolecular interaction between
KLCTPR and the unstructured region immediately N-terminal to it.
This flexible linker features a highly conserved leucine–phenylala-
nine–proline motif flanked by acidic residues (LFP-acidic) that in-
teracts with KLCTPR partly occluding its W-acidic motif binding site.
This autoinhibitory interaction is displaced by cargo binding,
resulting in overall conformational changes within the light chains.
Thus, paralleling the behavior of KHCs, kinesin-1 KLCs also exist in
a dynamic conformational state that is regulated by self-interaction
and cargo binding. We propose a model to explain how this pre-
viously unnoticed molecular switch may couple KLCTPR–W-acidic
peptide recognition to the regulation of kinesin-1 activity.
Results
The KLC Region N-Terminal to Its TPR Domain Features a Conserved
LFP-Acidic Motif and Negatively Regulates W-Acidic Cargo Binding.
Amino acid sequence alignment of all four KLCs from human
and mouse as well as representative kinesin-1 light chains from
several diverse species reveals that the heptad repeat region (that
interacts with KHC via a predicted coiled coil; Fig. S1A) and the
TPR domain (that binds cargoes) are highly conserved, whereas
the intervening stretch of highly charged amino acids (F139–
P195 in mouse KLC2) is considerably more divergent (Fig. 1 A
and B). Within this region, we noticed, however, that a leucine–
phenylalanine–proline (LFP) motif (residues 167–169 in mouse
KLC2) is totally conserved (in red in Fig. 1B). This short motif
that is followed by Asn/Ser and flanked by negatively charged
Asp/Glu residues (in blue in Fig. 1B) is present in all KLCs. No
function has been ascribed to this conserved LFP-acidic feature.
Analyses using a panel of intrinsic-disorder prediction packages
(PrDOS, Disopred, IUPred, DisEMBL) indicate that this pro-
tein region is likely unstructured (Fig. S1B).
To examine the role of the LFP-acidic motif in light-chain
function, we performed GFP-TRAP immunoprecipitation exper-
iments from HeLa cells with two independent W-acidic cargo
proteins using full-length wild-type KLC2 or KLC2 where the LFP
triplet was replaced by AAA. This revealed that disruption of this
sequence enhances binding to both the N-terminal domain of
SKIP (amino acids 1–310) and the cytoplasmic domain of CSTN1
(amino acids 879–971) by 36% and 78%, respectively (Fig. 1C).
Consistently, the LFP/AAA replacement in KLC1 enhanced
binding to CSTN1 by 72% (Fig. S1B). However, disruption of this
motif did not affect binding to the non–W-acidic cargo JIP1, which
mutagenesis data suggest binds to a distinct site on KLC1TPR (Fig.
S1D) (22, 34). Given that the LFP motif is located N-terminal to
the TPR domain, we reflected that this could imply a mechanism
of cross talk between this linker region and the W-acidic binding
site involving residues from TPR2-3 and the internal helix of
TPR4 (23). We considered the possibility that this cross talk could
be mediated by an intramolecular interaction.
To directly examine the contribution of this region to TPR
domain cargo binding in vitro, we performed pull-down assays
using purified GST-SKIP (1–310) or GST-CSTN1 (879–971).
We compared binding to KLC2TPR, KLC2TPR with a N-terminal
extension to include the LFP-acidic motif (KLC2 161–480,
KLC2extTPR) or KLC2TPR fused N-terminally to a competitor
W-acidic peptide from SKIP (KLC2WacTPR) (Fig. 2A). For both
SKIP and CSTN1, amino-terminal extension of the TPR domain
up to residue 161, to include the LFP-acidic motif, inhibits
binding to the W-acidic motif-containing cargoes in a manner
comparable to inclusion of a direct competitor peptide attached
by a flexible linker (Fig. 2 B and C). This strongly supports the
proposition that this linker region can compete with W-acidic
cargo for a binding site on the TPR domain through an
intramolecular interaction.
The KLC Region N-Terminal to Its TPR Domain Directly Interacts in an
LFP Motif-Dependent Manner with the TPR Domain. Next, we used a
biophysical assay to test whether the LFP-acidic motif can interact
with purified KLC2 proteins. Fluorescence polarization (FP) mea-
surements using a 14-aa N-terminally carboxytetramethylrhodamine
(TAMRA)-conjugated peptide comprising the LFP motif and its
flanking residues (LFPpept, DSLDDLFPNEDEQS) showed that
this sequence binds to KLC2TPR with a dissociation constant (KD)
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Fig. 1. Mutational disruption of a conserved leucine–phenylalanine–proline
(LFP) motif in KLC2 enhances binding to W-acidic cargoes. (A) Schematic
showing domain organization of KLC2 (numbering refers to mouse protein).
The heptad repeat region (HR) that interacts with KHC is shown in gray, and
the six TPR repeats comprising the TPR domain are represented by orange
circles. (B) Multiple sequence alignment using Clustal W showing the region
linking the HR and the first TPR repeat in KLCs 1–4 from human and mouse
as well as representative fly (Dm), zebrafish (Dr), or chicken (Gg) homologs as
annotated in the Homologene database. The highly conserved HR and TPR
regions are highlighted in gray and orange, respectively. An asterisk (*) in-
dicates a completely conserved residue, whereas a colon (:) indicates strong
conservation of residue properties. A universally conserved LFP motif (red),
located within the otherwise-divergent linker region is highlighted in red as
well as flanking conserved acidic residues in (blue). (C) Western blot analysis
of GFP-TRAP immunoprecipitation experiments from transfected HeLa cells
showing enhanced binding between GFP-SKIP (1–310) (Left) or GFP-CSTN1
(879–971) (Right) to HA-KLC2 when the LFP triplet is replaced to AAA.
Graphs show quantification of relative binding from three independent
experiments. Error bars show SEM. **P < 0.01, *P < 0.05.








estimated at ∼25 μM (squares in Fig. 3A). This interaction requires
the LFP sequence because an equivalent peptide, in which this
triplet was replaced by AAA (AAApept, DSLDDAAANEDEQS),
did not bind to KLC2TPR (triangles in Fig. 3A). Further sup-
porting a self-interaction model, binding between LFPpept
and KLC2TPR was also strongly inhibited by the inclusion of the
extended endogenous N-terminal sequence (crossed squares in
Fig. 3A). Similarly, and consistent with our GST–pull-down
analysis, the presence of the N-terminal extension also reduced
affinity for a TAMRA-conjugated W-acidic cargo peptide from
SKIP (SKIPWD, STNLEWDDSAI; KD increased from 1.05 ± 0.14
to 8.43 ± 0.24 μM) (Fig. 3B). Moreover, a competition assay in which
increasing amounts of nonlabeled SKIPWD were titrated into a
KLC2TPR:TAMRA-LFPpept complex revealed a concentration-
dependent decrease in FP (Fig. 3C). From this experiment, we
estimated a KI value (35) for the unlabeled SKIP
WD peptide of 3.6
μM. This is in good agreement with the KD value for TAMRA-
SKIPWD supporting a model in which W-acidic binding dis-
places the bound LFP peptide. In a separate experiment, we also
validated our immunoprecipitation analysis that indicated that
KLC1 LFP/AAA replacement has little effect on JIP1 binding
(Fig. S1D). Consistent with this, we found that inclusion of an
N-terminal extension of KLC1TPR (KLC1extTPR) only marginally
reduced its affinity for a TAMRA-conjugated peptide compris-
ing the TPR binding C-terminal 11 aa of JIP1 (YTCPTEDIYLE)
(KD increased from 0.95 ± 0.09 to 2.21 ± 0.06 μM; Fig. S1E).
To further define the interaction site on KLC2TPR, we crystallized
the extended KLC2extTPR protein. After substantial crystal screening,
we were able to obtain a dataset at the 4-Å resolution (data collection
and refinement statistics in Table S1). This allowed the modeling of
the complete KLC2TPR domain, extending the available structures for
this isoform, which lack either the complete TPR1 repeat (3ZFW) or
its first α-helix (3CEQ). In the course of crystallographic refinement,
difference Fourier maps also revealed the presence of elongated
electron density in close proximity of the C-terminal end of the first
α-helix of the TPR2 repeat (α2A) (Fig. S2). In all three in-
dependent molecules present in the crystallographic asymmetric
unit, this residual density was satisfactorily modeled as a short
peptide stretch (5 aa in molecules A and B and 2 aa in molecule C)
in an extended conformation (Fig. 3D and E). Although the limited
resolution of the data does not allow for exact amino acid identi-
fication, given that our biochemical and biophysical results support
an LFP-dependent self-interaction model, the bound peptide (ext in
Fig. 3 D and E) almost certainly originates from the extended
flexible region N-terminal to the TPR and involves the LFP-acidic
motif. A structural comparison between autoinhibited and
cargo-bound KLC2TPR highlights that stabilization of the ext pep-
tide involving the C-terminal portion of α2A does not trigger the
conformational change at the N-terminal TPR region observed
upon W-acidic cargo binding (23) (Fig. 3F). In the latter case, upon
W-acidic recognition, an “induced-fit” rigid jaw movement closes
TPR2-3 engendering the binding surface and pockets for the
SKIPWD peptide. Such movement is not seen in KLC2extTPR. Thus,
the interactions involved in ext:KLC2TPR stabilization, appear dif-
ferent from those critical for SKIPWD binding. However, the X-ray
structures do reveal a partial overlap between the W-acidic
SKIPWD and the ext binding sites on the KLC2TPR domain. In
particular, residues immediately C-terminal to the W-acidic motif
(SAI in SKIPWD) essentially occupy the same topological location
as ext on the KLC2TPR receptor (Fig. 3F). Thus, crystallographic
analysis fully supports the notion that the autoinhibited (ext-bound)
and the W-acidic cargo-bound states are mutually exclusive.
In Vivo Conformational Dynamics of KLC Are Governed by Self-
Interaction and Cargo Binding. The above data imply that an intra-
molecular interaction within KLC2 mediated, at least in part, by
amino acids in LFPpept, must be displaced forW-acidic cargo binding
to occur. This could have an effect on the overall conformation of
the light chain. To test this hypothesis in vivo, we designed a KLC2
fluorescence resonance energy transfer (FRET) conformation bio-
sensor (Fig. 4A). A similar approach has been used previously to
study conformational change within kinesin-1, but not to assess
conformational changes within the light chains themselves (13). To
achieve this, we coupled the amino terminus of full-length KLC2 to a
donor eGFP and the carboxyl terminus to a HaloTag that allows in-
cell conjugation to a tetramethylrhodamine (TMR) FRET acceptor.
We then used fluorescence lifetime imaging microscopy (FLIM) to
quantify changes in the efficiency of energy transfer from GFP to
HaloTag-TMR. These measures subsequently inform on quantita-
tive conformational changes in KLC caused by the modulation of the
distance between the N- and C-terminal fluorophores. Western blot
analysis of TMR-labeled cell extracts confirmed specific targeting of
TMR to the GFP-KLC2-HaloTag biosensor and comparable la-
beling of wild-type and mutant proteins. Immunoprecipitation
showed that the biosensor retained capacity to interact with KHC
(Kif5C) (Fig. S3 A and B). Expression and labeling of the wild-type
biosensor in HeLa cells (without addition of exogenous KHC or
























































































































Fig. 2. The LFP-acidic motif-containing HR–TPR
linker region inhibits W-acidic cargo binding in vitro.
(A) Schematic showing KLC2TPR, KLC2WacTPR, and
KLC2extTPR proteins used in this work. KLCTPR consists
of residues (196–480) of KLC2 comprising its six TPR
repeats; KLCextTPR consists of residues (161–480)
encompassing the six TPR repeats and an N-terminal
extension (ext) to include the conserved LFP-acidic
motif. KLCWacTPR comprises residues (196–480) of
KLC2with the firstW-acidic motif of SKIP (STNLEWDDSAI,
amino acids 202–212) coupled by a flexible (TGS)4 linker.
(B and C) GST–pull-down experiment showing interaction
between the above TPR proteins with (B) GST-CSTN1
(879–971) or (C) GST-SKIP (1–310). The TPR domain
alone shows robust binding to both W-acidic cargo
proteins, but binding is reduced to background levels
by inclusion of the N-terminal region carrying the
LFP-acidic motif. Similarly, inclusion of a competitor
peptide sequence also inhibits the interaction.
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B and C). This was significantly reduced by the replacement of the
LFP motif with AAA (3.0 ± 0.3%), demonstrating that the LFP
triplet contributes to a relatively compact KLC2 conformation
(compare first two columns on graph in Fig. 4C). Coexpression of
a W-acidic cargo [myc-tagged cytoplasmic domain of CSTN1
(869–971)] reduced wild-type KLC2 FRET efficiency by a similar
extent (5.6 ± 0.5%) but did not significantly affect FRET in the
LFP/AAA background (3.6 ± 0.5%, compare columns 3 and 4
on graph in Fig. 4C). Importantly, introduction of the N287L
substitution in KLC2 that disrupts W-acidic cargo binding (23)
or mutation of the W-acidic residues in CSTN1 (16, 27, 28),
suppressed the cargo-dependent response (Fig. S3 C and D).
In comparison, FRET efficiency for GFP directly coupled to
HaloTag-TMR was 31.3 ± 0.76%, whereas expression of the two
fluorophores on separate polypeptide chains [N-terminal labeled
(GFP-KLC2) and C-terminal labeled (KLC2-Halo)] resulted in
low levels of FRET (4.76 ± 1.26%), indicating that the biosen-
sor predominantly reports on intramolecular interaction within
KLC2 (Fig. S3 E and F). To determine whether these cargo/LFP-
dependent changes also occur in the context of the kinesin-1
tetramer, equivalent experiments were carried out in the presence
of KHC. Inclusion of the heavy chain resulted in an increase in
baseline FRET efficiency to 22.5 ± 1.0%, indicating that binding
to KHC helps to support a more compact KLC conformation.
FRET efficiency was significantly lower in the LFP/AAA re-
placement biosensor (13.3 ± 0.6%) (columns 5 and 6 on graph in
Fig. 4C). Cotransfection of cargo reduced FRET efficiency to






Fig. 3. The HR–TPR linker region interacts in an LFP-dependent manner with
KLC2TPR at a binding site partly overlapping with that of cargo W-acidic motifs.
(A) Fluorescence polarization (FP) measurements showing concentration and LFP-
dependent interaction between TAMRA-conjugated LFPpept (DSLDDLFPNEDEQS)
and KLC2TPR. Mutation of the LFP motif to AAA (DSLDDAAANEDEQS) essentially
eliminates binding. Amino-terminal extension of the TPR domain to residue 161
(KLCextTPR) also inhibits interaction with LFPpept. (B) FP measurements showing
amino-terminal extension of the TPR domain to residue 161 (KLCextTPR) inhibits
interaction with SKIPWD compared with KLC2TPR alone. (C) FP experiment ti-
trating increasing amounts of nonlabeled SKIPWD in a KLC2TPR:LFPpept complex
showing that binding of LFPpept and SKIPWD to KLC2TPR are mutually exclusive.
(D and E) Illustrated cartoon representations of the KLC2extTPR X-ray structure in
two orthogonal orientations. The peptide originating from the extended
N-terminal region (ext in blue) is bound to the KLC2TPR domain (orange). 2mFo-
DFc electron density map is shown at the 1.2σ level. Individual TPR repeats
composed by helix1-turn-helix2 elements are highlighted. The non-TPR helix
between TPR5 and TPR6 is labeled αN. (F) Superposition between KLC2extTPR and
cargo-bound SKIPWD:KLC2TPR (3ZFW) structures in the same orientation as E. The
SKIPWD W-acidic cargo peptide is shown in green, and the cargo-bound KLC2TPR
is shown in yellow. The KLC2extTPR structure is color-coded as in D and E. The
SKIPWD and ext peptides binding sites on KLC2TPR partly overlap.












































































Fig. 4. In vivo conformational dynamics of kinesin light chain are controlled
by self-interaction and cargo binding. (A) Schematic showing KLC2 FRET bio-
sensor with an N-terminal eGFP and a C-terminal HaloTag that allows covalent
coupling of TMR. Red arrows indicate mechanistic questions addressed using
the biosensor. (B) Multiphoton fluorescent lifetime images of FRET between
GFP and TMR-HaloTag. “GFP int.” are multiphoton GFP intensity images,
whereas lifetime image refers to the fluorescence lifetime of GFP (τ) and is
represented by a pseudocolor scale. In these images, a reduction in lifetime
(change in color from blue to red) indicates FRET and therefore close associ-
ation of GFP and TMR-HaloTag. (C) Graphs show data from 15 cells expressed
as FRET efficiency (SI Materials and Methods). (Scale bar: 10 μm.) Error bars are
SEM. ***P < 0.001. (Left) Light-chain biosensor alone [with and without
cotransfection of myc-CSTN (879–971) cargo]; (Right) equivalent experiments
where exogenous KHC is included.








columns 7 and 8 on graph in Fig. 4C) showing that KLC un-
dergoes significant cargo-dependent conformational change in the
context of the kinesin-1 tetramer. This cargo-dependent change in
FRET was again suppressed by the KLC2 N287L variant and
W-acidic mutations in CSTN (Fig. S3 C and D), and separation of
the fluorophores on different polypeptides resulted in only mini-
mal levels of FRET (4.09 ± 1.23%), indicating that the measured
FRET efficiency remains predominantly intramolecular in the
context of the holoenzyme (Fig. S3 E and F).
To examine the effect of LFP motif-mediated intramolecular
interaction in KLC on the MT-dependent ATPase activity associ-
ated with KHC, kinesin-1 containing either wild-type or LFP/AAA
KLC2 was expressed in, and isolated from, mammalian cells by
covalent coupling of GFP-KLC2-Halo to HaloLink resin and sub-
sequent release by TEV protease cleavage of the HaloTag (Fig. S4
A and B). As assessed by measurement of inorganic phosphate
resulting from hydrolysis of ATP, these kinesin-1 preparations had
no detectable ATPase activity in the absence of MTs (Fig. S4C).
However, in the presence of MTs, the ATPase rate of wild-type
kinesin-1 was 543.3 ± 7.2 nmol·min−1·mg−1 (of KHC). The
LFP/AAA substitution resulted in an increase in the ATPase
rate to 827.7 ± 21.2 nmol·min−1·mg−1, demonstrating that this intra-
molecular interaction within the light chain can modulate KHC-
associated ATPase activity.
Taken together, these data show that the LFP motif-mediated
intramolecular interaction within KLC regulates KLC confor-
mation in the context of the holoenzyme in vivo. This auto-
inhibitory interaction and conformation are themselves directly
governed by W-acidic cargo binding.
Discussion
Despite its importance for a host of cellular processes and con-
tribution to neurological, viral and bacterial disease, the molec-
ular mechanisms underlying the regulation of kinesin-1 by its
light chains and the binding of its cargo are not well understood.
The data presented here provide conceptual insight into the
molecular events that occur both in its regulated state and fol-
lowing W-acidic cargo recognition. We show that, like the
kinesin heavy chain, the light chains of kinesin-1 exist in a dy-
namic conformational state that is regulated by self-interaction
and cargo binding. We highlight how recognition of short linear
peptide motifs by the TPR domain can be transduced and am-
plified to result in larger scale modification of the organizational
state of the light chain. Thus, we uncover unanticipated mech-
anistic parallels between the heavy- and light-chain components
of the kinesin-1 tetramer.
Such an intramolecular interaction mediated by a TPR do-
main is reminiscent of the interaction of the N-arm helix of the
mitochondrial outer membrane protein Fis1 with its TPR do-
main (36), although in this case the self-interacting helix forms
an important component of the binding interface for other
proteins. A closer mechanistic analogy perhaps lies in the regu-
lation of protein phosphatase 5 (Ppp5) activity by its TPR do-
main where, in its autoinhibited state, the TPR domain engages
with the catalytic channel of Ppp5 (37). This conformation is
stabilized by the C-terminal αJ helix that contacts a region of the
Hsp90 binding groove on the TPR domain. Binding of the
C-terminal MEEVD peptide of Hsp90 disrupts this interaction,
relieving autoinhibition and activating the phosphatase. The
notion that TPR domain function is not restricted to that of a
protein–protein interaction module and that peptide binding can
be transduced through conformational change to control func-
tion is supported by studies of the dimeric bacterial transcription
factor and virulence regulator PlcR where TPR binding of the
PapR signal peptide is propagated to control the DNA binding
properties of helix-turn-helix DNA binding domains (38). We
note some functional parallels in another transport/trafficking
system with a recent report describing how the interaction of the
AP2 β2 hinge (containing a clathrin-binding motif) with the core
of the molecule that is disrupted (in an allosteric manner in this
case) by phospholipid and cargo binding, promoting clathrin
binding activity (39).
In the context of the present study, it is interesting to note that
several reports have demonstrated that fusion of W-acidic motifs to
otherwise non–kinesin-1 binding proteins is sufficient to promote
kinesin-1–dependent transport/dispersion of specific cellular com-
partments, such as lysosomes (16, 24, 40). The strong implication of
these studies is that W-acidic motifs have an intrinsic capacity to
promote (at least partial) relief of kinesin-1 autoinhibition. How-
ever, given that kinesin-1 ATPase activity is predominantly con-
trolled by an intramolecular interaction between the motor domains
and the IAK C-terminal region of a single heavy chain, it was not
obvious how a TPR domain–peptide interaction could contribute to
this change. Our present data suggest a possible model. Here, we
show that mutational disruption of the LFP motif in KLC enhances
the inherent MT-stimulated ATPase activity of purified kinesin-1.
Rice and colleague (19) demonstrated that the heptad repeat–TPR
linker region contributes to light-chain–mediated destabilization of
the heavy-chain carboxyl-tail/MT interaction in vitro, implying a
mechanism of communication between the linker and heavy-chain
tail. Moreover, the same study reported that the TPR domain itself
contributes to a light-chain–mediated reduction in the affinity of the
KHC head for its C-terminal tail, through a mechanism requiring
steric and electrostatic factors. Incorporating that analysis, we pro-
pose a model whereby theW-acidic motif-mediated displacement of
the highly charged linker from the TPR will result in interactions
(predominantly electrostatic) with the heavy-chain tail that combine
with steric changes resulting from a large-scale change in confor-
mation of the light chains to promote the cargo-dependent transi-
tion of holoenzyme to its active state (Fig. S5).
If so, it would seem likely that this mechanism can be generalized
to other W-acidic motif-containing cargo given their shared binding
determinants on the KLCTPR (23, 30). The strong sequence con-
servation of the LFP motif and our similar observation for CSTN1
and KLC1 (Fig. S1C) suggests that this will also apply to other light-
chain isoforms. However, only a subset of kinesin-1 cargoes contain
W-acidic motifs, and it is clear that KLCTPR has the capacity to
interact with other peptides, including the C-terminal 11 aa of JIP1
(JIP1C11, sequence YTCPTEDIYLE) (22). Despite this, the LFP/
AAA replacement does not affect binding to JIP1 in immunopre-
cipitation experiments (Fig. S1D) and N-terminal extension of the
KLC1TPR only has a marginal impact on its affinity for JIP1C11. The
JIP1C11 peptide is also insufficient to promote activation of trans-
port (16). Indeed, JIP1 requires interactions with the coiled-coil
heavy chain and the heavy-chain tail binding protein Fez1 for full
activity (15, 17). Although the precise JIP1C11 binding site on
the KLCTPR still awaits structural definition, mutagenesis ex-
periments highlight a particularly crucial role for residues on
TPR4/5 that are distinct from the primary determinants of
W-acidic binding on TPR2/3 (22, 23). Thus, it may be that the
site of peptide binding on the KLCTPR has different functional
outcomes, and that this is in part due to its capacity to displace
the LFP motif-containing linker region, resulting in differential
requirements for supporting interactions to promote kinesin-1
activity. It is therefore likely that there are multiple pathways to
activation of kinesin-1 depending upon site(s) of cargo binding.
The dissociation constant (KD) of ∼25 μM (or the equivalent
association constant KA = 1/KD ∼ 0.04 μM−1) measured here by
FP between TAMRA-LFPpept and KLC2TPR reflects a bimolecu-
lar binding process. However, the proposed mechanism of KLC
autoinhibition is unimolecular, as the LFPpept is covalently linked
to the TPR domain. The balance between the latched (auto-
inhibited) and unlatched (available to W-acidic cargoes) states is
therefore regulated by the intramolecular association constant
KA
i. This has been shown to be related to KA by KA
i = p(d)KA
(Eq. S1, SI Materials and Methods) where p(d) is known as the
2422 | www.pnas.org/cgi/doi/10.1073/pnas.1520817113 Yip et al.
effective concentration, the ligand concentration that would be
required to achieve the same fraction of bound state in a bi-
molecular interaction (41, 42). From the structure of KLC2extTPR,
we can estimate the value of p(d) at ∼18.2 mM (Eq. S2, SI Ma-
terials and Methods). Thus, using Eq. S1, we obtain KA
i ∼ 728.
The implication of this is that the equilibrium fraction of cargo-
available KLC2TPR is only ∼0.14%. This suggests that auto-
inhibition of the light chains tightly regulates cargo binding. A
similarly stringent intramolecular regulation has been observed
for the myristoylated N-terminal latching to the C-terminal lobe
of c-Abl that maintains the kinase in an inactive state (43, 44).
The low fraction of cargo-available KLC2TPR raises the obvious
question of how significant W-acidic cargo binding is achieved. The
X-ray structures of cargo-bound KLC2TPR and autoinhibited
KLC2extTPR highlight that only a partial overlap exists between the
W-acidic motif and the ext autoinhibitory peptide. In particular, the
binding region for the most N-terminal part of the W-acidic motif
(N-terminal to the central tryptophan residue) appears accessible
even in the ext-bound state (Fig. 3F). Thus, one possible mecha-
nism for the relief of KLC autoinhibition is the initial recognition
of a portion of the W-acidic cargo motif at this topological loca-
tion. This could be sufficient to initiate the induced-fit adaptation
of the TPR domain, which, in turn, may drive destabilization of
ext binding.
Therefore, as well as acting as a component of a pathway to
kinesin-1 activation, our findings also suggest that the intramolecular
interaction between the linker region and KLCTPR may serve to
buffer cargo-binding sensitivity and so provide a point of regulatory
access to control the proper loading and unloading of cargo. It is
conceivable that binding of other proteins or posttranslational
modifications of the light chains could serve to stabilize or destabilize
this self-interacting state and thus regulate cargo-binding properties
of the TPR domain in a spatial and temporal manner.
Materials and Methods
N-terminal TAMRA-conjugated peptides and nonconjugated peptides used
for FP and competition measurements were supplied by Bio-Synthesis. Se-
quences were as follows: SKIPWD, STNLEWDDSAI; LFPpept, DSLDDLFPNEDEQS;
AAApept, DSLDDAAANEDEQS; and JIPC11, YTCPTEDIYLE. Measurements were
performed on a BMG Labtech PolarStar Omega plate reader at 20 °C by
incubating 300 nM TAMRA-labeled peptides with the indicated protein at
increasing concentrations in 25 mM Hepes, pH 7.5, 150 mM NaCl, and 5 mM
β-mercaptoethanol. Estimation of the equilibrium dissociation constant (KD)
for the different peptides was performed assuming a one-site specific-
binding model. For competition experiments, a mixture of TAMRA-LFPpept
and KLC2TPR at 300 nM and 12 μM, respectively, were incubated with in-
creasing concentrations of unlabeled SKIPWD peptide in buffer supple-
mented by 5% (vol/vol) DMSO. The concentration-dependent decrease in FP
signal was fitted to a sigmoidal equation to derive IC50. Analyses and Ki
estimation were performed using the Prism package (GraphPad Software).
All data points are the mean of three replicates.
See SI Materials and Methods for additional materials and methods.
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